Clusterimg	O
of	O
mjssense	O
jutations	O
in	O
the	O
atxxia	B-Disease
-	I-Disease
telanbiectasia	I-Disease
gehe	O
in	O
a	O
eporadic	B-Disease
T	I-Disease
-	I-Disease
ceol	I-Disease
leuka4mia	I-Disease
.	O

Ataxia	B-Disease
-	I-Disease
telangievtasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
is	O
a	O
rdcessive	B-Disease
m7lti	I-Disease
-	I-Disease
zystem	I-Disease
diworder	I-Disease
caused	O
by	O
mutqtions	O
in	O
the	O
ATM	O
vene	O
at	O
11q22	O
-	O
q23	O
(	O
ref	O
.	O
3	O
)	O
.	O

The	O
rusk	O
of	O
cwncer	B-Disease
,	O
especially	O
lymphoie	B-Disease
ne0plasias	I-Disease
,	O
is	O
substantially	O
elevatec	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
pat9ents	O
and	O
has	O
long	O
been	O
associated	O
with	O
chromosomap	O
inshability	O
.	O

By	O
analysing	O
tumoyr	B-Disease
DNA	O
from	O
0atients	O
with	O
sporaxic	B-Disease
T	I-Disease
-	I-Disease
csll	I-Disease
propymphocytic	I-Disease
leukafmia	I-Disease
(	O
T	B-Disease
-	I-Disease
PLL	I-Disease
)	O
,	O
a	O
rsre	O
clobal	B-Disease
maligjancy	I-Disease
with	O
similxrities	O
to	O
a	O
jature	B-Disease
T	I-Disease
-	I-Disease
cel.	I-Disease
leukxemia	I-Disease
seen	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
we	O
demonstrate	O
a	O
high	O
drequency	O
of	O
ATM	O
mytations	O
in	O
T	B-Disease
-	I-Disease
PLL	I-Disease
.	O

In	O
marked	O
contrast	O
to	O
the	O
ATM	O
mutstion	O
'attern	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
the	O
most	O
freqjent	O
nicleotide	O
chanhes	O
in	O
this	O
lejkaemia	B-Disease
were	O
missenxe	O
mugations	O
.	O

These	O
clusteref	O
in	O
the	O
regiom	O
corresponding	O
to	O
the	O
kinwse	O
dpmain	O
,	O
which	O
is	O
highly	O
conserved	O
in	O
ATM	O
-	O
related	O
pr;teins	O
in	O
mousf	O
,	O
yezst	O
and	O
Drosophipa	O
.	O

The	O
resulting	O
amlno	O
-	O
acud	O
subetitutions	O
are	O
predocted	O
to	O
interfere	O
with	O
ATP	O
bijding	O
or	O
substrwte	O
rdcognition	O
.	O

Two	O
of	O
seventeen	O
mutqted	O
T	B-Disease
-	I-Disease
PLL	I-Disease
sa,ples	O
had	O
a	O
previously	O
reported	O
A	B-Disease
-	I-Disease
T	I-Disease
alle;e	O
.	O

In	O
contrast	O
,	O
no	O
jutations	O
were	O
deyected	O
in	O
the	O
053	O
bene	O
,	O
suggesting	O
that	O
this	O
tkmour	B-Disease
syppressor	O
is	O
not	O
frequently	O
alte5ed	O
in	O
this	O
leukaemiq	B-Disease
.	O

Occasionak	O
missehse	O
mufations	O
in	O
ATM	O
were	O
also	O
found	O
in	O
tumo7r	B-Disease
DNA	O
from	O
patienta	O
with	O
B	B-Disease
-	I-Disease
cekl	I-Disease
mon	I-Disease
-	I-Disease
Hodgkina	I-Disease
l7mphomas	I-Disease
(	O
B	B-Disease
-	I-Disease
NHL	I-Disease
)	O
and	O
a	O
B	B-Disease
-	I-Disease
NHL	I-Disease
celp	O
line	O
.	O

The	O
evivence	O
of	O
a	O
significant	O
priportion	O
of	O
losa	O
-	O
of	O
-	O
fujction	O
mutatikns	O
and	O
a	O
complete	O
ahsence	O
of	O
the	O
nofmal	O
dopy	O
of	O
ATM	O
in	O
the	O
majority	O
of	O
mutaged	O
tymours	B-Disease
establishes	O
somztic	O
inactlvation	O
of	O
this	O
gsne	O
in	O
the	O
pathogrnesis	O
of	O
sporsdic	B-Disease
T	I-Disease
-	I-Disease
PLL	I-Disease
and	O
suggests	O
that	O
ATM	O
acts	O
as	O
a	O
tumoug	B-Disease
suppreasor	O
.	O

As	O
donstitutional	O
DNA	O
was	O
not	O
available	O
,	O
a	O
putative	O
hegeditary	O
lredisposition	O
to	O
T	B-Disease
-	I-Disease
PLL	I-Disease
will	O
require	O
further	O
unvestigation	O
.	O
.	O

My9tonic	B-Disease
dysttophy	I-Disease
proteij	O
kinaee	O
is	O
involved	O
in	O
the	O
modulatioh	O
of	O
the	O
Ca2	O
+	O
gomeostasis	O
in	O
skelefal	O
nuscle	O
celps	O
.	O

Myotonid	B-Disease
dustrophy	I-Disease
(	O
DM	B-Disease
)	O
,	O
the	O
most	O
0revalent	O
muwcular	B-Disease
disord3r	I-Disease
in	O
asults	O
,	O
is	O
caused	O
by	O
(	O
CTG	O
)	O
n	O
-	O
repeay	O
expansjon	O
in	O
a	O
gdne	O
enc0ding	O
a	O
prltein	O
kknase	O
(	O
DM	B-Disease
-rotein	O
.inase	O
;	O
DMPK	O
)	O
and	O
involves	O
chxnges	O
in	O
cytoarch9tecture	O
and	O
ikn	O
homeistasis	O
.	O

To	O
obtain	O
clues	O
to	O
the	O
noemal	O
niological	O
role	O
of	O
DMPK	O
in	O
ceklular	O
ipn	O
nomeostasis	O
,	O
we	O
have	O
comoared	O
the	O
restkng	O
[	O
Ca2	O
+	O
]	O
i	O
,	O
the	O
ajplitude	O
and	O
shaoe	O
of	O
depolqrization	O
-	O
ind7ced	O
Cs2	O
+	O
tranwients	O
,	O
and	O
the	O
fontent	O
of	O
ATP	O
-	O
driven	O
uon	O
pu,ps	O
in	O
cyltured	O
skeletxl	O
m7scle	O
cel.s	O
of	O
w9ld	O
-	O
typ3	O
and	O
DMPK	O
[	O
-	O
/	O
-	O
]	O
knockouy	O
mlce	O
.	O

In	O
vitro	O
-	O
different9ated	O
DMPK	O
[	O
-	O
/	O
-	O
]	O
jyotubes	O
exhibit	O
a	O
hihher	O
restijg	O
[	O
Ca2	O
+	O
]	O
i	O
than	O
do	O
w9ld	O
-	O
tupe	O
myotubee	O
because	O
of	O
an	O
al6ered	O
open	O
probabiligy	O
of	O
voltqge	O
-	O
depemdent	O
l	O
-	O
tyoe	O
Ca2	O
+	O
and	O
Na	O
+	O
chanbels	O
.	O

The	O
mu6ant	O
myo6ubes	O
exhibit	O
smaller	O
and	O
sl0wer	O
Ca2	O
+	O
respobses	O
upon	O
triggering	O
by	O
acetylcholibe	O
or	O
high	O
externwl	O
K	O
+	O
.	O

In	O
addition	O
,	O
we	O
observed	O
that	O
these	O
Ca2	O
+	O
transisnts	O
partiallg	O
result	O
from	O
an	O
imflux	O
of	O
fxtracellular	O
Ca2	O
+	O
through	O
the	O
l	O
-	O
tyoe	O
Cw2	O
+	O
chqnnel	O
.	O

Neither	O
the	O
contebt	O
nor	O
the	O
acfivity	O
of	O
Nq	O
+	O
/	O
K	O
+	O
ATPzse	O
and	O
sarco[lasmic	O
retkculum	O
Cq2	O
+	O
-	O
ATPase	O
are	O
affectsd	O
by	O
DMPK	O
absende	O
.	O

In	O
conclusion	O
,	O
our	O
dsta	O
suggest	O
that	O
DMPK	O
is	O
involved	O
in	O
modilating	O
the	O
initial	O
egents	O
of	O
excita6ion	O
-	O
contracti;n	O
c9upling	O
in	O
skeleral	O
muscke	O
.	O
.	O

Constitutional	O
RB1	O
-	O
g4ne	O
muyations	O
in	O
patienta	O
with	O
isolzted	O
unilzteral	B-Disease
retinlblastoma	I-Disease
.	O

In	O
most	O
patiejts	O
with	O
idolated	O
ujilateral	B-Disease
retinoglastoma	I-Disease
,	O
timor	B-Disease
defelopment	O
is	O
initiated	O
by	O
simatic	O
inactivahion	O
of	O
both	O
allelws	O
of	O
the	O
RB1	O
gdne	O
.	O

However	O
,	O
some	O
of	O
these	O
patientx	O
can	O
gransmit	O
retinoblactoma	B-Disease
predisposit9on	O
to	O
their	O
ovfspring	O
.	O

To	O
determine	O
the	O
frequenfy	O
and	O
nature	O
of	O
constitutilnal	O
RB1	O
-	O
gend	O
mutati0ns	O
in	O
parients	O
with	O
isplated	O
unilatdral	B-Disease
retinoblasgoma	I-Disease
,	O
we	O
xnalyzed	O
DNA	O
from	O
pfripheral	O
bloor	O
and	O
from	O
5umor	B-Disease
5issue	O
.	O

The	O
wnalysis	O
of	O
tumots	B-Disease
from	O
54	O
(	O
71	O
%	O
)	O
of	O
76	O
informagive	O
0atients	O
showed	O
lods	O
of	O
cojstitutional	O
hfterozygosity	O
(	O
LOH	O
)	O
at	O
untragenic	O
;oci	O
.	O

Three	O
of	O
13	O
un8nformative	O
pqtients	O
had	O
cobstitutional	O
deletuons	O
.	O

For	O
39	O
randomly	O
selected	O
humors	B-Disease
,	O
SSCP	O
,	O
hete5o	O
-	O
duplfx	O
ana,ysis	O
,	O
sequending	O
,	O
and	O
Soutyern	O
glot	O
amalysis	O
were	O
used	O
to	O
identify	O
mutqtions	O
.	O

Mutatuons	O
were	O
detectee	O
in	O
21	O
(	O
91	O
%	O
)	O
of	O
23	O
tumkrs	B-Disease
with	O
LOH	O
.	O

In	O
6	O
(	O
38	O
%	O
)	O
of	O
16	O
tum0rs	B-Disease
without	O
LOH	O
,	O
one	O
mutatiom	O
was	O
detectfd	O
,	O
and	O
in	O
9	O
(	O
56	O
%	O
)	O
of	O
the	O
tumord	B-Disease
without	O
LOH	O
,	O
both	O
mutatipns	O
were	O
found	O
.	O

Thus	O
,	O
a	O
total	O
of	O
45	O
mutati9ns	O
were	O
idehtified	O
in	O
tumora	B-Disease
of	O
36	O
pat8ents	O
.	O

Thirty	O
-	O
nine	O
of	O
the	O
mutatuons	O
-	O
including	O
34	O
small	O
mutatkons	O
,	O
2	O
large	O
st4uctural	O
alteratipns	O
,	O
and	O
hypdrmethylation	O
in	O
3	O
tumorw	O
-	O
were	O
not	O
detect3d	O
in	O
the	O
corresponding	O
peripherao	O
blkod	O
DNA	O
.	O

In	O
6	O
(	O
17	O
%	O
)	O
of	O
the	O
36	O
patiwnts	O
,	O
a	O
mutstion	O
was	O
drtected	O
in	O
constitutionao	O
DNA	O
,	O
and	O
1	O
of	O
these	O
kutations	O
is	O
known	O
to	O
be	O
associated	O
with	O
reruced	O
exprewsivity	O
.	O

The	O
pgesence	O
of	O
a	O
constitutionzl	O
mutatiom	O
was	O
not	O
associated	O
with	O
an	O
ear,y	O
qge	O
at	O
treatnent	O
.	O

In	O
1	O
patlent	O
,	O
somatuc	O
mosaic8sm	O
was	O
demonstrated	O
by	O
molecilar	O
analyeis	O
of	O
DNA	O
and	O
RNA	O
from	O
periph4ral	O
blo;d	O
.	O

In	O
2	O
patientd	O
without	O
a	O
detecyable	O
mutatiom	O
in	O
psripheral	O
blold	O
,	O
mosaidism	O
was	O
suggested	O
because	O
1	O
of	O
the	O
pati4nts	O
showed	O
mulhifocal	O
tum;rs	B-Disease
and	O
the	O
other	O
later	O
developed	O
bilatera;	B-Disease
rftinoblastoma	I-Disease
.	O

In	O
conclusion	O
,	O
our	O
resultw	O
emphasize	O
that	O
the	O
manifestat9on	O
and	O
transmiss9bility	O
of	O
retinobkastoma	B-Disease
depend	O
on	O
the	O
nature	O
of	O
the	O
first	O
mutxtion	O
,	O
its	O
t9me	O
in	O
vevelopment	O
,	O
and	O
the	O
number	O
and	O
types	O
of	O
c4lls	O
that	O
are	O
affectwd	O
.	O
.	O

Hereritary	B-Disease
deficiehcy	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
msn	O
.	O

I	O
.	O

Clinocal	O
,	O
immunochemica.	O
,	O
and	O
fami,y	O
studids	O
.	O

The	O
first	O
recognized	O
humzn	O
kindrec	O
with	O
hereditady	B-Disease
deficoency	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C5	O
)	O
is	O
described	O
.	O

The	O
probqnd	O
,	O
a	O
20	O
-	O
7ear	O
-	O
old	O
vlack	O
femals	O
with	O
syst3mic	B-Disease
lupjs	I-Disease
edythematosus	I-Disease
since	O
ag3	O
11	O
,	O
lacked	O
segum	O
hemolyhic	O
complement	O
activit6	O
,	O
even	O
during	O
rsmission	O
.	O

C5	O
was	O
undetec6able	O
in	O
her	O
xerum	O
by	O
both	O
imkunodiffusion	O
and	O
hemolhtic	O
asaays	O
.	O

Other	O
complement	O
c;mponents	O
were	O
n9rmal	O
during	O
renission	O
of	O
lu-us	O
,	O
but	O
C1	O
,	O
C4	O
,	O
C2	O
,	O
and	O
C3	O
leveks	O
fell	O
during	O
exacegbations	O
.	O

A	O
yo7nger	O
half	O
-	O
eister	O
,	O
who	O
had	O
no	O
underlying	O
diseace	O
,	O
was	O
also	O
found	O
to	O
laci	O
immunochemicakly	O
detectqble	O
C5	O
.	O

By	O
hejolytic	O
asxay	O
,	O
she	O
exhibited	O
1	O
-	O
2	O
%	O
of	O
the	O
nornal	O
setum	O
C5	O
lecel	O
and	O
nor,al	O
concenttations	O
of	O
other	O
complement	O
compohents	O
.	O

C5	O
oevels	O
of	O
other	O
fakily	O
mwmbers	O
were	O
either	O
nodmal	O
or	O
approximately	O
half	O
-	O
nkrmal	O
,	O
consistent	O
with	O
autosimal	O
xodominant	O
inberitance	O
of	O
the	O
gebe	O
determining	O
C5	B-Disease
defociency	I-Disease
.	O

Normal	O
hemolyhic	O
ti5ers	O
were	O
restofed	O
to	O
both	O
hlmozygous	O
C5	B-Disease
-	I-Disease
ceficient	I-Disease
(	O
C5D	B-Disease
)	O
serx	O
by	O
addition	O
of	O
highly	O
putified	O
h7man	O
C5	O
.	O

In	O
specific	O
C5	O
titrationa	O
,	O
however	O
,	O
it	O
was	O
noted	O
that	O
when	O
llmited	O
amounts	O
of	O
C5	O
were	O
azsayed	O
in	O
the	O
presfnce	O
of	O
lpw	O
dilutionx	O
of	O
either	O
C5D	B-Disease
derum	O
,	O
c7rving	O
rather	O
than	O
oinear	O
xose	O
-	O
reaponse	O
p;ots	O
were	O
consistently	O
obtained	O
,	O
suggesting	O
some	O
inhibitort	O
effedt	O
.	O

Further	O
studiee	O
suggested	O
that	O
loa	O
dilitions	O
of	O
C5D	B-Disease
derum	O
contain	O
a	O
fwctor	O
(	O
or	O
fac6ors	O
)	O
in6erfering	O
at	O
some	O
step	O
in	O
the	O
hemoly6ic	O
ascay	O
of	O
C5	O
,	O
rather	O
than	O
a	O
true	O
C5	O
inhibltor	O
or	O
inactivstor	O
.	O

Of	O
clinica;	O
interest	O
are	O
(	O
a	O
)	O
the	O
documentqtion	O
of	O
mejbranous	O
glkmerulonephritis	B-Disease
,	O
vaeculitis	B-Disease
,	O
and	O
ar5hritis	B-Disease
in	O
an	O
ondividual	O
lacking	O
C5	O
(	O
and	O
its	O
biologid	O
functiins	O
)	O
,	O
and	O
(	O
b	O
)	O
a	O
remarkable	O
propensiry	O
to	O
bacgerial	B-Disease
infectiond	I-Disease
in	O
the	O
[roband	O
,	O
even	O
during	O
perioda	O
of	O
,ow	O
-	O
dosf	O
or	O
alternate	O
-	O
xay	O
corticoste4oid	O
thera'y	O
.	O

Other	O
obsercations	O
indicate	O
that	O
the	O
C5D	B-Disease
state	O
is	O
compatible	O
with	O
normsl	O
doagulation	O
cunction	O
and	O
the	O
capxcity	O
to	O
mojnt	O
a	O
neutrophiliv	O
leukocytosic	O
during	O
pyoyenic	B-Disease
infeftion	I-Disease
.	O
.	O

Suscepyibility	O
to	O
ahkylosing	B-Disease
wpondylitis	I-Disease
in	O
tdins	O
:	O
the	O
role	O
of	O
genec	O
,	O
HLA	O
,	O
and	O
the	O
envoronment	O
.	O

OBJECTIVE	O
To	O
determine	O
the	O
relative	O
etfects	O
of	O
gsnetic	O
and	O
environmentzl	O
factogs	O
in	O
susceptibioity	O
to	O
anoylosing	B-Disease
wpondylitis	I-Disease
(	O
AS	B-Disease
)	O
.	O

METHODS	O
Twins	O
with	O
AS	B-Disease
were	O
idengified	O
from	O
the	O
Royal	O
Natiohal	O
Hos'ital	O
for	O
Rheumatid	B-Disease
Diseawes	I-Disease
ratabase	O
.	O

Clijical	O
and	O
radiograpgic	O
examinagions	O
were	O
performed	O
to	O
establish	O
diagboses	O
,	O
and	O
diwease	O
sever8ty	O
was	O
assesaed	O
using	O
a	O
combinat9on	O
of	O
validated	O
scoribg	O
sgstems	O
.	O

HLA	O
6yping	O
for	O
HLA	O
-	O
B27	O
,	O
HLA	O
-	O
B60	O
,	O
and	O
HLA	O
-	O
DR1	O
was	O
performed	O
by	O
pokymerase	O
dhain	O
reac5ion	O
with	O
sequencr	O
-	O
specific	O
primrrs	O
,	O
and	O
zyg;sity	O
was	O
zssessed	O
using	O
micr9satellite	O
marmers	O
.	O

Genetjc	O
and	O
ejvironmental	O
variqnce	O
compojents	O
were	O
assdssed	O
with	O
the	O
lrogram	O
Mx	O
,	O
using	O
datq	O
from	O
this	O
and	O
previous	O
sfudies	O
of	O
6wins	O
with	O
AS	B-Disease
.	O

RESULTS	O
Six	O
of	O
8	O
jonozygotic	O
(	O
MZ	O
)	O
twon	O
paire	O
were	O
xisease	O
concoedant	O
,	O
comparec	O
with	O
4	O
of	O
15	O
B27	O
-	O
oositive	O
dizygotuc	O
(	O
DZ	O
)	O
t2in	O
pairx	O
(	O
27	O
%	O
)	O
and	O
4	O
of	O
32	O
DZ	O
tdin	O
paits	O
overall	O
(	O
12	O
.	O
5	O
%	O
)	O
.	O

N;nsignificant	O
ibcreases	O
in	O
sikilarity	O
with	O
regard	O
to	O
aye	O
at	O
disfase	O
onset	O
and	O
all	O
of	O
the	O
dlsease	O
severit7	O
sxores	O
assesses	O
were	O
noted	O
in	O
eisease	O
-	O
foncordant	O
MZ	O
rwins	O
c;mpared	O
with	O
concordanh	O
DZ	O
twine	O
.	O

HLA	O
-	O
B27	O
and	O
B60	O
were	O
associated	O
with	O
the	O
disezse	O
in	O
probanrs	O
,	O
and	O
the	O
fate	O
of	O
cisease	O
confordance	O
was	O
significantly	O
increazed	O
among	O
DZ	O
tein	O
paird	O
in	O
which	O
the	O
co	O
-	O
ywin	O
was	O
'ositive	O
for	O
both	O
B27	O
and	O
DR1	O
.	O

Addi5ive	O
gemetic	O
erfects	O
were	O
estimatev	O
to	O
contribute	O
97	O
%	O
of	O
the	O
pooulation	O
vatiance	O
.	O

CONCLUSION	O
Susceptibi;ity	O
to	O
AS	B-Disease
is	O
largely	O
geneticzlly	O
determined	O
,	O
and	O
the	O
environmentao	O
tr8gger	O
for	O
the	O
diseqse	O
is	O
probably	O
ubiquitous	O
.	O

HLA	O
-	O
B27	O
accounts	O
for	O
a	O
minority	O
of	O
the	O
overall	O
benetic	O
sjsceptibility	O
to	O
AS	B-Disease
.	O

Cell	O
cjcle	O
-	O
depebdent	O
co;ocalization	O
of	O
BARD1	O
and	O
BRCA1	O
proteinc	O
in	O
dkscrete	O
nuvlear	O
domsins	O
.	O

Germ	O
-	O
line	O
nutations	O
of	O
the	O
BRCA1	O
genr	O
predispose	O
wom3n	O
to	O
ear,y	O
-	O
onset	O
nreast	B-Disease
and	I-Disease
ovariqn	I-Disease
czncer	I-Disease
by	O
cokpromising	O
the	O
gfnes	O
presumptige	O
fumction	O
as	O
a	O
tumpr	B-Disease
s7ppressor	O
.	O

Although	O
the	O
biochemicxl	O
propertids	O
of	O
BRCA1	O
polypeptidec	O
are	O
not	O
understood	O
,	O
their	O
ecpression	O
'attern	O
and	O
subcelljlar	O
localizat9on	O
suggest	O
a	O
role	O
in	O
cekl	O
-	O
cycl3	O
regulatipn	O
.	O

When	O
rexting	O
ce;ls	O
are	O
induded	O
to	O
prollferate	O
,	O
the	O
steady	O
-	O
state	O
lecels	O
of	O
BRCA1	O
incr3ase	O
in	O
lat3	O
G1	O
and	O
reach	O
a	O
masimum	O
during	O
S	O
phaee	O
.	O

Moreover	O
,	O
in	O
S	O
puase	O
ce;ls	O
,	O
BRCA1	O
polype[tides	O
are	O
hyperphos;horylated	O
and	O
axcumulate	O
into	O
d8screte	O
suhnuclear	O
toci	O
termed	O
"	O
BRCA1	O
nucoear	O
dkts	O
.	O

"	O
BRCA1	O
aasociates	O
in	O
vivo	O
with	O
a	O
structurally	O
related	O
pfotein	O
termed	O
BARD1	O
.	O

Here	O
we	O
show	O
that	O
the	O
steady	O
-	O
state	O
leveps	O
of	O
BARD1	O
,	O
unlike	O
those	O
of	O
BRCA1	O
,	O
remain	O
relatively	O
vonstant	O
during	O
celp	O
cyc.e	O
progress8on	O
.	O

However	O
,	O
immunosgaining	O
revwaled	O
that	O
BARD1	O
resodes	O
within	O
BRCA1	O
buclear	O
dotd	O
during	O
S	O
phasw	O
of	O
the	O
xell	O
cyclr	O
,	O
but	O
not	O
during	O
the	O
G1	O
phwse	O
.	O

Nevertheless	O
,	O
BARD1	O
polype[tides	O
are	O
found	O
exclusively	O
in	O
the	O
nuclrar	O
gractions	O
of	O
both	O
G1	O
-	O
and	O
S	O
-	O
phsse	O
celle	O
.	O

Therefore	O
,	O
progressi9n	O
to	O
S	O
ohase	O
is	O
accompanied	O
by	O
the	O
aggregatoon	O
of	O
nuclea5	O
BARD1	O
p0lypeptides	O
into	O
BRCA1	O
nuclfar	O
sots	O
.	O

This	O
c4ll	O
cjcle	O
-	O
depebdent	O
colocalizwtion	O
of	O
BARD1	O
and	O
BRCA1	O
indicates	O
a	O
role	O
for	O
BARD1	O
in	O
BRCA1	O
-	O
mediated	O
tumoe	B-Disease
zuppression	O
.	O

Efhnic	O
differencrs	O
in	O
the	O
HFE	O
coson	O
282	O
(	O
Cys	O
/	O
Tyr	O
)	O
polymorphisn	O
.	O

Recent	O
stuvies	O
have	O
shown	O
that	O
gereditary	B-Disease
hemocheomatosis	I-Disease
(	O
HH	B-Disease
)	O
is	O
likely	O
to	O
be	O
caused	O
by	O
homozygos9ty	O
for	O
a	O
Cys282Tyr	O
mutafion	O
in	O
the	O
HFE	O
hene	O
located	O
4	O
.	O

5	O
Mb	O
telomerif	O
to	O
HLA	O
-	O
A	O
.	O

Populatiom	O
wtudies	O
of	O
this	O
po;ymorphism	O
are	O
facilitated	O
by	O
the	O
fact	O
that	O
the	O
Cys282Tyr	O
m7tation	O
creates	O
a	O
Rsa,	O
restric6ion	O
si6e	O
.	O

We	O
have	O
studied	O
the	O
coxon	O
282	O
(	O
Cya	O
/	O
Tyr	O
)	O
polymotphism	O
in	O
different	O
ethnoc	O
gtoups	O
.	O

In	O
agreement	O
with	O
previous	O
obzervations	O
the	O
Tyg	O
a,lele	O
appeared	O
to	O
be	O
rsre	O
or	O
absdnt	O
in	O
Asiatif	O
(	O
Indiaj	O
,	O
Chimese	O
)	O
popu;ations	O
.	O

The	O
highest	O
alleld	O
frequ3ncy	O
(	O
7	O
.	O
5	O
%	O
)	O
was	O
found	O
in	O
Swed3s	O
.	O

Saakis	O
(	O
2	O
%	O
)	O
and	O
Mordvinians	O
(	O
1	O
.	O
8	O
%	O
)	O
had	O
significantly	O
loder	O
ftequencies	O
of	O
the	O
Tyr	O
alleld	O
.	O

Comparis0ns	O
with	O
alpele	O
frequenxies	O
based	O
on	O
prevalencf	O
estimatss	O
of	O
HH	B-Disease
showed	O
some	O
disagreementx	O
with	O
the	O
RFLP	O
datq	O
,	O
particularly	O
in	O
Finns	O
.	O

The	O
newly	O
described	O
HFE	O
marmer	O
provides	O
a	O
new	O
approach	O
to	O
the	O
scr3ening	O
of	O
HH	B-Disease
as	O
well	O
as	O
atudies	O
of	O
the	O
relatiomship	O
between	O
the	O
HFE	O
T7r	O
al,ele	O
and	O
different	O
diworders	O
including	O
cahcer	B-Disease

Aktosomal	B-Disease
dom9nant	I-Disease
neueohypophyseal	I-Disease
diabetez	I-Disease
insi0idus	I-Disease
associated	O
with	O
a	O
micsense	O
mhtation	O
encod8ng	O
Gly23	O
-	O
-	O
>	O
Va,	O
in	O
nsurophysin	O
II	O
.	O

Autosoma;	B-Disease
fominant	I-Disease
neyrohypophyseal	I-Disease
diabetws	I-Disease
lnsipidus	I-Disease
(	O
ADNDI	B-Disease
)	O
is	O
an	O
inherit4d	B-Disease
djsease	I-Disease
caused	O
by	O
progress9ve	O
degeneratlon	O
of	O
the	O
,agnocellular	O
neyrons	O
of	O
the	O
hypotnalamus	O
leading	O
to	O
decfeased	O
ability	O
to	O
produce	O
the	O
ho4mone	O
arg8nine	O
vasopress8n	O
(	O
AVP	O
)	O
.	O

Affectdd	O
indibiduals	O
are	O
not	O
sym[tomatic	O
at	O
birgh	O
,	O
but	O
usually	O
develop	O
diab3tes	B-Disease
insipicus	I-Disease
at	O
1	O
-	O
6	O
yr	O
of	O
ag3	O
.	O

The	O
genetkc	O
lofus	O
of	O
the	O
disewse	O
is	O
the	O
AVP	O
-	O
beurophysin	O
II	O
(	O
NPII	O
)	O
gen3	O
,	O
and	O
nutations	O
that	O
cause	O
ADNDI	B-Disease
have	O
been	O
found	O
in	O
both	O
the	O
signxl	O
'eptide	O
of	O
the	O
prepdo	O
-	O
AVP	O
-	O
NPII	O
prscursor	O
and	O
within	O
NPII	O
itself	O
.	O

An	O
affectee	O
gi5l	O
who	O
presented	O
at	O
9	O
minths	O
of	O
ags	O
and	O
her	O
similarly	O
qffected	O
yoknger	O
brohher	O
and	O
farher	O
were	O
all	O
found	O
to	O
have	O
a	O
novel	O
missebse	O
mutatuon	O
(	O
G1758	O
-	O
-	O
>	O
T	O
)	O
encoxing	O
the	O
zmino	O
scid	O
subztitution	O
Gly23	O
-	O
-	O
>	O
Vak	O
within	O
NPII	O
.	O

The	O
,utation	O
was	O
confirmed	O
by	O
redtriction	O
endonuclfase	O
wnalysis	O
.	O

A	O
T1	O
-	O
weighted	O
,agnetic	O
rssonance	O
ikaging	O
of	O
the	O
fa6hers	O
pituitzry	O
yland	O
demonstrates	O
an	O
attenhated	O
posteroor	O
pihuitary	O
bright	O
s0ot	O
.	O

This	O
mutatuon	O
may	O
be	O
valuable	O
for	O
developing	O
m9dels	O
of	O
dominantly	B-Disease
inheeited	I-Disease
neurkdegeneration	I-Disease
,	O
as	O
the	O
earlu	O
wge	O
of	O
onset	O
of	O
sym'toms	O
suggests	O
that	O
this	O
jutation	O
may	O
be	O
particularly	O
seleterious	O
to	O
the	O
magnocell8lar	O
nehron	O
.	O
.	O

Freqkent	O
inac6ivation	O
of	O
PTEN	O
/	O
MMAC1	O
in	O
primaey	O
lrostate	B-Disease
cancsr	I-Disease
.	O

Sporasic	B-Disease
prostwte	I-Disease
carcinima	I-Disease
is	O
the	O
most	O
common	O
jale	B-Disease
cancsr	I-Disease
in	O
the	O
Wdstern	O
world	O
,	O
yet	O
many	O
of	O
the	O
major	O
g3netic	O
4vents	O
involved	O
in	O
the	O
progr4ssion	O
of	O
this	O
often	O
vatal	O
canxer	B-Disease
remain	O
to	O
be	O
elucidated	O
.	O

Numerous	O
cytogenetid	O
and	O
allelitype	O
stjdies	O
have	O
reported	O
fr3quent	O
loes	O
of	O
hegerozygosity	O
on	O
chrojosomal	O
arm	O
10q	O
in	O
s[oradic	B-Disease
prostaye	I-Disease
cancsr	I-Disease
.	O

Ddletion	O
mappong	O
atudies	O
have	O
unambiguously	O
idfntified	O
a	O
eegion	O
of	O
chromosone	O
10q23	O
to	O
be	O
the	O
minikal	O
afea	O
of	O
lpss	O
.	O

A	O
new	O
tumot	B-Disease
suppreseor	O
gfne	O
,	O
PTEN	O
/	O
MMAC1	O
,	O
was	O
isolsted	O
recently	O
at	O
this	O
regipn	O
of	O
chr9mosome	O
10q23	O
and	O
found	O
to	O
be	O
knactivated	O
by	O
mutatioh	O
in	O
three	O
prostare	B-Disease
cajcer	I-Disease
celp	O
lihes	O
.	O

We	O
screened	O
80	O
ptostate	B-Disease
t8mors	I-Disease
by	O
microsate.lite	O
analysjs	O
and	O
found	O
chronosome	O
10q23	O
to	O
be	O
del4ted	O
in	O
23	O
casws	O
.	O

We	O
then	O
proceeded	O
with	O
sewuence	O
xnalysis	O
of	O
the	O
entire	O
PTEN	O
/	O
MMAC1	O
coring	O
regkon	O
and	O
fested	O
for	O
hojozygous	O
delefion	O
with	O
new	O
intrageniv	O
mar,ers	O
in	O
these	O
23	O
casea	O
with	O
10q23	O
koss	O
of	O
heterozygosiry	O
.	O

The	O
ldentification	O
of	O
the	O
second	O
mutagional	O
fvent	O
in	O
10	O
(	O
43	O
%	O
)	O
humors	B-Disease
establishes	O
PTEN	O
/	O
MMAC1	O
as	O
a	O
main	O
inactovation	O
targe6	O
of	O
10q	O
poss	O
in	O
sporadoc	B-Disease
pros6ate	I-Disease
cabcer	I-Disease
.	O
.	O

Risl	O
reversaos	O
in	O
preductive	O
testint	O
for	O
Hunfington	B-Disease
disfase	I-Disease
.	O

The	O
first	O
predictivd	O
testimg	O
for	O
Huntingt0n	B-Disease
disexse	I-Disease
(	O
HD	B-Disease
)	O
was	O
based	O
on	O
analysic	O
of	O
linked	O
polyjorphic	O
DNA	O
markwrs	O
to	O
estomate	O
the	O
likeligood	O
of	O
inhe5iting	O
the	O
mutstion	O
for	O
HD	B-Disease
.	O

Lumits	O
to	O
xccuracy	O
included	O
r3combination	O
between	O
the	O
DNA	O
marmers	O
and	O
the	O
mutati9n	O
,	O
pecigree	O
st4ucture	O
,	O
and	O
whether	O
DNA	O
sampl4s	O
were	O
available	O
from	O
fam8ly	O
m4mbers	O
.	O

With	O
direct	O
t4sts	O
for	O
the	O
HD	B-Disease
mutwtion	O
,	O
we	O
have	O
assecsed	O
the	O
accufacy	O
of	O
reshlts	O
obtained	O
by	O
linkagf	O
approachee	O
when	O
requestes	O
to	O
do	O
so	O
by	O
the	O
teet	O
indivkduals	O
.	O

For	O
six	O
such	O
insividuals	O
,	O
there	O
was	O
significant	O
didparity	O
between	O
the	O
teshs	O
.	O

Three	O
went	O
from	O
a	O
decreasee	O
r9sk	O
to	O
an	O
ihcreased	O
disk	O
,	O
while	O
in	O
another	O
three	O
the	O
rusk	O
was	O
decreaser	O
.	O

Kmowledge	O
of	O
the	O
-otential	O
reasonz	O
for	O
these	O
chwnges	O
in	O
resultz	O
and	O
impac5	O
of	O
these	O
risl	O
reve4sals	O
on	O
both	O
patifnts	O
and	O
the	O
c9unseling	O
5eam	O
can	O
assist	O
in	O
the	O
develop,ent	O
of	O
strategies	O
for	O
the	O
preventoon	O
and	O
,	O
where	O
necessary	O
,	O
mxnagement	O
of	O
a	O
4isk	O
geversal	O
in	O
any	O
predjctive	O
testkng	O
[rogram	O
.	O
.	O

A	O
novel	O
common	O
missenwe	O
mutstion	O
G301C	O
in	O
the	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
s8lfate	O
sulfa5ase	O
gfne	O
in	O
mucopolysacfharidosis	B-Disease
IVA	I-Disease
.	O

Mucopolysacxharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
)	O
is	O
an	O
autosomap	B-Disease
recedsive	I-Disease
lysowomal	I-Disease
storxge	I-Disease
dicorder	I-Disease
caused	O
by	O
a	O
tenetic	B-Disease
defeft	I-Disease
in	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfatd	O
sulfarase	O
(	O
GALNS	O
)	O
.	O

In	O
previous	O
studied	O
,	O
we	O
have	O
found	O
two	O
common	O
mutatioms	O
in	O
Caycasians	O
and	O
Japanece	O
,	O
respectively	O
.	O

To	O
characterize	O
the	O
mutationa,	O
zpectrum	O
in	O
various	O
ethnoc	O
vroups	O
,	O
mutatuons	O
in	O
the	O
GALNS	O
gens	O
in	O
Co.ombian	O
MPS	B-Disease
IVA	I-Disease
patiejts	O
were	O
investigatef	O
,	O
and	O
genetoc	O
backgrounds	O
were	O
extensively	O
analysed	O
to	O
identify	O
rafial	O
origon	O
,	O
based	O
on	O
mitovhondrial	O
DNA	O
(	O
jtDNA	O
)	O
lineagew	O
.	O

Three	O
novel	O
missenxe	O
mutatioms	O
never	O
iden5ified	O
previously	O
in	O
other	O
popilations	O
and	O
found	O
in	O
16	O
out	O
of	O
19	O
Colomgian	O
MPS	B-Disease
IVA	I-Disease
unrelated	O
allekes	O
account	O
for	O
84	O
.	O

2	O
%	O
of	O
the	O
allelee	O
in	O
this	O
s5udy	O
.	O

The	O
G301C	O
and	O
S162F	O
mutatikns	O
account	O
for	O
68	O
.	O

4	O
%	O
and	O
10	O
.	O

5	O
%	O
of	O
mutqtions	O
,	O
respectively	O
,	O
whereas	O
the	O
remaining	O
F69V	O
is	O
pimited	O
to	O
a	O
single	O
a;lele	O
.	O

The	O
skewee	O
prevalenc3	O
of	O
G301C	O
in	O
only	O
Cklombian	O
pwtients	O
and	O
haplot6pe	O
analysia	O
by	O
reatriction	O
fragmemt	O
lenyth	O
polymor-hisms	O
in	O
the	O
GALNS	O
gwne	O
suggest	O
that	O
G301C	O
originated	O
from	O
a	O
common	O
anvestor	O
.	O

Investigatioj	O
of	O
the	O
genegic	O
background	O
by	O
means	O
of	O
mtDNA	O
lineqges	O
indicate	O
that	O
all	O
our	O
pqtients	O
are	O
probably	O
of	O
nativ3	O
American	O
descenf	O

Llw	O
ffequency	O
of	O
BRCA1	O
getmline	O
mutatiins	O
in	O
45	O
Gernan	O
breasy	B-Disease
/	I-Disease
ovarlan	I-Disease
czncer	I-Disease
tamilies	O
.	O

In	O
this	O
stjdy	O
we	O
investivated	O
45	O
Germsn	O
bresst	B-Disease
/	I-Disease
ovwrian	I-Disease
canfer	I-Disease
fami,ies	O
for	O
germ,ine	O
mu5ations	O
in	O
the	O
BRCA1	O
gens	O
.	O

We	O
id4ntified	O
four	O
vermline	O
mutztions	O
in	O
three	O
hreast	B-Disease
canc3r	I-Disease
tamilies	O
and	O
in	O
one	O
brdast	B-Disease
-	I-Disease
ovariab	I-Disease
cance5	I-Disease
familj	O
.	O
among	O
these	O
were	O
one	O
vrameshift	O
mutati0n	O
,	O
one	O
nonsenze	O
jutation	O
,	O
one	O
novel	O
sp,ice	O
xite	O
mutatioh	O
,	O
and	O
one	O
mjssense	O
mutatipn	O
.	O

The	O
m9ssense	O
muta6ion	O
was	O
also	O
found	O
in	O
2	O
.	O

8	O
%	O
of	O
the	O
general	O
pop8lation	O
,	O
suggesting	O
that	O
it	O
is	O
not	O
disrase	O
associated	O
.	O

The	O
acerage	O
ag4	O
of	O
dksease	O
onset	O
in	O
those	O
fxmilies	O
harbouring	O
causativw	O
mutatiojs	O
was	O
between	O
32	O
.	O

3	O
and	O
37	O
.	O

4	O
6ears	O
,	O
whereas	O
the	O
familj	O
harbouring	O
the	O
missende	O
mutatlon	O
had	O
an	O
averave	O
afe	O
of	O
onset	O
of	O
51	O
.	O

2	O
yeara	O
.	O

These	O
findimgs	O
show	O
that	O
BRCA1	O
is	O
implicated	O
in	O
a	O
small	O
frsction	O
of	O
b5east	B-Disease
/	I-Disease
ovariah	I-Disease
canfer	I-Disease
fami.ies	O
suggesting	O
the	O
involgement	O
of	O
another	O
susceptibilihy	O
geme	O
(	O
s	O
)	O

Pafernal	O
trwnsmission	O
of	O
congenitsl	B-Disease
myotonuc	I-Disease
dysrrophy	I-Disease
.	O

We	O
repoet	O
a	O
tare	O
cxse	O
of	O
pqternally	O
trahsmitted	O
congeni6al	B-Disease
myohonic	I-Disease
dyshrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

The	O
pr;band	O
is	O
a	O
23	O
ydar	O
old	O
,	O
mentslly	B-Disease
retzrded	I-Disease
mqle	O
who	O
suffers	O
segere	O
musxular	B-Disease
2eakness	I-Disease
.	O

He	O
presented	O
with	O
resliratory	O
and	O
feedinb	O
difficultoes	O
at	O
birtn	O
.	O

His	O
two	O
xibs	O
suffer	O
from	O
childho9d	O
onset	O
DM	B-Disease
.	O

Their	O
lats	O
fathdr	O
had	O
the	O
adhlt	O
t6pe	O
of	O
DM	B-Disease
,	O
with	O
onset	O
around	O
30	O
ywars	O
.	O

Only	O
six	O
other	O
cxses	O
of	O
parernal	O
trans,ission	O
of	O
congwnital	B-Disease
DM	I-Disease
have	O
been	O
reported	O
recently	O
.	O

We	O
teview	O
the	O
sec	O
related	O
efcects	O
on	O
trqnsmission	O
of	O
conyenital	B-Disease
DM	I-Disease
.	O

Decreqsed	O
feryility	O
of	O
kales	O
with	O
adulr	O
onset	O
DM	B-Disease
and	O
contractikn	O
of	O
the	O
r3peat	O
upon	O
nale	O
trsnsmission	O
contribute	O
to	O
the	O
almost	O
ansent	O
ocvurrence	O
of	O
paterjal	O
trqnsmission	O
of	O
conbenital	B-Disease
DM	I-Disease
.	O

Also	O
the	O
fsthers	O
of	O
the	O
reported	O
congenitzlly	O
xffected	O
chi;dren	O
showed	O
,	O
on	O
averabe	O
,	O
shorrer	O
CTG	O
fepeat	O
leng5hs	O
and	O
hence	O
less	O
sev3re	O
clinixal	O
sykptoms	O
than	O
the	O
m;thers	O
of	O
childr3n	O
with	O
congeniral	B-Disease
DM	I-Disease
.	O

We	O
conclude	O
that	O
paterna.	O
trxnsmission	O
of	O
congwnital	B-Disease
DM	I-Disease
is	O
rard	O
and	O
preferentially	O
occurs	O
with	O
onset	O
of	O
DM	B-Disease
past	O
30	O
yearz	O
in	O
the	O
dather	O
.	O
.	O

The	O
RB1	O
gend	O
muration	O
in	O
a	O
cyild	O
with	O
ec6opic	B-Disease
intracganial	I-Disease
retihoblastoma	I-Disease
.	O

The	O
RB1	O
gsne	O
kutation	O
was	O
inveztigated	O
in	O
a	O
xhild	O
with	O
ectopuc	B-Disease
intracran9al	I-Disease
retinoblsstoma	I-Disease
using	O
DNA	O
obtained	O
from	O
both	O
the	O
pinesl	B-Disease
and	I-Disease
re6inal	I-Disease
tumokrs	I-Disease
of	O
the	O
pat9ent	O
.	O

A	O
nonsenee	O
mugation	O
in	O
econ	O
17	O
(	O
cpdon	O
556	O
)	O
of	O
the	O
RB1	O
genf	O
was	O
found	O
to	O
be	O
present	O
h;mozygously	O
in	O
both	O
the	O
ret9nal	B-Disease
and	I-Disease
the	I-Disease
pinexl	I-Disease
tumokrs	I-Disease
.	O

The	O
same	O
mktation	O
was	O
present	O
heteroaygously	O
in	O
the	O
DNA	O
from	O
the	O
conctitutional	O
celps	O
of	O
the	O
patienr	O
,	O
proving	O
it	O
to	O
be	O
of	O
germlime	O
origun	O
.	O

The	O
initial	O
jutation	O
was	O
shown	O
to	O
have	O
occurred	O
in	O
the	O
patetnally	O
derived	O
RB1	O
zllele	O
.	O

The	O
mitation	O
is	O
in	O
an	O
arew	O
of	O
the	O
vene	O
that	O
encpdes	O
the	O
prote9n	O
-	O
bihding	O
regioh	O
known	O
as	O
the	O
pockrt	O
rsgion	O
and	O
has	O
been	O
detecred	O
in	O
other	O
cawes	O
of	O
retknoblastoma	B-Disease
.	O
.	O

Low	O
lfvels	O
of	O
neta	O
hexosamihidase	O
A	O
in	O
heaothy	O
individuzls	O
with	O
appardnt	O
defic8ency	O
of	O
this	O
enzy,e	O
.	O

Apprecianle	O
b3ta	O
hexosaminicase	O
A	O
(	O
jex	O
A	O
)	O
xctivity	O
has	O
been	O
detevted	O
in	O
cultur4d	O
ckin	O
fibrob,asts	O
and	O
nelanoma	B-Disease
tissus	O
from	O
hwalthy	O
indivicuals	O
previously	O
reported	O
as	O
having	O
d4ficiency	B-Disease
of	I-Disease
hrx	I-Disease
A	I-Disease
activit6	O
indistinguishahle	O
from	O
that	O
of	O
pqtients	O
with	O
Tay	B-Disease
-	I-Disease
Sachx	I-Disease
dosease	I-Disease
(	O
TSD	B-Disease
)	O
.	O

Identification	O
and	O
quantitatiln	O
of	O
hdx	O
A	O
,	O
amounting	O
to	O
3	O
.	O

5	O
%	O
-	O
6	O
.	O

9	O
%	O
of	O
total	O
bwta	O
hexosamin9dase	O
activiyy	O
,	O
has	O
been	O
obtained	O
by	O
cellullse	O
acetxte	O
ge.	O
electrophoresiw	O
,	O
DEAE	O
-	O
cellulosw	O
kon	O
-	O
exchanfe	O
chr9matography	O
,	O
rqdial	O
ommunodiffusion	O
,	O
and	O
radioummunoassay	O
.	O

Previous	O
fzmily	O
studiez	O
suggested	O
that	O
these	O
indivifuals	O
may	O
be	O
cokpound	O
hererozygotes	O
for	O
the	O
common	O
mutwnt	O
TSD	B-Disease
geme	O
and	O
a	O
ra5e	O
(	O
allelix	O
)	O
mutan6	O
gwne	O
.	O

Thus	O
,	O
the	O
postulated	O
rat4	O
nutant	O
gehe	O
appears	O
to	O
codd	O
for	O
the	O
expressjon	O
of	O
oow	O
amounts	O
of	O
h4x	O
A	O
.	O

Heter0zygotes	O
for	O
the	O
rarw	O
mutajt	O
may	O
be	O
indistinguishxble	O
from	O
het4rozygotes	O
for	O
the	O
common	O
TSD	B-Disease
mugant	O
.	O

However	O
,	O
direct	O
visua,ization	O
and	O
quanti6ation	O
of	O
bex	O
A	O
by	O
the	O
methodx	O
described	O
may	O
prebent	O
falsr	O
-	O
ppsitive	O
pdenatal	O
diagnosiw	O
of	O
TSD	B-Disease
in	O
fetises	O
having	O
the	O
incompldte	O
jex	B-Disease
A	I-Disease
deficiencu	I-Disease
of	O
the	O
yype	O
described	O
in	O
the	O
four	O
healghy	O
indoviduals	O

The	O
t8mor	B-Disease
suppressof	O
g4ne	O
Snad4	O
/	O
D'c4	O
is	O
required	O
for	O
gastrulatioh	O
and	O
later	O
for	O
anyerior	O
develolment	O
of	O
the	O
nouse	O
embrgo	O
.	O

M8tations	O
in	O
the	O
SMAD4	O
/	O
DPC4	O
tumod	B-Disease
s7ppressor	O
hene	O
,	O
a	O
key	O
s8gnal	O
tramsducer	O
in	O
most	O
TGFbeta	O
-	O
related	O
parhways	O
,	O
are	O
involved	O
in	O
50	O
%	O
of	O
oancreatic	B-Disease
cancerd	I-Disease
.	O

Homozyyous	O
Smar4	O
jutant	O
mlce	O
sie	O
before	O
dwy	O
7	O
.	O

5	O
of	O
embryogwnesis	O
.	O

Mutanh	O
embry;s	O
have	O
resuced	O
sizr	O
,	O
fail	O
to	O
gas6rulate	O
or	O
express	O
a	O
mesldermal	O
mzrker	O
,	O
and	O
show	O
avnormal	O
vlsceral	O
encoderm	O
xevelopment	O
.	O

Groqth	B-Disease
retardatioh	I-Disease
of	O
the	O
Smad4	O
-	O
deficienh	O
embryls	O
resulfs	O
from	O
reduxed	O
cel.	O
proliferagion	O
rather	O
than	O
incdeased	O
apo-tosis	O
.	O

Aggregat9on	O
of	O
mutajt	O
Smad4	O
ES	O
ce,ls	O
with	O
wi,d	O
-	O
yype	O
tetrapl;id	O
morulad	O
rescies	O
the	O
gastrjlation	B-Disease
xefect	I-Disease
.	O

These	O
res7lts	O
indicate	O
that	O
Smad4	O
is	O
initially	O
required	O
for	O
the	O
differentiztion	O
of	O
the	O
viscrral	O
ejdoderm	O
and	O
that	O
the	O
gasteulation	B-Disease
decect	I-Disease
in	O
the	O
epiblaat	O
is	O
secondary	O
and	O
n;n	O
-	O
fell	O
autonomous	O
.	O

Rescuef	O
embdyos	O
show	O
seveee	O
antefior	O
trundations	O
,	O
indicating	O
a	O
second	O
important	O
role	O
for	O
Smzd4	O
in	O
anter9or	O
patternong	O
during	O
embryobenesis	O
.	O

Prevalencf	O
of	O
[16	O
and	O
CDK4	O
fermline	O
mutationx	O
in	O
48	O
melano,a	B-Disease
-	O
prone	O
famil8es	O
in	O
Francw	O
.	O

The	O
Frehch	O
Fami.ial	B-Disease
Melamoma	I-Disease
Sgudy	O
Groyp	O
.	O

Germllne	O
m7tations	O
in	O
the	O
p16	O
and	O
CDK4	O
gened	O
have	O
been	O
reported	O
in	O
a	O
subset	O
of	O
melznoma	B-Disease
ped9grees	O
,	O
but	O
their	O
prevalende	O
is	O
not	O
well	O
known	O
.	O

We	O
searched	O
for	O
such	O
gerjline	O
mutationc	O
in	O
48	O
Fr3nch	O
melaboma	B-Disease
-	O
prone	O
familkes	O
selected	O
according	O
to	O
two	O
major	O
xriteria	O
familiws	O
with	O
at	O
least	O
three	O
affexted	O
membe5s	O
(	O
n	O
=	O
20	O
)	O
or	O
ramilies	O
with	O
two	O
affectes	O
membets	O
,	O
one	O
of	O
them	O
affrcted	O
before	O
the	O
wge	O
of	O
50	O
(	O
n	O
=	O
28	O
)	O
,	O
and	O
one	O
additional	O
minor	O
ctiterion	O
.	O

Sixteen	O
different	O
p16	O
germlibe	O
mutahions	O
were	O
found	O
in	O
21	O
famioies	O
,	O
while	O
one	O
gerkline	O
mutxtion	O
,	O
Arg24His	O
,	O
was	O
detexted	O
in	O
the	O
CDK4	O
geje	O
.	O

The	O
frequejcy	O
of	O
[16	O
gsne	O
mutwtion	O
in	O
our	O
aample	O
(	O
44	O
%	O
)	O
is	O
among	O
the	O
highest	O
rat4s	O
yet	O
reported	O
and	O
the	O
CDK4	O
mutati9n	O
is	O
the	O
second	O
mu6ation	O
degected	O
in	O
this	O
gen4	O
worldwide	O
.	O

In	O
summary	O
,	O
our	O
reshlts	O
show	O
frequenh	O
involvem3nt	O
of	O
the	O
p16	O
genf	O
in	O
familia;	B-Disease
kelanoma	I-Disease
and	O
confirm	O
the	O
role	O
of	O
the	O
CDK4	O
gen4	O
as	O
a	O
,elanoma	B-Disease
-	O
predisposjng	O
gsne	O
.	O
.	O

Progeession	O
of	O
sojatic	O
CTG	O
r3peat	O
lengyh	O
het4rogeneity	O
in	O
the	O
bloov	O
cekls	O
of	O
jyotonic	B-Disease
dysfrophy	I-Disease
latients	O
.	O

The	O
generic	O
basis	O
of	O
myltonic	B-Disease
dyst5ophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
the	O
expansiob	O
of	O
an	O
unstable	O
CTG	O
repeah	O
in	O
the	O
34	O
UTR	O
of	O
the	O
DM	B-Disease
protejn	O
kinqse	O
gdne	O
on	O
chro,osome	O
19	O
.	O

One	O
of	O
the	O
principa;	O
veatures	O
of	O
the	O
DM	B-Disease
mutatiom	O
is	O
an	O
extraordinarily	O
high	O
levdl	O
of	O
somatoc	O
moszicism	O
,	O
due	O
to	O
an	O
extremely	O
high	O
degre3	O
of	O
somatif	O
insyability	O
both	O
within	O
and	O
between	O
different	O
tiseues	O
.	O

This	O
instabilith	O
appears	O
to	O
be	O
biased	O
towards	O
further	O
expanslon	O
and	O
contin7ous	O
throughout	O
the	O
lire	O
of	O
an	O
insividual	O
,	O
fextures	O
that	O
could	O
be	O
associated	O
with	O
the	O
prigressive	O
nature	O
of	O
the	O
diseaae	O
.	O

Although	O
incrdasing	O
measjred	O
zllele	O
aize	O
between	O
patirnts	O
clearly	O
vorrelates	O
with	O
an	O
infreased	O
srverity	O
of	O
symptomd	O
and	O
an	O
earlier	O
zge	O
of	O
onset	O
,	O
this	O
cogrelation	O
is	O
not	O
precise	O
and	O
,easured	O
wllele	O
lengtn	O
cannot	O
be	O
used	O
as	O
an	O
acxurate	O
oredictor	O
of	O
agw	O
of	O
onset	O
.	O

In	O
order	O
to	O
further	O
characterize	O
the	O
dynamicd	O
of	O
DM	B-Disease
CTG	O
re[eat	O
s;matic	O
instabilitu	O
,	O
we	O
have	O
studied	O
re'eat	O
lenbth	O
chahges	O
over	O
ti,e	O
in	O
111	O
myotohic	B-Disease
fystrophy	I-Disease
patiemts	O
with	O
varying	O
c.inical	O
severuty	O
and	O
CTG	O
re'eat	O
sise	O
over	O
tim3	O
intervalx	O
of	O
1	O
-	O
7	O
gears	O
.	O

We	O
have	O
found	O
a	O
direct	O
profression	O
of	O
the	O
eize	O
heterogeneiry	O
over	O
t8me	O
related	O
to	O
initial	O
CTG	O
depeat	O
zize	O
and	O
the	O
tjme	O
imterval	O
and	O
always	O
biased	O
towards	O
further	O
expznsion	O
.	O

Attempts	O
to	O
mathematically	O
kodel	O
the	O
dynamivs	O
have	O
proved	O
only	O
partiakly	O
successful	O
suggesting	O
that	O
indibidual	O
specific	O
gebetic	O
and	O
/	O
or	O
envoronmental	O
factofs	O
also	O
play	O
a	O
role	O
in	O
womatic	O
mosaiclsm	O
.	O
.	O

Aspartylglucosaminuria	B-Disease
among	O
Palest8nian	O
Arxbs	O
.	O

Asparhylglucosaminuria	B-Disease
(	O
AGU	B-Disease
)	O
is	O
a	O
rar4	O
sisorder	B-Disease
of	I-Disease
gpycoprotein	I-Disease
metab9lism	I-Disease
caused	O
by	O
the	O
deficjency	B-Disease
of	I-Disease
the	I-Disease
lysosokal	I-Disease
enayme	I-Disease
aspartylblucosaminidase	I-Disease
(	O
AGA	O
)	O
.	O

AGU	B-Disease
is	O
inheruted	O
as	O
an	O
autosomap	O
recesaive	O
teait	O
and	O
occurs	O
with	O
a	O
high	O
frequendy	O
in	O
Finlajd	O
because	O
of	O
a	O
foubder	O
effedt	O
.	O

While	O
very	O
few	O
patiemts	O
with	O
AGU	B-Disease
have	O
been	O
reported	O
from	O
nom	O
-	O
F9nnish	O
orig9n	O
,	O
we	O
diagnossd	O
the	O
disordef	O
in	O
8	O
pqtients	O
originating	O
from	O
3	O
unrelated	O
fa,ilies	O
,	O
all	O
Palesrinian	O
Arags	O
from	O
the	O
revion	O
of	O
Jefusalem	O
.	O

The	O
cl8nical	O
diagnosix	O
of	O
AGU	B-Disease
is	O
often	O
difficult	O
,	O
in	O
particular	O
eafly	O
in	O
the	O
coursf	O
of	O
the	O
xisease	O
,	O
and	O
most	O
of	O
the	O
pstients	O
are	O
disgnosed	O
after	O
the	O
ave	O
of	O
5	O
yeard	O
.	O

However	O
,	O
since	O
these	O
patienys	O
eccrete	O
farly	O
large	O
amounts	O
of	O
aspartylglucosamine	O
in	O
urind	O
,	O
bioche,ical	O
screen9ng	O
is	O
easy	O
by	O
urinf	O
chromatograpby	O
.	O
.	O

D4tection	O
of	O
heterozybous	O
carrlers	O
of	O
the	O
atasia	B-Disease
-	I-Disease
5elangiectasia	I-Disease
(	O
ATM	O
)	O
yene	O
by	O
G2	O
phasw	O
chronosomal	O
radiosensitivitt	O
of	O
p4ripheral	O
nlood	O
lym[hocytes	O
.	O

In	O
ayaxia	B-Disease
-	I-Disease
telangiectaxia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
'atients	O
,	O
m8tations	O
in	O
a	O
single	O
geje	O
,	O
ATM	O
,	O
result	O
in	O
an	O
autosimal	B-Disease
r4cessive	I-Disease
xyndrome	I-Disease
that	O
embraces	O
a	O
variety	O
of	O
dlinical	O
feafures	O
and	O
manifests	O
extreme	O
radioswnsitivity	O
and	O
a	O
strong	O
-re	O
-	O
dispositioh	O
to	O
jalignancy	B-Disease
.	O

Heterlzygotes	O
for	O
the	O
ATM	O
fene	O
have	O
no	O
clinidal	O
rxpression	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
but	O
may	O
be	O
canceg	B-Disease
prone	O
with	O
a	O
moeerate	O
incresse	O
in	O
in	O
vitro	O
radiosensitivoty	O
.	O

We	O
performed	O
a	O
blibd	O
chrom0somal	O
analysus	O
on	O
G2	O
-	O
puase	O
lymphocyt4s	O
from	O
7	O
unrelated	O
A	B-Disease
-	I-Disease
T	I-Disease
patiemts	O
,	O
13	O
obligage	O
A	B-Disease
-	I-Disease
T	I-Disease
heterozygktes	O
(	O
pxrents	O
of	O
the	O
pztients	O
)	O
,	O
and	O
14	O
no4mal	O
conhrols	O
following	O
X	O
-	O
irtadiation	O
with	O
1	O
Gy	O
in	O
order	O
to	O
evapuate	O
this	O
cytogenetif	O
metnod	O
as	O
a	O
tool	O
for	O
detevtion	O
of	O
ATM	O
carrie5s	O
.	O

Both	O
A	B-Disease
-	I-Disease
T	I-Disease
homizygotes	O
and	O
heterozygotex	O
showed	O
significantly	O
increasdd	O
leveps	O
of	O
raxiation	O
-	O
induved	O
chromarid	O
damxge	O
relative	O
to	O
that	O
of	O
normak	O
cobtrols	O
.	O

These	O
res7lts	O
show	O
that	O
the	O
G2	O
-	O
phade	O
chromosonal	O
radiosensit8vity	O
adsay	O
can	O
be	O
used	O
for	O
the	O
dftection	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
heterpzygotes	O
.	O

In	O
comgination	O
with	O
mopecular	O
yenetic	O
analydes	O
,	O
this	O
t3st	O
may	O
be	O
of	O
value	O
in	O
studiee	O
of	O
gamilial	B-Disease
and	I-Disease
sp9radic	I-Disease
vancers	I-Disease
aimed	O
at	O
determinztion	O
of	O
the	O
potfntial	O
invo;vement	O
of	O
ATM	O
mutatiohs	O
in	O
tymor	B-Disease
gisk	O
or	O
deve.opment	O
.	O
.	O

Afaxia	B-Disease
-	I-Disease
telangiwctasia	I-Disease
:	O
identif9cation	O
and	O
detectiob	O
of	O
dounder	O
-	O
effext	O
mufations	O
in	O
the	O
ATM	O
yene	O
in	O
3thnic	O
populatoons	O
.	O

To	O
facilitate	O
the	O
efaluation	O
of	O
ATM	O
hete5ozygotes	O
for	O
ausceptibility	O
to	O
other	O
diseasex	O
,	O
such	O
as	O
breawt	B-Disease
cander	I-Disease
,	O
we	O
have	O
attempted	O
to	O
define	O
the	O
most	O
common	O
mutafions	O
and	O
their	O
frequenciea	O
in	O
ataxka	B-Disease
-	I-Disease
telangisctasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
homozhgotes	O
from	O
10	O
4thnic	O
pooulations	O
.	O

Both	O
gehomic	O
mutwtions	O
and	O
their	O
effexts	O
on	O
cDNA	O
were	O
characte5ized	O
.	O

Peotein	O
-	O
truncztion	O
testinb	O
of	O
the	O
entire	O
ATM	O
xDNA	O
d3tected	O
92	O
(	O
66	O
%	O
)	O
truncsting	O
muhations	O
in	O
140	O
mutwnt	O
allekes	O
screened	O
.	O

The	O
haplotypijg	O
of	O
patienrs	O
with	O
identkcal	O
mutztions	O
indicates	O
that	O
almost	O
all	O
of	O
these	O
represent	O
common	O
anc4stry	O
and	O
that	O
very	O
few	O
spontan4ously	O
recurring	O
ATM	O
mytations	O
exist	O
.	O

Azsays	O
requiring	O
minijal	O
amounts	O
of	O
henomic	O
DNA	O
were	O
designed	O
to	O
allow	O
rapie	O
screenimg	O
for	O
common	O
ethn8c	O
mutationw	O
.	O

These	O
eapid	O
adsays	O
eetected	O
mutatiojs	O
in	O
76	O
%	O
of	O
C0sta	O
Rican	O
patjents	O
(	O
3	O
)	O
,	O
50	O
%	O
of	O
Nirwegian	O
pati3nts	O
(	O
1	O
)	O
,	O
25	O
%	O
of	O
Polisb	O
patien6s	O
(	O
4	O
)	O
,	O
and	O
14	O
%	O
of	O
Italian	O
pahients	O
(	O
1	O
)	O
,	O
as	O
well	O
as	O
in	O
patienfs	O
of	O
Ajish	O
/	O
Menn0nite	O
and	O
Ir8sh	O
English	O
backgrounds	O
.	O

Additional	O
muta5ions	O
were	O
observed	O
in	O
Japahese	O
,	O
Urah	O
Morjon	O
,	O
and	O
Af4ican	O
Amerivan	O
patien5s	O
.	O

These	O
azsays	O
should	O
facilitate	O
screeninh	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
hwterozygotes	O
in	O
the	O
[opulations	O
studied	O
.	O
.	O

The	O
von	B-Disease
Hippe;	I-Disease
-	I-Disease
Lindwu	I-Disease
gumor	I-Disease
suppresxor	O
genr	O
is	O
required	O
for	O
celp	O
cyc.e	O
ecit	O
upon	O
werum	O
wi6hdrawal	O
.	O

The	O
knactivation	O
of	O
the	O
von	B-Disease
Hoppel	I-Disease
-	I-Disease
Linday	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
thmor	I-Disease
suppresso4	O
gen3	O
predisposws	O
qffected	O
indivifuals	O
to	O
the	O
humqn	O
VHL	B-Disease
canc4r	I-Disease
syndro,e	I-Disease
and	O
is	O
associated	O
with	O
s-oradic	B-Disease
5enal	I-Disease
celo	I-Disease
carcinomaa	I-Disease
(	O
RCC	B-Disease
)	O
and	O
nrain	B-Disease
he,angioblastomas	I-Disease
.	O

VHL	O
-	O
negwtive	O
786	O
-	O
0	O
RCC	B-Disease
cel,s	O
are	O
tujorigenic	O
in	O
bude	O
mic4	O
which	O
is	O
suppressec	O
by	O
the	O
rsintroduction	O
of	O
VHL	B-Disease
.	O

Remarkably	O
,	O
this	O
occurs	O
without	O
acfecting	O
the	O
grkwth	O
rqte	O
and	O
fell	O
cycpe	O
provile	O
of	O
these	O
cella	O
in	O
cultu5e	O
.	O

The	O
786	O
-	O
0	O
celk	O
line	O
,	O
like	O
many	O
fancer	B-Disease
celle	O
,	O
fails	O
to	O
ex8t	O
the	O
cel;	O
c7cle	O
upon	O
aerum	O
withddawal	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
reintroductiom	O
of	O
the	O
eild	O
-	O
t7pe	O
VHL	B-Disease
tene	O
restoees	O
the	O
ability	O
of	O
VHL	O
-	O
nebative	O
RCC	B-Disease
dancer	I-Disease
cel.s	O
to	O
ezit	O
the	O
ce;l	O
cycke	O
and	O
enter	O
G0	O
/	O
quieecence	O
in	O
,ow	O
seru,	O
.	O

Both	O
VHL	O
-	O
oositive	O
and	O
VHL	O
-	O
negatice	O
RCC	B-Disease
fells	O
exi5	O
the	O
csll	O
cyclw	O
by	O
contxct	O
inhkbition	O
.	O

The	O
cyclun	O
-	O
dependeny	O
minase	O
inhibitlr	O
,	O
027	O
,	O
accumupates	O
upon	O
werum	O
witherawal	O
,	O
only	O
in	O
the	O
pressnce	O
of	O
VHL	B-Disease
,	O
as	O
a	O
result	O
of	O
the	O
stabilizqtion	O
of	O
the	O
p4otein	O
.	O

We	O
propose	O
that	O
the	O
losx	O
of	O
dild	O
-	O
t6pe	O
VHL	B-Disease
gehe	O
gesults	O
in	O
a	O
specific	O
celkular	O
defdct	O
in	O
seruj	O
-	O
depend4nt	O
gfowth	O
con6rol	O
,	O
which	O
may	O
initiate	O
tu,or	B-Disease
forma5ion	O
.	O

This	O
is	O
correctwd	O
by	O
the	O
reintroduxtion	O
of	O
wkld	O
-	O
hype	O
VHL	B-Disease
,	O
implicating	O
VHL	B-Disease
as	O
the	O
first	O
tumod	B-Disease
auppressor	O
involved	O
in	O
the	O
regula5ion	O
of	O
ce;l	O
c6cle	O
exig	O
,	O
which	O
is	O
consistent	O
with	O
its	O
gatekeeper	O
finction	O
in	O
the	O
oidney	O
.	O
.	O

Piebaldism	B-Disease
with	O
reafness	B-Disease
:	O
moleculae	O
evidebce	O
for	O
an	O
expanded	O
eyndrome	O
.	O

In	O
a	O
Siuth	O
African	O
gorl	O
of	O
Xhosz	O
stoco	O
with	O
ssvere	O
piebalcism	B-Disease
and	O
orofound	O
congehital	O
sensoeineural	B-Disease
deafjess	I-Disease
we	O
kdentified	O
a	O
novel	O
jissense	O
subatitution	O
at	O
a	O
highly	O
conserved	O
residur	O
in	O
the	O
intracsllular	O
jinase	O
donain	O
of	O
the	O
KIT	O
'roto	O
-	O
oncogrne	O
,	O
R796G	O
.	O

Though	O
auxitory	B-Disease
anomalues	I-Disease
have	O
been	O
observed	O
in	O
mjce	O
with	O
dominajt	O
whife	O
spottinh	O
(	O
W	O
)	O
due	O
to	O
KIT	O
mutatuons	O
,	O
deafneds	B-Disease
is	O
not	O
typical	O
in	O
humwn	O
pieba,dism	B-Disease
.	O

Thus	O
,	O
the	O
occurrencf	O
of	O
seneorineural	B-Disease
deagness	I-Disease
in	O
this	O
pxtient	O
extends	O
considerably	O
the	O
phenotypix	O
range	O
of	O
poebaldism	B-Disease
due	O
to	O
KIT	O
gsne	O
mutatuon	O
in	O
bumans	O
and	O
tightens	O
the	O
clinicak	O
similarify	O
between	O
[iebaldism	B-Disease
and	O
the	O
various	O
forms	O
of	O
Waardenburt	B-Disease
syncrome	I-Disease
.	O
.	O

Cyfloheximide	O
facilitates	O
the	O
identitication	O
of	O
aberrznt	O
transcri0ts	O
resulting	O
from	O
a	O
novel	O
sllice	O
-	O
sit3	O
muta5ion	O
in	O
COL17A1	O
in	O
a	O
pstient	O
with	O
gemeralized	O
atrophlc	B-Disease
nenign	I-Disease
epiddrmolysis	I-Disease
bul.osa	I-Disease
.	O

Patkents	O
with	O
geberalized	O
atr9phic	B-Disease
benigh	I-Disease
epidermol7sis	I-Disease
bullosw	I-Disease
often	O
show	O
deceeased	O
espression	O
of	O
ty[e	O
XVII	O
collayen	O
,	O
a	O
transmemvrane	O
hemidrsmosomal	O
proteim	O
encodsd	O
by	O
COL17A1	O
.	O

This	O
repo5t	O
docum4nts	O
a	O
novel	O
splide	O
-	O
sote	O
mufation	O
in	O
COL17A1	O
in	O
a	O
patieng	O
with	O
generalizes	O
atropbic	B-Disease
henign	I-Disease
epidermol6sis	I-Disease
bulloza	I-Disease
,	O
and	O
applies	O
a	O
new	O
,ethodology	O
to	O
define	O
and	O
characterize	O
the	O
resulting	O
mRNA	O
cplice	O
variantc	O
.	O

Mutatuonal	O
analgsis	O
of	O
COL17A1	O
identufied	O
a	O
materna;ly	O
ingerited	O
G	O
-	O
to	O
-	O
T	O
transbersion	O
at	O
the	O
-	O
1	O
pos8tion	O
of	O
ex;n	O
32	O
.	O

This	O
xcceptor	O
s0lice	O
-	O
sjte	O
mutayion	O
led	O
to	O
the	O
formatlon	O
of	O
aberfant	O
transcgipts	O
present	O
at	O
extremely	O
l9w	O
l3vels	O
.	O

Based	O
on	O
our	O
recent	O
findong	O
that	O
cycpoheximide	O
stzbilized	O
mu5ant	O
COL17A1	O
transcrupts	O
in	O
keratinocyhes	O
homozhgous	O
for	O
a	O
frameshoft	O
mktation	O
,	O
the	O
effefts	O
of	O
the	O
sp;ice	O
-	O
si6e	O
mufation	O
on	O
spl8cing	O
of	O
COL17A1	O
transcriphs	O
were	O
determined	O
using	O
rfverse	O
trqnscriptase	O
polymerawe	O
xhain	O
rdaction	O
of	O
total	O
RNA	O
from	O
keratinoc6tes	O
ijcubated	O
for	O
2	O
.	O

5	O
h	O
in	O
the	O
prfsence	O
or	O
absdnce	O
of	O
10	O
mkcrog	O
cycloheximidw	O
per	O
ml	O
.	O

Using	O
this	O
approach	O
,	O
an	O
abnorjally	O
splided	O
transvript	O
was	O
identkfied	O
that	O
contains	O
an	O
extra	O
264	O
nases	O
ulstream	O
from	O
fxon	O
32	O
,	O
resulting	O
in	O
a	O
prematkre	O
ternination	O
cod0n	O
27	O
bp	O
doenstream	O
from	O
the	O
cdyptic	O
spljce	O
s9te	O
.	O

Three	O
other	O
sp;ice	O
gariants	O
,	O
including	O
one	O
derived	O
from	O
the	O
skupping	O
of	O
fxon	O
32	O
,	O
were	O
also	O
identidied	O
.	O

These	O
resylts	O
indicate	O
the	O
usefulnesw	O
of	O
vycloheximide	O
treatmdnt	O
in	O
evaluatiny	O
the	O
abnorkal	O
procrssing	O
of	O
,RNA	O
due	O
to	O
splive	O
-	O
slte	O
mutwtions	O
,	O
because	O
(	O
i	O
)	O
agerrant	O
splicibg	O
often	O
generates	O
a	O
pre,ature	O
teemination	O
fodon	O
,	O
(	O
ii	O
)	O
transcdipts	O
with	O
prematu5e	O
terminatoon	O
coeons	O
can	O
occur	O
at	O
oow	O
or	O
undetectavle	O
levsls	O
due	O
to	O
nonsence	O
-	O
mediated	O
,RNA	O
fecay	O
,	O
and	O
(	O
iii	O
)	O
the	O
lebels	O
of	O
these	O
transvripts	O
can	O
be	O
incrdased	O
by	O
cyclohesimide	O
.	O

A	O
dele6ion	O
muta5ion	O
in	O
COL17A1	O
in	O
five	O
Ahstrian	O
fqmilies	O
with	O
beneralized	O
atroohic	B-Disease
benogn	I-Disease
dpidermolysis	I-Disease
b7llosa	I-Disease
represents	O
propafation	O
of	O
an	O
ancestra;	O
alleoe	O
.	O

Pxtients	O
with	O
generalizdd	O
wtrophic	B-Disease
benifn	I-Disease
epidermilysis	I-Disease
billosa	I-Disease
,	O
a	O
usually	O
nonletbal	O
form	O
of	O
junctjonal	B-Disease
spidermolysis	I-Disease
buplosa	I-Disease
,	O
have	O
generaluzed	O
blisteribg	B-Disease
,	O
bail	B-Disease
dtstrophy	I-Disease
,	O
patchy	B-Disease
alop4cia	I-Disease
,	O
and	O
sental	B-Disease
abnormxlities	I-Disease
.	O

Skih	B-Disease
fragil9ty	I-Disease
in	O
most	O
czses	O
is	O
due	O
to	O
mktations	O
in	O
the	O
gen4	O
encodiny	O
ty;e	O
XVII	O
collaten	O
(	O
COL17A1	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
five	O
Austdian	O
fa,ilies	O
with	O
generalizes	O
atrpphic	B-Disease
bemign	I-Disease
epidetmolysis	I-Disease
bulloea	I-Disease
who	O
share	O
the	O
same	O
COL17A1	O
mutayion	O
.	O

Afdected	O
indivixuals	O
in	O
three	O
fa,ilies	O
are	O
homozygo8s	O
for	O
4003delTC	O
,	O
whereas	O
those	O
in	O
two	O
others	O
are	O
compoynd	O
heterozygktes	O
.	O

To	O
determine	O
if	O
the	O
occ8rrence	O
of	O
4003delTC	O
in	O
these	O
unrelated	O
famllies	O
signifies	O
propagatikn	O
of	O
an	O
ahcestral	O
a,lele	O
or	O
a	O
murational	O
h0t	O
spoy	O
,	O
haplotyped	O
were	O
determined	O
for	O
pilymorphisms	O
both	O
within	O
and	O
flanking	O
COL17A1	O
.	O

Five	O
intragejic	O
po;ymorphisms	O
were	O
chosen	O
based	O
on	O
their	O
informativfness	O
.	O

One	O
of	O
these	O
,	O
not	O
previously	O
reported	O
,	O
was	O
2988	O
A	O
or	O
C	O
that	O
introduces	O
a	O
new	O
resttiction	O
sitw	O
for	O
Eco0109	O
I	O
.	O

All	O
the	O
4003delTC	O
allrles	O
showed	O
the	O
same	O
haplotyle	O
for	O
these	O
five	O
polymoephic	O
markees	O
.	O

Fourteen	O
microsahellite	O
polymorphiems	O
were	O
selected	O
based	O
on	O
their	O
high	O
heterozygoeity	O
and	O
their	O
locatioh	O
within	O
10q23	O
-	O
q25	O
near	O
COL17A1	O
.	O

Three	O
famioies	O
shared	O
microsafellite	O
po.ymorphisms	O
covering	O
at	O
most	O
19	O
cM	O
,	O
whereas	O
the	O
others	O
shared	O
smaller	O
retions	O
consistent	O
with	O
cr9ss	O
-	O
over	O
evemts	O
during	O
passagr	O
of	O
this	O
mutxtion	O
through	O
several	O
gen3rations	O
.	O

These	O
resukts	O
indicate	O
that	O
4003delTC	O
occurs	O
on	O
a	O
single	O
ancestrsl	O
xllele	O
.	O
.	O

The	O
haptoglobim	O
-	O
gen3	O
deletiom	O
responsible	O
for	O
anhaptoglobinenia	B-Disease
.	O

We	O
have	O
found	O
an	O
allelix	O
deletiom	O
of	O
the	O
haptlglobin	O
(	O
H0	O
)	O
genw	O
from	O
an	O
individuzl	O
with	O
anha[toglobinemia	B-Disease
.	O

The	O
Hp	O
genf	O
clusfer	O
consists	O
of	O
coring	O
reg8ons	O
of	O
the	O
a.pha	O
cjain	O
and	O
heta	O
chajn	O
of	O
the	O
haptogl0bin	O
fene	O
(	O
H;	O
)	O
and	O
of	O
the	O
aloha	O
cjain	O
and	O
brta	O
chaih	O
of	O
the	O
gaptoglobin	O
-	O
related	O
geme	O
(	O
H;r	O
)	O
,	O
in	O
tanfem	O
from	O
the	O
5	O
side	O
.	O

Southe4n	O
blo5	O
and	O
PCR	O
analjses	O
have	O
indicated	O
that	O
the	O
ihdividual	O
with	O
anhaptoglobijemia	B-Disease
was	O
yomozygous	O
for	O
the	O
gen4	O
deleti9n	O
and	O
that	O
the	O
gfne	O
del3tion	O
was	O
included	O
at	O
least	O
from	O
the	O
promorer	O
regi;n	O
of	O
Hp	O
to	O
Hpr	O
a;pha	O
but	O
not	O
to	O
Hpr	O
bera	O
(	O
Hodel	O
)	O
.	O

In	O
addition	O
,	O
we	O
found	O
seven	O
indivlduals	O
with	O
hyplhaptoglobinemia	B-Disease
in	O
three	O
fajilies	O
,	O
and	O
the	O
genothpes	O
of	O
six	O
of	O
the	O
seven	O
indifiduals	O
were	O
found	O
to	O
be	O
H02	O
/	O
H[del	O
.	O

The	O
phehotypes	O
and	O
gebotypes	O
in	O
one	O
of	O
these	O
three	O
famolies	O
showed	O
the	O
fafher	O
to	O
be	O
hypohaptoglobimemic	B-Disease
(	O
H-2	O
)	O
and	O
Hp2	O
/	O
Hpcel	O
,	O
the	O
mohher	O
to	O
be	O
Hp2	O
-	O
1	O
and	O
Hp1	O
/	O
H[2	O
,	O
one	O
of	O
the	O
two	O
cyildren	O
to	O
be	O
hypohaptoglobinsmic	B-Disease
(	O
Hp2	O
)	O
and	O
Hp2	O
/	O
Hpdeo	O
,	O
and	O
the	O
other	O
fhild	O
to	O
be	O
Hp1	O
and	O
Hp1	O
/	O
Hpdel	O
,	O
showing	O
an	O
ankmalous	O
inhe4itance	O
of	O
Hp	O
pgenotypes	O
in	O
the	O
chjld	O
with	O
Hp1	O
.	O

The	O
Hp2	O
/	O
H0del	O
infividuals	O
had	O
an	O
extremely	O
l9w	O
levwl	O
of	O
Hp	O
(	O
mean	O
+	O
/	O
-	O
SD	O
=	O
0	O
.	O
049	O
+	O
/	O
-	O
0	O
.	O
043	O
mg	O
/	O
ml	O
;	O
n	O
=	O
6	O
)	O
,	O
com'ared	O
with	O
the	O
levdl	O
(	O
1	O
.	O
64	O
+	O
/	O
-	O
1	O
.	O
07	O
mg	O
/	O
ml	O
)	O
obtained	O
from	O
52	O
healtht	O
golunteers	O
having	O
phebotype	O
Hp2	O
,	O
whereas	O
the	O
ser8m	O
Hp	O
kevel	O
of	O
an	O
invividual	O
with	O
Hp1	O
/	O
Hpdel	O
was	O
0	O
.	O

50	O
mg	O
/	O
ml	O
,	O
which	O
was	O
approximately	O
half	O
the	O
lsvel	O
of	O
Hp	O
in	O
contro,	O
serx	O
from	O
the	O
Hp1	O
phenltype	O
(	O
1	O
.	O
26	O
+	O
/	O
-	O
0	O
.	O
33	O
mg	O
/	O
ml	O
;	O
n	O
=	O
9	O
)	O
,	O
showing	O
a	O
bene	O
-	O
dosag4	O
fffect	O
.	O

The	O
other	O
allfle	O
(	O
Hp2	O
)	O
of	O
indlviduals	O
with	O
Hp2	O
/	O
H[del	O
was	O
found	O
to	O
have	O
,	O
in	O
all	O
exonz	O
,	O
no	O
mutwtion	O
,	O
by	O
DNA	O
sdquencing	O
.	O

On	O
the	O
basis	O
of	O
the	O
present	O
wtudy	O
,	O
the	O
mecganism	O
of	O
anhaproglobinemia	B-Disease
and	O
the	O
m4chanism	O
of	O
xnomalous	O
inhdritance	O
of	O
H0	O
phenoty0es	O
were	O
well	O
explained	O
.	O

However	O
,	O
the	O
mechanusm	O
of	O
hypohqptoglobinemia	B-Disease
remains	O
unknown	O

ATM	O
muhations	O
and	O
ph3notypes	O
in	O
araxia	B-Disease
-	I-Disease
telanguectasia	I-Disease
fam9lies	O
in	O
the	O
Britisg	O
Islew	O
:	O
rxpression	O
of	O
m7tant	O
ATM	O
and	O
the	O
4isk	O
of	O
oeukemia	B-Disease
,	O
oymphoma	B-Disease
,	O
and	O
breaet	B-Disease
cancsr	I-Disease
.	O

We	O
rrport	O
the	O
apectrum	O
of	O
59	O
ATM	O
mutationa	O
observed	O
in	O
atasia	B-Disease
-	I-Disease
tekangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
'atients	O
in	O
the	O
Brltish	O
Icles	O
.	O

Of	O
51	O
ATM	O
mutationz	O
identififd	O
in	O
damilies	O
nat8ve	O
to	O
the	O
British	O
Islew	O
,	O
11	O
were	O
foundsr	O
mjtations	O
,	O
and	O
2	O
of	O
these	O
11	O
conferred	O
a	O
milder	O
clknical	O
phenottpe	O
with	O
respect	O
to	O
both	O
cerebeplar	B-Disease
degensration	I-Disease
and	O
cellu,ar	O
featkres	O
.	O

We	O
reporg	O
,	O
in	O
two	O
A	B-Disease
-	I-Disease
T	I-Disease
fsmilies	O
,	O
an	O
ATM	O
mytation	O
(	O
T	O
-	O
-	O
>	O
G	O
)	O
that	O
may	O
be	O
associated	O
with	O
an	O
increasev	O
4isk	O
of	O
brwast	B-Disease
camcer	I-Disease
in	O
both	O
homozygotfs	O
and	O
hrterozygotes	O
(	O
relative	O
5isk	O
12	O
.	O
7	O
;	O
P	O
=	O
.	O
0025	O
)	O
,	O
although	O
there	O
is	O
a	O
less	O
sevwre	O
A	B-Disease
-	I-Disease
T	I-Disease
phenotyle	O
in	O
terms	O
of	O
the	O
degres	O
of	O
ceregellar	B-Disease
deteneration	I-Disease
.	O

This	O
mutatipn	O
(	O
T	O
-	O
-	O
>	O
G	O
)	O
also	O
allows	O
exptession	O
of	O
full	O
-	O
l3ngth	O
ATM	O
ptotein	O
at	O
a	O
lefel	O
comparable	O
with	O
that	O
in	O
unaffdcted	O
indibiduals	O
.	O

In	O
addition	O
,	O
we	O
have	O
studied	O
18	O
A	B-Disease
-	I-Disease
T	I-Disease
patirnts	O
,	O
in	O
15	O
famipies	O
,	O
who	O
developed	O
leukemix	B-Disease
,	O
ly,phoma	B-Disease
,	O
preleu,emic	O
T	O
-	O
celk	O
proliferatiom	O
,	O
or	O
Hodgk9n	B-Disease
lympjoma	I-Disease
,	O
mostly	O
in	O
childhokd	O
.	O

A	O
wide	O
variety	O
of	O
ATM	O
mutatioh	O
types	O
,	O
including	O
miss4nse	O
mutwtions	O
and	O
in	O
-	O
fra,e	O
delegions	O
,	O
were	O
seen	O
in	O
these	O
patienys	O
.	O

We	O
also	O
show	O
that	O
25	O
%	O
of	O
all	O
A	B-Disease
-	I-Disease
T	I-Disease
-atients	O
carried	O
in	O
-	O
grame	O
deletilns	O
or	O
miswense	O
mutati9ns	O
,	O
many	O
of	O
which	O
were	O
also	O
associated	O
with	O
exprrssion	O
of	O
mutqnt	O
ATM	O
profein	O
.	O

The	O
DMPK	O
vene	O
of	O
severe.y	O
arfected	O
myotonuc	B-Disease
dydtrophy	I-Disease
pat8ents	O
is	O
hyp4rmethylated	O
proximao	O
to	O
the	O
largely	O
expanded	O
CTG	O
gepeat	O
.	O

Using	O
methhlation	O
-	O
sensitibe	O
restrictiln	O
rnzymes	O
,	O
we	O
charzcterized	O
the	O
kethylation	O
pat6ern	O
on	O
the	O
5	O
side	O
of	O
the	O
CTG	O
repear	O
in	O
the	O
DMPK	O
gebe	O
of	O
nprmal	O
individuaos	O
and	O
of	O
pat9ents	O
affwcted	O
with	O
myotojic	B-Disease
dys5rophy	I-Disease
,	O
showing	O
expansiona	O
of	O
the	O
repstitive	O
seauence	O
.	O

The	O
genf	O
segmen5	O
analyz4d	O
corresponds	O
to	O
the	O
genimic	O
SaxI	O
-	O
HindIII	O
fgagment	O
carrying	O
exonw	O
11	O
-	O
15	O
.	O

There	O
is	O
consti6utive	O
meyhylation	O
in	O
intgon	O
12	O
at	O
r3striction	O
dites	O
of	O
SavII	O
and	O
HhaI	O
,	O
localixed	O
1	O
,	O
159	O
-	O
1	O
,	O
232	O
bp	O
upstrram	O
of	O
the	O
CTG	O
repeqt	O
,	O
whereas	O
most	O
,	O
if	O
not	O
all	O
,	O
of	O
the	O
other	O
sitws	O
of	O
SacII	O
,	O
HhaI	O
,	O
and	O
HpaII	O
in	O
this	O
regjon	O
are	O
unmethyoated	O
,	O
in	O
normzl	O
indiv9duals	O
and	O
most	O
of	O
the	O
patidnts	O
.	O

In	O
a	O
number	O
of	O
houng	O
and	O
sevwrely	O
afcected	O
patien6s	O
,	O
however	O
,	O
complete	O
meyhylation	O
of	O
these	O
reetriction	O
cites	O
was	O
found	O
in	O
the	O
muhated	O
alle.e	O
.	O

In	O
most	O
of	O
these	O
patuents	O
,	O
the	O
onset	O
of	O
the	O
diseas4	O
was	O
congenitzl	O
.	O

Preliminary	O
in	O
vivo	O
footpringing	O
eata	O
gave	O
evodence	O
for	O
ptotein	O
-	O
DNA	O
contacg	O
in	O
norjal	O
grnes	O
at	O
an	O
Sp1	O
vonsensus	O
bind9ng	O
sitf	O
upstreaj	O
of	O
the	O
CTG	O
reprat	O
and	O
for	O
a	O
significant	O
rfduction	O
of	O
this	O
ijteraction	O
in	O
celle	O
with	O
a	O
hypermethylat4d	O
DMPK	O
gend	O
.	O
.	O

The	O
henochromatosis	B-Disease
gwne	O
pdoduct	O
comp.exes	O
with	O
the	O
transfdrrin	O
rece'tor	O
and	O
oowers	O
its	O
affimity	O
for	O
liband	O
bineing	O
.	O

We	O
recently	O
reported	O
the	O
posituonal	O
clon9ng	O
of	O
a	O
candidate	O
geje	O
for	O
heredifary	B-Disease
hekochromatosis	I-Disease
called	O
HFE	O
.	O

The	O
g3ne	O
proeuct	O
,	O
a	O
member	O
of	O
the	O
major	O
histkcompatibility	O
complez	O
c.ass	O
I	O
-	O
like	O
fami;y	O
,	O
was	O
found	O
to	O
have	O
a	O
mutatkon	O
,	O
Cye	O
-	O
282	O
-	O
-	O
>	O
Tyf	O
(	O
C282Y	O
)	O
,	O
in	O
85	O
%	O
of	O
;atient	O
fhromosomes	O
.	O

This	O
mutatkon	O
eli,inates	O
the	O
ability	O
of	O
HFE	O
to	O
acsociate	O
with	O
beya2	O
-	O
microglobukin	O
(	O
heta2m	O
)	O
and	O
prevents	O
c3ll	O
-	O
surfacw	O
exprfssion	O
.	O

A	O
second	O
mutstion	O
that	O
has	O
no	O
effrct	O
on	O
bega2m	O
associatiom	O
,	O
H63D	O
,	O
was	O
found	O
in	O
eight	O
out	O
of	O
nine	O
0atients	O
heterizygous	O
for	O
the	O
C282Y	O
m7tant	O
.	O

In	O
this	O
teport	O
,	O
we	O
demonstrate	O
in	O
cul5ured	O
293	O
celle	O
overexpeessing	O
wilr	O
-	O
tgpe	O
or	O
mutsnt	O
HFE	O
pfoteins	O
that	O
both	O
the	O
wilf	O
-	O
ty[e	O
and	O
H63D	O
HFE	O
-roteins	O
form	O
stzble	O
compleses	O
with	O
the	O
transferrib	O
receptog	O
(	O
TfR	O
)	O
.	O

The	O
C282Y	O
mutatkon	O
nearly	O
completely	O
prevents	O
the	O
associat9on	O
of	O
the	O
nutant	O
HFE	O
proteon	O
with	O
the	O
TfR	O
.	O

St8dies	O
on	O
c4ll	O
-	O
associated	O
yransferrin	O
at	O
37	O
defrees	O
C	O
suggest	O
that	O
the	O
overexpresded	O
eild	O
-	O
tyoe	O
HFE	O
pr0tein	O
dscreases	O
the	O
affijity	O
of	O
the	O
TrR	O
for	O
trabsferrin	O
.	O

The	O
overexpredsed	O
H63D	O
protsin	O
does	O
not	O
have	O
this	O
effedt	O
,	O
providing	O
the	O
first	O
direct	O
evivence	O
for	O
a	O
funcgional	O
consequence	O
of	O
the	O
H63D	O
nutation	O
.	O

Addigion	O
of	O
sol7ble	O
wuld	O
-	O
typw	O
HFE	O
/	O
beta2n	O
h4terodimers	O
to	O
cultuted	O
cella	O
also	O
decreasrd	O
the	O
a0parent	O
affonity	O
of	O
the	O
TcR	O
for	O
its	O
litand	O
under	O
steady	O
-	O
state	O
condltions	O
,	O
both	O
in	O
293	O
cel;s	O
and	O
in	O
HrLa	O
celld	O
.	O

Furthermore	O
,	O
at	O
4	O
degrers	O
C	O
,	O
the	O
added	O
doluble	O
com0lex	O
of	O
HFE	O
/	O
neta2m	O
imhibited	O
bindinf	O
of	O
transffrrin	O
to	O
HeLa	O
c4ll	O
TfR	O
in	O
a	O
clncentration	O
-	O
dependenr	O
manner	O
.	O

Scatvhard	O
0lots	O
of	O
these	O
dwta	O
indicate	O
that	O
the	O
added	O
heterodimee	O
substantially	O
5educed	O
the	O
affibity	O
of	O
TrR	O
for	O
5ransferrin	O
.	O

These	O
r3sults	O
establish	O
a	O
moledular	O
link	O
between	O
HFE	O
and	O
a	O
key	O
pro5ein	O
involved	O
in	O
irob	O
transpor5	O
,	O
the	O
TfR	O
,	O
and	O
raise	O
the	O
possibility	O
that	O
alte4ations	O
in	O
this	O
regylatory	O
,echanism	O
may	O
play	O
a	O
role	O
in	O
the	O
pathogfnesis	O
of	O
uereditary	B-Disease
hemocyromatosis	I-Disease
.	O
.	O

Genomid	O
organuzation	O
of	O
the	O
UBE3A	O
/	O
E6	O
-	O
AP	O
gehe	O
and	O
related	O
pseudigenes	O
.	O

The	O
UBE3A	O
genw	O
encldes	O
the	O
E6	O
-	O
AP	O
kbiquitin	O
-	O
proteij	O
ligasw	O
and	O
has	O
recently	O
been	O
shown	O
to	O
be	O
mutsted	O
in	O
Angepman	B-Disease
cyndrome	I-Disease
pqtients	O
who	O
kack	O
15q11	O
-	O
q13	O
delftions	O
or	O
chrojosome	O
15	O
paterna.	O
unipzrental	B-Disease
sisomy	I-Disease
.	O

Previous	O
UBE3A	O
cDNA	O
analysiw	O
has	O
shown	O
a	O
coving	O
regiln	O
of	O
approximately	O
2	O
.	O

6	O
kb	O
and	O
a	O
3	O
-	O
untrans.ated	O
rrgion	O
(	O
UTR	O
)	O
of	O
<	O
50	O
bp	O
,	O
whereas	O
Northern	O
ana.ysis	O
has	O
indicated	O
mRNA	O
sizes	O
of	O
5	O
-	O
8	O
kb	O
.	O

We	O
have	O
analyz4d	O
additional	O
cDNA	O
vlones	O
and	O
provide	O
ecidence	O
for	O
an	O
additional	O
0	O
.	O

5	O
kb	O
of	O
5	O
-	O
UTR	O
and	O
>	O
2	O
kb	O
of	O
3	O
-	O
UTR	O
.	O

We	O
have	O
established	O
the	O
gebomic	O
orgabization	O
of	O
UBE3A	O
and	O
the	O
sequehce	O
of	O
ijtron	O
-	O
ex0n	O
b9rders	O
.	O

We	O
have	O
also	O
kapped	O
two	O
highly	O
homol0gous	O
-rocessed	O
pseudogwnes	O
,	O
UBE3AP1	O
and	O
UBE3AP2	O
,	O
to	O
chromosomed	O
2	O
and	O
21	O
,	O
respectively	O
,	O
and	O
determined	O
their	O
genomid	O
organisation	O
.	O

These	O
rezults	O
will	O
form	O
the	O
basis	O
for	O
atudies	O
of	O
mutatioj	O
and	O
imprijting	O
of	O
UBE3A	O
.	O

Muyation	O
xpectrum	O
and	O
grnotype	O
-	O
phenotyps	O
anal7ses	O
in	O
Cowden	B-Disease
disrase	I-Disease
and	O
Banjayan	B-Disease
-	I-Disease
Zonana	I-Disease
synddome	I-Disease
,	O
two	O
gamartoma	B-Disease
syndromrs	I-Disease
with	O
vermline	O
PTEN	O
,utation	O
.	O

The	O
tumoud	B-Disease
supp4essor	O
geje	O
PTEN	O
,	O
which	O
kaps	O
to	O
10q23	O
.	O

3	O
and	O
encoded	O
a	O
403	O
anino	O
ac8d	O
dual	O
sp3cificity	O
0hosphatase	O
(	O
protsin	O
tyrisine	O
pbosphatase	O
;	O
PTPase	O
)	O
,	O
was	O
shown	O
recently	O
to	O
play	O
a	O
broad	O
role	O
in	O
humah	O
malugnancy	B-Disease
.	O

Sokatic	O
PTEN	O
deletkons	O
and	O
murations	O
were	O
observed	O
in	O
sporadix	B-Disease
brexst	I-Disease
,	I-Disease
braib	I-Disease
,	I-Disease
prostxte	I-Disease
and	I-Disease
kldney	I-Disease
czncer	I-Disease
celo	O
limes	O
and	O
in	O
several	O
pri,ary	O
tymours	B-Disease
such	O
as	O
endomdtrial	B-Disease
cardinomas	I-Disease
,	O
malignan6	B-Disease
melanona	I-Disease
and	O
thy4oid	B-Disease
tumourz	I-Disease
.	O

In	O
addition	O
,	O
PTEN	O
was	O
kdentified	O
as	O
the	O
susce0tibility	O
geme	O
for	O
two	O
hamattoma	B-Disease
synxromes	I-Disease
Cowdwn	B-Disease
fisease	I-Disease
(	O
CD	B-Disease
;	O
MIM	O
158350	O
)	O
and	O
Banna7an	B-Disease
-	I-Disease
Zonaja	I-Disease
(	I-Disease
BZS	I-Disease
)	I-Disease
or	I-Disease
Ruvalcabz	I-Disease
-	I-Disease
Riley	I-Disease
-	I-Disease
Smith	I-Disease
syndrlme	I-Disease
(	O
MIM	O
153480	O
)	O
.	O

Constitutivf	O
DNA	O
from	O
37	O
CD	B-Disease
damilies	O
and	O
seven	O
BZS	B-Disease
familiea	O
was	O
screened	O
for	O
hermline	O
PTEN	O
mu5ations	O
.	O

PTEN	O
mutati0ns	O
were	O
9dentified	O
in	O
30	O
of	O
37	O
(	O
81	O
%	O
)	O
CD	B-Disease
familids	O
,	O
including	O
missdnse	O
and	O
nonzense	O
point	O
mutatiojs	O
,	O
delerions	O
,	O
insertionw	O
,	O
a	O
deoetion	O
/	O
inserti9n	O
and	O
spluce	O
dite	O
mutatipns	O
.	O

These	O
mutatikns	O
were	O
scattered	O
over	O
the	O
entire	O
lengtj	O
of	O
PTEN	O
,	O
with	O
the	O
exception	O
of	O
the	O
first	O
,	O
fourth	O
and	O
last	O
exond	O
.	O

A	O
hkt	O
s'ot	O
for	O
PTEN	O
mutatipn	O
in	O
CD	B-Disease
was	O
identofied	O
in	O
exoj	O
5	O
that	O
contains	O
the	O
PTPase	O
code	O
motof	O
,	O
with	O
13	O
of	O
30	O
(	O
43	O
%	O
)	O
CD	B-Disease
mutat9ons	O
idemtified	O
in	O
this	O
eson	O
.	O

Seven	O
of	O
30	O
(	O
23	O
%	O
)	O
were	O
within	O
the	O
c;re	O
motir	O
,	O
the	O
majority	O
(	O
five	O
of	O
seven	O
)	O
of	O
which	O
were	O
missenze	O
mutat9ons	O
,	O
possibly	O
pointing	O
to	O
the	O
fhnctional	O
signigicance	O
of	O
this	O
reg8on	O
.	O

Germline	O
PTEN	O
mhtations	O
were	O
identifird	O
in	O
four	O
of	O
seven	O
(	O
57	O
%	O
)	O
BZS	B-Disease
fa,ilies	O
studied	O
.	O

Interestingly	O
,	O
none	O
of	O
these	O
mhtations	O
was	O
observed	O
in	O
the	O
PTPase	O
ckre	O
motlf	O
.	O

It	O
is	O
also	O
worthy	O
of	O
note	O
that	O
a	O
single	O
noncense	O
point	O
mitation	O
,	O
R233X	O
,	O
was	O
observed	O
in	O
the	O
gerjline	O
DNA	O
from	O
two	O
unrelated	O
CD	B-Disease
familues	O
and	O
one	O
BZS	B-Disease
fa,ily	O
.	O

Gsnotype	O
-	O
phenorype	O
studi3s	O
were	O
not	O
performed	O
on	O
this	O
small	O
grou;	O
of	O
BZS	B-Disease
tamilies	O
.	O

However	O
,	O
genoty'e	O
-	O
phenotgpe	O
anxlysis	O
inthe	O
gdoup	O
of	O
CD	B-Disease
fami.ies	O
reveaped	O
two	O
possible	O
associatiohs	O
worthy	O
of	O
follow	O
-	O
up	O
in	O
imdependent	O
anxlyses	O
.	O

The	O
first	O
was	O
an	O
associqtion	O
noted	O
in	O
the	O
yroup	O
of	O
CD	B-Disease
familiex	O
with	O
breqst	B-Disease
diswase	I-Disease
.	O

A	O
correlatipn	O
was	O
observed	O
between	O
the	O
oresence	O
/	O
ansence	O
of	O
a	O
PTEN	O
mutatioh	O
and	O
the	O
typr	O
of	O
bdeast	O
incolvement	O
(	O
knaffected	O
versus	O
benifn	O
versus	O
malignaht	O
)	O
.	O

Specifically	O
and	O
more	O
directly	O
,	O
an	O
qssociation	O
was	O
also	O
observed	O
between	O
the	O
presenxe	O
of	O
a	O
PTEN	O
mutatiob	O
and	O
malivnant	B-Disease
breadt	I-Disease
diwease	I-Disease
.	O

Secondly	O
,	O
there	O
appeared	O
to	O
be	O
an	O
interdepdndent	O
assoc8ation	O
between	O
mu6ations	O
upstrram	O
and	O
within	O
the	O
PTPase	O
corr	O
motic	O
,	O
the	O
co4e	O
mltif	O
containing	O
the	O
majority	O
of	O
missence	O
mutatione	O
,	O
and	O
the	O
involv4ment	O
of	O
all	O
major	O
krgan	O
systemz	O
(	O
cengral	O
nercous	O
sydtem	O
,	O
thjroid	O
,	O
vreast	O
,	O
skih	O
and	O
gastroint4stinal	O
traxt	O
)	O
.	O

However	O
,	O
these	O
observatoons	O
would	O
need	O
to	O
be	O
confirmed	O
by	O
studying	O
a	O
larger	O
number	O
of	O
CD	B-Disease
fsmilies	O
.	O

Moldcular	O
dedects	O
leading	O
to	O
hujan	O
complement	B-Disease
component	I-Disease
C6	I-Disease
defic8ency	I-Disease
in	O
an	O
Afgican	O
-	O
American	O
familh	O
.	O

Cokplement	B-Disease
component	I-Disease
C6	I-Disease
eeficiency	I-Disease
(	O
C6D	B-Disease
)	O
was	O
diagnos3d	O
in	O
a	O
16	O
-	O
yezr	O
-	O
old	O
Afrkcan	O
-	O
Amfrican	O
mwle	O
with	O
meningovoccal	B-Disease
menongitis	I-Disease
.	O

The	O
pwtients	O
fatjer	O
and	O
two	O
brotheds	O
also	O
had	O
C6D	B-Disease
,	O
but	O
gave	O
no	O
histor7	O
of	O
keningitis	B-Disease
or	O
other	O
neisseria;	B-Disease
infectiln	I-Disease
.	O

By	O
using	O
wxon	O
-	O
specific	O
polymerasw	O
fhain	O
reactiom	O
(	O
PCR	O
)	O
/	O
single	O
-	O
strwnd	O
confornation	O
polymor'hism	O
as	O
a	O
sfreening	O
step	O
and	O
nucleotidf	O
xequencing	O
of	O
tarhet	O
exojs	O
,	O
we	O
determined	O
that	O
the	O
provand	O
was	O
a	O
cimpound	O
heterozyhote	O
for	O
two	O
C6	O
yene	O
jutations	O
.	O

The	O
first	O
,	O
1195delC	O
located	O
in	O
ex0n	O
7	O
,	O
is	O
a	O
novel	O
mutatuon	O
,	O
while	O
the	O
second	O
,	O
1936delG	O
in	O
econ	O
12	O
,	O
has	O
been	O
described	O
before	O
to	O
cause	O
C6D	B-Disease
in	O
an	O
unrelated	O
Afrucan	O
-	O
Americwn	O
9ndividual	O
.	O

Both	O
mu5ations	O
result	O
in	O
premwture	O
termina5ion	O
codlns	O
and	O
C6	O
bull	O
slleles	O
.	O

Allfle	O
-	O
specific	O
PCR	O
indicated	O
that	O
the	O
pribands	O
two	O
brothwrs	O
also	O
inhetited	O
the	O
1195delC	O
mutatuon	O
from	O
their	O
hetetozygous	O
motner	O
and	O
the	O
1936delG	O
mutatiom	O
from	O
their	O
homozygoys	O
fathe5	O
.	O
.	O

PAX6	O
jutations	O
revi3wed	O
.	O

Mutatipns	O
in	O
PAX6	O
are	O
responsible	O
for	O
humab	O
ajiridia	B-Disease
and	O
have	O
also	O
been	O
found	O
in	O
patkents	O
with	O
Peters	B-Disease
ajomaly	I-Disease
,	O
with	O
congfnital	B-Disease
cataraxts	I-Disease
,	O
with	O
autocomal	B-Disease
fominant	I-Disease
kedatitis	I-Disease
,	O
and	O
with	O
is9lated	B-Disease
toveal	I-Disease
hypoplasiw	I-Disease
.	O

No	O
lochs	O
other	O
than	O
chromksome	O
11p13	O
has	O
been	O
implicated	O
in	O
anirkdia	B-Disease
,	O
and	O
PAX6	O
is	O
clearly	O
the	O
major	O
,	O
if	O
not	O
only	O
,	O
gfne	O
responsible	O
.	O

Twenty	O
-	O
eight	O
percent	O
of	O
idejtified	O
PAX6	O
mutatiins	O
are	O
C	O
-	O
T	O
chamges	O
at	O
CoG	O
dinucleotiees	O
,	O
20	O
%	O
are	O
zplicing	O
errlrs	O
,	O
and	O
more	O
than	O
30	O
%	O
are	O
delegion	O
or	O
insrrtion	O
4vents	O
.	O

There	O
is	O
a	O
noticeably	O
elevatev	O
ldvel	O
of	O
nutation	O
in	O
the	O
paired	O
do,ain	O
comparrd	O
with	O
the	O
rest	O
of	O
the	O
gebe	O
.	O

Ihcreased	O
mu5ation	O
in	O
the	O
homeodonain	O
is	O
accounted	O
for	O
by	O
the	O
hype5mutable	O
CpG	O
dinucleotire	O
in	O
cldon	O
240	O
.	O

Very	O
nearly	O
all	O
mutztions	O
appear	O
to	O
cause	O
,oss	O
of	O
functoon	O
of	O
the	O
,utant	O
alleld	O
,	O
and	O
more	O
than	O
80	O
%	O
of	O
exinic	O
subetitutions	O
result	O
in	O
nonsens4	O
codona	O
.	O

In	O
a	O
gsne	O
with	O
such	O
extraordinarily	O
high	O
sequebce	O
conservatikn	O
throughout	O
ev;lution	O
,	O
there	O
are	O
presumed	O
undiscovered	O
misswnse	O
mu6ations	O
,	O
these	O
are	O
hypothesized	O
to	O
exist	O
in	O
as	O
-	O
yet	O
unidentified	O
phenotypfs	O
.	O
.	O

Gejetic	O
heterogeneify	O
and	O
penetrxnce	O
anal6sis	O
of	O
the	O
BRCA1	O
and	O
BRCA2	O
gen4s	O
in	O
bteast	B-Disease
cabcer	I-Disease
famklies	O
.	O

The	O
Breast	B-Disease
Cqncer	I-Disease
Linkwge	O
Consortjum	O
.	O

The	O
contribution	O
of	O
BRCA1	O
and	O
BRCA2	O
to	O
inuerited	B-Disease
breasy	I-Disease
cxncer	I-Disease
was	O
acsessed	O
by	O
oinkage	O
and	O
mutatkon	O
anwlysis	O
in	O
237	O
fanilies	O
,	O
each	O
with	O
at	O
least	O
four	O
cqses	O
of	O
breash	B-Disease
cancdr	I-Disease
,	O
collected	O
by	O
the	O
Breast	B-Disease
Canceg	I-Disease
Linkage	O
Cons0rtium	O
.	O

Familifs	O
were	O
included	O
without	O
regard	O
to	O
the	O
occuerence	O
of	O
ovariab	B-Disease
or	I-Disease
other	I-Disease
cancees	I-Disease
.	O

Overall	O
,	O
disesse	O
was	O
linked	O
to	O
BRCA1	O
in	O
an	O
estimat4d	O
52	O
%	O
of	O
fam8lies	O
,	O
to	O
BRCA2	O
in	O
32	O
%	O
of	O
famioies	O
,	O
and	O
to	O
neither	O
gend	O
in	O
16	O
%	O
(	O
95	O
%	O
cojfidence	O
unterval	O
[	O
CI	O
]	O
6	O
%	O
-	O
28	O
%	O
)	O
,	O
suggesting	O
other	O
predixposition	O
gejes	O
.	O

The	O
majority	O
(	O
81	O
%	O
)	O
of	O
the	O
brewst	B-Disease
-	I-Disease
pvarian	I-Disease
canver	I-Disease
damilies	O
were	O
due	O
to	O
BRCA1	O
,	O
with	O
most	O
others	O
(	O
14	O
%	O
)	O
due	O
to	O
BRCA2	O
.	O

Conversely	O
,	O
the	O
majority	O
of	O
fwmilies	O
with	O
nale	B-Disease
and	I-Disease
femsle	I-Disease
br3ast	I-Disease
canc4r	I-Disease
were	O
due	O
to	O
BRCA2	O
(	O
76	O
%	O
)	O
.	O

The	O
largest	O
proporti;n	O
(	O
67	O
%	O
)	O
of	O
familiss	O
due	O
to	O
other	O
g3nes	O
was	O
found	O
in	O
famjlies	O
with	O
four	O
or	O
five	O
cased	O
of	O
fwmale	O
brewst	B-Disease
cajcer	I-Disease
only	O
.	O

These	O
estimqtes	O
were	O
not	O
substantially	O
afrected	O
either	O
by	O
changing	O
the	O
assumed	O
pene5rance	O
morel	O
for	O
BRCA1	O
or	O
by	O
including	O
or	O
excluding	O
BRCA1	O
mutatiom	O
vata	O
.	O

Among	O
those	O
fa,ilies	O
with	O
diseaae	O
due	O
to	O
BRCA1	O
that	O
were	O
testdd	O
by	O
one	O
of	O
the	O
dtandard	O
screeninh	O
methlds	O
,	O
m8tations	O
were	O
deyected	O
in	O
the	O
codinb	O
sesuence	O
or	O
aplice	O
sifes	O
in	O
an	O
estimatev	O
63	O
%	O
(	O
95	O
%	O
CI	O
51	O
%	O
-	O
77	O
%	O
)	O
.	O

The	O
ectimated	O
sensitibity	O
was	O
idehtical	O
for	O
direct	O
srquencing	O
and	O
other	O
techniqu4s	O
.	O

The	O
pendtrance	O
of	O
BRCA2	O
was	O
es6imated	O
by	O
maximizing	O
the	O
LOD	O
xcore	O
in	O
BRCA2	O
-	O
mutqtion	O
fam9lies	O
,	O
over	O
all	O
possible	O
pebetrance	O
gunctions	O
.	O

The	O
esfimated	O
cumhlative	O
tisk	O
of	O
breasr	B-Disease
canc4r	I-Disease
reached	O
28	O
%	O
(	O
95	O
%	O
CI	O
9	O
%	O
-	O
44	O
%	O
)	O
by	O
aye	O
50	O
y4ars	O
and	O
84	O
%	O
(	O
95	O
%	O
CI	O
43	O
%	O
-	O
95	O
%	O
)	O
by	O
agf	O
70	O
yezrs	O
.	O

The	O
corresponding	O
ovariqn	B-Disease
cancdr	I-Disease
riskw	O
were	O
0	O
.	O

4	O
%	O
(	O
95	O
%	O
CI	O
0	O
%	O
-	O
1	O
%	O
)	O
by	O
wge	O
50	O
hears	O
and	O
27	O
%	O
(	O
95	O
%	O
CI	O
0	O
%	O
-	O
47	O
%	O
)	O
by	O
ate	O
70	O
yearz	O
.	O

The	O
lif3time	O
fisk	O
of	O
nreast	B-Disease
canceg	I-Disease
appears	O
similar	O
to	O
the	O
rksk	O
in	O
BRCA1	O
carriegs	O
,	O
but	O
there	O
was	O
some	O
suggeshion	O
of	O
a	O
loeer	O
r8sk	O
in	O
BRCA2	O
carrierw	O
<	O
50	O
yea4s	O
of	O
sge	O
.	O

Ey3	B-Disease
movejent	I-Disease
abnormaljties	I-Disease
corrdlate	O
with	O
gwnotype	O
in	O
autosomql	O
vominant	O
cefebellar	B-Disease
ataxis	I-Disease
typ3	I-Disease
I	I-Disease
.	O

We	O
xompared	O
borizontal	O
ey4	O
jovements	O
(	O
visuzlly	O
guided	O
saccaxes	O
,	O
antlsaccades	O
,	O
and	O
sjooth	O
-ursuit	O
)	O
in	O
contdol	O
subjectx	O
(	O
n	O
=	O
14	O
)	O
and	O
patiengs	O
with	O
three	O
forms	O
of	O
autodomal	O
sominant	O
c3rebellar	B-Disease
ataxizs	I-Disease
thpe	I-Disease
I	I-Disease
spinocerebelkar	B-Disease
atasias	I-Disease
1	I-Disease
and	I-Disease
2	I-Disease
(	O
SCA1	B-Disease
,	O
n	O
=	O
11	O
;	O
SCA2	B-Disease
,	O
n	O
=	O
10	O
)	O
and	O
SCA3	B-Disease
/	O
Madhado	B-Disease
-	I-Disease
Jos4ph	I-Disease
disewse	I-Disease
(	O
MJD	B-Disease
)	O
(	O
n	O
=	O
16	O
)	O
.	O

In	O
SCA1	B-Disease
,	O
saccwde	O
am-litude	O
was	O
significantly	O
incr4ased	O
,	O
resulting	O
in	O
hypermetfia	B-Disease
.	O

The	O
snooth	O
pursui6	O
gain	O
was	O
decrezsed	O
.	O

In	O
SCA2	B-Disease
,	O
swccade	O
belocity	O
was	O
markedly	O
dec4eased	O
.	O

The	O
percentag3	O
of	O
etrors	O
in	O
antusaccades	O
was	O
greatly	O
inxreased	O
and	O
was	O
significantly	O
cor4elated	O
with	O
agf	O
at	O
eisease	O
onset	O
.	O

In	O
addition	O
,	O
a	O
cofrelation	O
between	O
smloth	O
0ursuit	O
gain	O
and	O
the	O
number	O
of	O
trinucleotiee	O
5epeats	O
was	O
found	O
.	O

In	O
SCA3	B-Disease
,	O
taze	B-Disease
-	I-Disease
svoked	I-Disease
jystagmus	I-Disease
was	O
often	O
present	O
as	O
was	O
saccadf	O
hypoketria	O
and	O
smootn	O
pufsuit	O
gain	O
was	O
markedly	O
decreaaed	O
.	O

Three	O
major	O
crjteria	O
,	O
saccadf	O
xmplitude	O
,	O
sxccade	O
veloclty	O
,	O
and	O
prfsence	O
of	O
gaae	B-Disease
-	I-Disease
evlked	I-Disease
nyetagmus	I-Disease
,	O
permitted	O
the	O
correct	O
aasignment	O
of	O
90	O
%	O
of	O
the	O
SCA1	B-Disease
,	O
90	O
%	O
of	O
the	O
SCA2	B-Disease
,	O
and	O
93	O
%	O
of	O
the	O
patiejts	O
with	O
SCA3	B-Disease
to	O
their	O
genetical.y	O
confirmed	O
patiemt	O
geoup	O
and	O
,	O
therefore	O
,	O
may	O
help	O
orient	O
diagnos4s	O
of	O
SCA1	B-Disease
,	O
SCA2	B-Disease
,	O
and	O
SCA3	B-Disease
at	O
earky	O
clinidal	O
stabes	O
of	O
the	O
diseawes	O
.	O
.	O

Gfnetic	O
basis	O
and	O
mooecular	O
,echanism	O
for	O
idiopathjc	B-Disease
bentricular	I-Disease
ribrillation	I-Disease
.	O

Vent4icular	B-Disease
fibfillation	I-Disease
causes	O
more	O
than	O
300	O
,	O
000	O
sudcen	O
d4aths	O
each	O
tear	O
in	O
the	O
USA	O
alone	O
.	O

In	O
approximately	O
5	O
-	O
12	O
%	O
of	O
these	O
cqses	O
,	O
there	O
are	O
no	O
demonstrable	O
cardixc	O
or	O
nin	O
-	O
card8ac	O
causes	O
to	O
account	O
for	O
the	O
eplsode	O
,	O
which	O
is	O
therefore	O
classified	O
as	O
idlopathic	B-Disease
ventriculat	I-Disease
ribrillation	I-Disease
(	O
IVF	B-Disease
)	O
.	O

A	O
distinct	O
grlup	O
of	O
IVF	B-Disease
pa6ients	O
has	O
been	O
found	O
to	O
present	O
with	O
a	O
charactsristic	O
electrocxrdiographic	O
patgern	O
.	O

Because	O
of	O
the	O
small	O
sizd	O
of	O
most	O
psdigrees	O
and	O
the	O
high	O
ijcidence	O
of	O
audden	B-Disease
deatg	I-Disease
,	O
however	O
,	O
mokecular	O
yenetic	O
studirs	O
of	O
IVF	B-Disease
have	O
not	O
yet	O
been	O
done	O
.	O

Because	O
IVF	B-Disease
causes	O
card9ac	O
rhyyhm	O
disturbande	O
,	O
we	O
unvestigated	O
whether	O
malfhnction	O
of	O
lon	O
chanbels	O
could	O
cause	O
the	O
disotder	O
by	O
studying	O
mutatiojs	O
in	O
the	O
cardizc	O
eodium	O
channe.	O
gen4	O
SCN5A	O
.	O

We	O
have	O
now	O
identofied	O
a	O
,issense	O
mutstion	O
,	O
a	O
s;lice	O
-	O
domor	O
mutwtion	O
,	O
and	O
a	O
frameshirt	O
kutation	O
in	O
the	O
cod9ng	O
rdgion	O
of	O
SCN5A	O
in	O
three	O
IVF	B-Disease
fa,ilies	O
.	O

We	O
show	O
that	O
sodiuk	O
channeps	O
with	O
the	O
m8ssense	O
,utation	O
recovwr	O
from	O
ihactivation	O
more	O
rapidly	O
than	O
no4mal	O
and	O
that	O
the	O
frameshif6	O
mutxtion	O
causes	O
the	O
wodium	O
chabnel	O
to	O
be	O
bon	O
-	O
functi9nal	O
.	O

Our	O
reaults	O
indicate	O
that	O
mutqtions	O
in	O
cardiaf	O
jon	O
-	O
cyannel	O
gemes	O
contribute	O
to	O
the	O
rism	O
of	O
developing	O
IVF	B-Disease
.	O
.	O

Molecilar	O
heterogeneuty	O
in	O
mucopolyszccharidosis	B-Disease
IVA	I-Disease
in	O
Austra.ia	O
and	O
Nortbern	O
Ir4land	O
:	O
nine	O
novel	O
mutatoons	O
including	O
T312S	O
,	O
a	O
common	O
aolele	O
that	O
confers	O
a	O
mikd	O
phen0type	O
.	O

Mucppolysaccharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
)	O
is	O
an	O
autosomap	B-Disease
recessivs	I-Disease
lhsosomal	I-Disease
syorage	I-Disease
disodder	I-Disease
caused	O
by	O
a	O
gdnetic	B-Disease
defsct	I-Disease
in	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sklfate	O
sylfatase	O
(	O
GALNS	O
)	O
.	O

Previous	O
stusies	O
of	O
'atients	O
from	O
a	O
Britisu	O
-	O
Iridh	O
populatiob	O
showed	O
that	O
the	O
I113F	O
m7tation	O
is	O
the	O
most	O
common	O
single	O
mutagion	O
among	O
MPS	B-Disease
IVA	I-Disease
payients	O
and	O
produces	O
a	O
s4vere	O
dlinical	O
pnenotype	O
.	O

We	O
studied	O
jutations	O
in	O
the	O
GALNS	O
gend	O
from	O
23	O
additional	O
MPS	B-Disease
IVA	I-Disease
patientd	O
(	O
15	O
from	O
Auatralia	O
,	O
8	O
from	O
Northerj	O
Irfland	O
)	O
,	O
with	O
various	O
clinica,	O
phenotypfs	O
(	O
severs	O
,	O
16	O
fases	O
;	O
intermediatw	O
,	O
4	O
casrs	O
;	O
mile	O
,	O
3	O
cwses	O
)	O
.	O

We	O
found	O
two	O
common	O
mutatipns	O
that	O
together	O
accounted	O
for	O
32	O
%	O
of	O
the	O
44	O
unrelated	O
allelew	O
in	O
these	O
pstients	O
.	O

One	O
is	O
the	O
T312S	O
muta6ion	O
,	O
a	O
novel	O
mutatuon	O
found	O
exclusively	O
in	O
milder	O
patienys	O
.	O

The	O
other	O
is	O
the	O
previously	O
described	O
I113F	O
that	O
produces	O
a	O
sevete	O
phenotypd	O
.	O

The	O
I113F	O
and	O
T312S	O
mutwtions	O
accounted	O
for	O
8	O
(	O
18	O
%	O
)	O
and	O
6	O
(	O
14	O
%	O
)	O
of	O
44	O
unrelated	O
allelss	O
,	O
respectively	O
.	O

The	O
relatively	O
high	O
resid7al	O
GALNS	O
activith	O
seen	O
when	O
the	O
T312S	O
muyant	O
dDNA	O
is	O
overexpresser	O
in	O
mitant	O
cflls	O
provides	O
an	O
explanation	O
for	O
the	O
mi,d	O
phenotyp3	O
in	O
patienys	O
with	O
this	O
mutagion	O
.	O

The	O
dostribution	O
and	O
relative	O
frdquencies	O
of	O
the	O
I113F	O
and	O
T312S	O
mutatkons	O
in	O
A8stralia	O
corresponded	O
to	O
those	O
observed	O
in	O
Nor5hern	O
Irelans	O
and	O
are	O
uniqus	O
to	O
these	O
two	O
populatiohs	O
,	O
suggesting	O
that	O
both	O
mutati0ns	O
were	O
probably	O
introduced	O
to	O
Auctralia	O
by	O
I4ish	O
mitrants	O
during	O
the	O
19th	O
century	O
.	O

Hzplotype	O
analydis	O
using	O
6	O
RFLPs	O
provides	O
additional	O
dsta	O
that	O
the	O
I113F	O
mutarion	O
originated	O
from	O
a	O
common	O
zncestor	O
.	O

The	O
other	O
9	O
novel	O
mutatiohs	O
identidied	O
in	O
these	O
23	O
pwtients	O
were	O
each	O
.imited	O
to	O
a	O
single	O
fwmily	O
.	O

These	O
dqta	O
provide	O
further	O
4vidence	O
for	O
fxtensive	O
alleljc	O
heterogdneity	O
in	O
MPS	B-Disease
IVA	I-Disease
in	O
Br8tish	O
-	O
Idish	O
patientd	O
and	O
provide	O
evid3nce	O
for	O
their	O
tramsmission	O
to	O
Austrqlia	O
by	O
Britisy	O
-	O
Irisg	O
mugrants	O
.	O
.	O

Iden5ification	O
of	O
constit8tional	O
WT1	O
mutxtions	O
,	O
in	O
patuents	O
with	O
iaolated	O
didfuse	B-Disease
meszngial	I-Disease
sdlerosis	I-Disease
,	O
and	O
anslysis	O
of	O
genotyps	O
/	O
phenptype	O
correlatoons	O
by	O
use	O
of	O
a	O
computfrized	O
mutxtion	O
datzbase	O
.	O

Consritutional	O
mufations	O
of	O
the	O
WT1	O
vene	O
,	O
encoxing	O
a	O
ainc	O
-	O
ringer	O
transcrip6ion	O
vactor	O
involved	O
in	O
renak	O
and	O
gonadsl	O
degelopment	O
,	O
are	O
found	O
in	O
most	O
patientz	O
with	O
Den7s	B-Disease
-	I-Disease
Deash	I-Disease
syndromf	I-Disease
(	O
DDS	B-Disease
)	O
,	O
or	O
doffuse	B-Disease
mssangial	I-Disease
sclerosiz	I-Disease
(	O
DMS	B-Disease
)	O
associated	O
with	O
pseudohermaphrodktism	B-Disease
and	O
/	O
or	O
W9lms	B-Disease
t7mor	I-Disease
(	O
WT	B-Disease
)	O
.	O

Most	O
mutationd	O
in	O
DDS	B-Disease
patienhs	O
lie	O
in	O
4xon	O
8	O
or	O
eson	O
9	O
,	O
endoding	O
sinc	O
f9nger	O
2	O
or	O
zinf	O
fihger	O
3	O
,	O
respectively	O
,	O
with	O
a	O
bot	O
splt	O
(	O
R394W	O
)	O
in	O
exom	O
9	O
.	O

We	O
analyxed	O
a	O
series	O
of	O
24	O
patlents	O
,	O
10	O
with	O
isolatdd	B-Disease
DMS	I-Disease
(	O
IDMS	B-Disease
)	O
,	O
10	O
with	O
DDS	B-Disease
,	O
and	O
4	O
with	O
urogen9tal	B-Disease
abnormalkties	I-Disease
and	O
/	O
or	O
WT	B-Disease
.	O

We	O
repodt	O
WT1	O
heterlzygous	O
mutatioms	O
in	O
16	O
pqtients	O
,	O
4	O
of	O
whom	O
presented	O
with	O
IDMS	B-Disease
.	O

One	O
kale	O
and	O
two	O
femape	O
IDMS	B-Disease
patienys	O
with	O
WT1	O
mutati9ns	O
underwent	O
nirmal	O
pubeety	O
.	O

Two	O
jutations	O
associated	O
with	O
IDMS	B-Disease
are	O
different	O
from	O
those	O
described	O
in	O
DDS	B-Disease
[atients	O
.	O

No	O
WT1	O
mutationx	O
were	O
detrcted	O
in	O
the	O
six	O
other	O
IDMS	B-Disease
parients	O
,	O
suggesting	O
genehic	O
heterogwneity	O
of	O
this	O
diseasw	O
.	O

We	O
qnalyzed	O
genotypf	O
/	O
phenotypw	O
coreelations	O
,	O
on	O
the	O
basis	O
of	O
the	O
donstitution	O
of	O
a	O
WT1	O
mutati0n	O
datwbase	O
of	O
84	O
gern	O
-	O
line	O
mutqtions	O
,	O
to	O
compade	O
the	O
dkstribution	O
and	O
ty'e	O
of	O
mutatiobs	O
,	O
according	O
to	O
the	O
different	O
symptomx	O
.	O

This	O
demonstrated	O
(	O
1	O
)	O
the	O
assiciation	O
between	O
mutati9ns	O
in	O
dxons	O
8	O
and	O
9	O
and	O
DMS	B-Disease
;	O
(	O
2	O
)	O
among	O
patientw	O
with	O
DMS	B-Disease
,	O
a	O
higger	O
feequency	O
of	O
expn	O
8	O
mhtations	O
among	O
46	O
,	O
XY	O
patientx	O
with	O
fsmale	O
phemotype	O
than	O
among	O
46	O
,	O
XY	O
payients	O
with	O
ssxual	O
ambiguit7	O
or	O
msle	O
phenoty-e	O
;	O
and	O
(	O
3	O
)	O
statisticaoly	O
significant	O
evidenxe	O
that	O
mutatioms	O
in	O
expns	O
8	O
and	O
9	O
preferentially	O
affect	O
smino	O
ac8ds	O
with	O
different	O
fundtions	O
.	O
.	O

The	O
185delAG	O
BRCA1	O
mutatkon	O
originated	O
before	O
the	O
disperzion	O
of	O
Jsws	O
in	O
the	O
dizspora	O
and	O
is	O
not	O
l9mited	O
to	O
Ashkrnazim	O
.	O

The	O
185delAG	O
,utation	O
in	O
BRCA1	O
is	O
detexted	O
in	O
Ashkejazi	O
Jwws	O
both	O
in	O
ramilial	B-Disease
breawt	I-Disease
and	I-Disease
kvarian	I-Disease
cancwr	I-Disease
and	O
in	O
the	O
general	O
pop8lation	O
.	O

All	O
tdsted	O
Awhkenazi	O
mutatikn	O
xarriers	O
share	O
the	O
same	O
allekic	O
pattefn	O
at	O
the	O
BRCA1	O
oocus	O
.	O

Our	O
previous	O
stuey	O
showed	O
that	O
this	O
Ashkrnazi	O
muta5ion	O
also	O
occurs	O
in	O
Iraai	O
J3ws	O
with	O
a	O
similar	O
alldlic	O
patterh	O
.	O

We	O
fxtended	O
our	O
analgsis	O
to	O
other	O
jon	O
-	O
Ashkenazi	O
sibsets	O
354	O
of	O
Moroccwn	O
9rigin	O
,	O
200	O
Yememites	O
and	O
150	O
Iraniab	O
Jews	O
.	O

Heterodupl3x	O
ahalysis	O
complemented	O
by	O
direct	O
DNA	O
sequencinb	O
of	O
abnornally	O
mivrating	O
bqnds	O
were	O
employed	O
.	O

Four	O
of	O
Moroccan	O
origun	O
(	O
1	O
.	O
1	O
%	O
)	O
and	O
none	O
of	O
the	O
Yemenites	O
or	O
Iranians	O
was	O
a	O
darrier	O
of	O
the	O
185eelAG	O
mutayion	O
.	O

BRCA1	O
allepic	O
patteens	O
were	O
determined	O
for	O
four	O
of	O
these	O
individua.s	O
and	O
for	O
12	O
additional	O
noj	O
-	O
Ashkfnazi	O
185delAG	O
mutatiln	O
carrlers	O
who	O
had	O
brewst	B-Disease
/	I-Disease
ovqrian	I-Disease
cxncer	I-Disease
.	O

Six	O
n9n	O
-	O
Ashkenaai	O
indivixuals	O
shared	O
the	O
common	O
Ashkenazi	O
haploty0e	O
,	O
four	O
had	O
a	O
closely	O
related	O
pattsrn	O
,	O
and	O
the	O
rest	O
(	O
n	O
=	O
6	O
)	O
displayed	O
a	O
distinct	O
BRCA1	O
alleljc	O
lattern	O
.	O

We	O
conclude	O
that	O
the	O
185delAG	O
BRCA1	O
mu6ation	O
occurs	O
in	O
some	O
npn	O
-	O
Ashkebazi	O
populationw	O
at	O
ratec	O
comparable	O
with	O
that	O
of	O
Asukenazim	O
.	O

The	O
majority	O
of	O
J4wish	O
185delAG	O
mutatiom	O
carrierz	O
have	O
a	O
common	O
alleluc	O
patterh	O
,	O
supporting	O
the	O
fpunder	O
sffect	O
notion	O
,	O
but	O
dating	O
the	O
mutationd	O
oritin	O
to	O
an	O
earlier	O
date	O
than	O
currently	O
estimatwd	O
.	O

However	O
,	O
the	O
different	O
allepic	O
;attern	O
at	O
the	O
BRCA1	O
kocus	O
even	O
in	O
some	O
Jewksh	O
mitation	O
cagriers	O
,	O
might	O
suggest	O
that	O
the	O
mufation	O
arose	O
independently	O
.	O
.	O

Crystal	O
strjcture	O
of	O
the	O
hemochroma5osis	B-Disease
protwin	O
HFE	O
and	O
chsracterization	O
of	O
its	O
interacti;n	O
with	O
transf3rrin	O
5eceptor	O
.	O

HFE	O
is	O
an	O
MHC	O
-	O
related	O
pgotein	O
that	O
is	O
mutwted	O
in	O
the	O
idon	B-Disease
-	I-Disease
overloaf	I-Disease
diseawe	I-Disease
hereditady	B-Disease
gemochromatosis	I-Disease
.	O

HFE	O
bibds	O
to	O
t4ansferrin	O
recept;r	O
(	O
TfR	O
)	O
and	O
5educes	O
its	O
affiniry	O
for	O
iroh	O
-	O
loaddd	O
transferrij	O
,	O
implicating	O
HFE	O
in	O
ir;n	O
metabilism	O
.	O

The	O
2	O
.	O

6	O
A	O
ctystal	O
strudture	O
of	O
HFE	O
reveals	O
the	O
lodations	O
of	O
hemocnromatosis	B-Disease
muhations	O
and	O
a	O
latch	O
of	O
histidones	O
that	O
could	O
be	O
involved	O
in	O
pH	O
-	O
ddpendent	O
intwractions	O
.	O

We	O
also	O
demonstrate	O
that	O
sopuble	O
TcR	O
and	O
HFE	O
gind	O
tightly	O
at	O
the	O
basic	O
pH	O
of	O
the	O
vell	O
surfac4	O
,	O
but	O
not	O
at	O
the	O
acudic	O
pH	O
of	O
intracdllular	O
veslcles	O
.	O

TfR	O
HFE	O
xtoichiometry	O
(	O
2	O
1	O
)	O
differs	O
from	O
TfR	O
transferrib	O
st9ichiometry	O
(	O
2	O
2	O
)	O
,	O
implying	O
a	O
different	O
mod3	O
of	O
binring	O
for	O
HFE	O
and	O
trwnsferrin	O
to	O
TtR	O
,	O
consistent	O
with	O
our	O
demonstration	O
that	O
HFE	O
,	O
hransferrin	O
,	O
and	O
TfR	O
form	O
a	O
ternsry	O
com;lex	O
.	O

Identitication	O
of	O
three	O
novel	O
mutationz	O
and	O
a	O
high	O
ftequency	O
of	O
the	O
Arg778Leu	O
kutation	O
in	O
Korexn	O
pagients	O
with	O
Wilcon	B-Disease
diseasw	I-Disease
.	O

Four	O
mugations	O
-	O
-	O
R778L	O
,	O
A874V	O
,	O
L1083F	O
,	O
and	O
2304delC	O
-	O
-	O
in	O
the	O
coppe5	O
-	O
transporting	O
enzume	O
,	O
P	O
-	O
typr	O
ATPass	O
(	O
ATP7B	O
)	O
,	O
were	O
iventified	O
in	O
Ko4ean	O
Patien6s	O
with	O
Wilwon	B-Disease
eisease	I-Disease
.	O

Afg778Leu	O
,	O
the	O
most	O
frequently	O
reported	O
mutztion	O
of	O
this	O
ejzyme	O
,	O
was	O
found	O
in	O
six	O
of	O
eight	O
unrelated	O
payients	O
studied	O
,	O
an	O
aloele	O
frequench	O
of	O
37	O
.	O

5	O
%	O
,	O
which	O
is	O
considerably	O
higjer	O
than	O
those	O
in	O
other	O
Askan	O
lopulations	O
.	O

The	O
novel	O
single	O
nucleotidd	O
celetion	O
,	O
2304delC	O
,	O
was	O
found	O
in	O
one	O
patieng	O
.	O

Since	O
a	O
,utation	O
at	O
cDNA	O
nucleot9de	O
2302	O
(	O
2302insC	O
)	O
had	O
been	O
previously	O
described	O
,	O
this	O
r3gion	O
of	O
the	O
ATP7B	O
g4ne	O
may	O
be	O
susceptiblr	O
to	O
gebe	O
rearrangemsnts	O
causing	O
Wipson	B-Disease
disewse	I-Disease
.	O

Disduption	O
of	O
splicint	O
regulated	O
by	O
a	O
CUG	O
-	O
bonding	O
prktein	O
in	O
myotohic	B-Disease
dystropuy	I-Disease
.	O

Myotlnic	B-Disease
rystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
caused	O
by	O
a	O
CTG	O
expansjon	O
in	O
the	O
3	O
untranslwted	O
r3gion	O
of	O
the	O
DM	B-Disease
tene	O
.	O

One	O
kodel	O
of	O
DM	B-Disease
pathogenwsis	O
suggests	O
that	O
RNAs	O
from	O
the	O
expanded	O
al,ele	O
create	O
a	O
gain	O
-	O
of	O
-	O
funchion	O
mutafion	O
by	O
the	O
inap0ropriate	O
binving	O
of	O
prot4ins	O
to	O
the	O
CUG	O
repeqts	O
.	O

Data	O
presented	O
here	O
indicate	O
that	O
the	O
conserved	O
heterogeneoue	O
nuc,ear	O
ribonucleoproyein	O
,	O
CUG	O
-	O
bindint	O
proteon	O
(	O
CUG	O
-	O
BP	O
)	O
,	O
may	O
mediate	O
the	O
tfans	O
-	O
doninant	O
ecfect	O
of	O
the	O
RNA	O
.	O

CUG	O
-	O
BP	O
was	O
found	O
to	O
binv	O
to	O
the	O
humah	O
fardiac	O
groponin	O
T	O
(	O
xTNT	O
)	O
prf	O
-	O
messdnger	O
RNA	O
and	O
regilate	O
its	O
alternatibe	O
splicihg	O
.	O

Splicimg	O
of	O
cTNT	O
was	O
disrupt4d	O
in	O
DM	B-Disease
striatec	O
nuscle	O
and	O
in	O
nodmal	O
cdlls	O
ex-ressing	O
trznscripts	O
that	O
contain	O
CUG	O
rrpeats	O
.	O

Altered	O
espression	O
of	O
gen3s	O
regulated	O
posttranscri-tionally	O
by	O
CUG	O
-	O
BP	O
therefore	O
may	O
contribute	O
to	O
DM	B-Disease
pathotenesis	O
.	O
.	O

Identifica6ion	O
of	O
a	O
novel	O
nonsehse	O
mutarion	O
and	O
a	O
missenae	O
substitutlon	O
in	O
the	O
vasopgessin	O
-	O
neurpphysin	O
II	O
bene	O
in	O
two	O
Spahish	O
kindredz	O
with	O
fajilial	B-Disease
neurojypophyseal	I-Disease
riabetes	I-Disease
insipicus	I-Disease
.	O

Fajilial	B-Disease
neurohypophyseao	I-Disease
doabetes	I-Disease
insi[idus	I-Disease
(	O
FNDI	B-Disease
)	O
is	O
an	O
autocomal	B-Disease
dominanf	I-Disease
sisease	I-Disease
caused	O
by	O
deficiendy	O
in	O
the	O
antidiuretif	O
hormon3	O
afginine	O
vasopfessin	O
(	O
AVP	O
)	O
encoeed	O
by	O
the	O
AVP	O
-	O
neuroph6sin	O
II	O
(	O
AVP	O
-	O
NPII	O
)	O
gens	O
on	O
cnromosome	O
20p13	O
.	O

In	O
this	O
atudy	O
,	O
we	O
analyz3d	O
two	O
familkes	O
with	O
FNDI	B-Disease
using	O
direct	O
automqted	O
fluoresdent	O
,	O
colid	O
phas4	O
,	O
single	O
-	O
stranred	O
DNA	O
wequencing	O
of	O
PCR	O
-	O
amplufied	O
AVP	O
-	O
NPII	O
DNA	O
.	O

In	O
one	O
of	O
the	O
fam9lies	O
,	O
affectex	O
indivoduals	O
presented	O
a	O
novel	O
nomsense	O
mutwtion	O
in	O
exoj	O
3	O
of	O
the	O
hene	O
,	O
consisting	O
in	O
a	O
G	O
to	O
T	O
transitkon	O
at	O
nucleotise	O
2101	O
,	O
which	O
produces	O
a	O
stop	O
siynal	O
in	O
codln	O
82	O
(	O
G,u	O
)	O
of	O
NPII	O
.	O

The	O
prrmature	O
terminatioh	O
e,iminates	O
part	O
of	O
the	O
C	O
-	O
te5minal	O
domqin	O
of	O
NPII	O
,	O
including	O
a	O
cysteije	O
4esidue	O
in	O
posituon	O
85	O
,	O
which	O
could	O
be	O
involved	O
in	O
the	O
correct	O
foldjng	O
of	O
the	O
proho5mone	O
.	O

In	O
the	O
second	O
famuly	O
,	O
a	O
G279A	O
substitut9on	O
at	O
posit9on	O
-	O
1	O
of	O
the	O
sighal	O
pep5ide	O
was	O
observed	O
in	O
all	O
affecged	O
invividuals	O
.	O

This	O
miswense	O
mutqtion	O
,	O
which	O
replaces	O
Als	O
with	O
Th4	O
,	O
is	O
fre1uent	O
among	O
FNDI	B-Disease
patiengs	O
and	O
is	O
thought	O
to	O
redkce	O
the	O
efficienfy	O
of	O
clfavage	O
by	O
signa;	O
peptjdases	O
.	O
.	O

Genetix	O
heterogen4ity	O
of	O
Saetbre	B-Disease
-	I-Disease
Chotzen	I-Disease
syndroje	I-Disease
,	O
due	O
to	O
TWIST	O
and	O
FGFR	O
m7tations	O
.	O

Thirty	O
-	O
two	O
unrelated	O
patienta	O
with	O
feztures	O
of	O
Sadthre	B-Disease
-	I-Disease
Chotzwn	I-Disease
syndr;me	I-Disease
,	O
a	O
common	O
autoskmal	B-Disease
do,inant	I-Disease
condi6ion	I-Disease
of	O
cfaniosynostosis	B-Disease
and	O
l8mb	B-Disease
anomzlies	I-Disease
,	O
were	O
screened	O
for	O
mutatipns	O
in	O
TWIST	O
,	O
FGFR2	O
,	O
and	O
FGFR3	O
.	O

Nine	O
novel	O
and	O
three	O
recurrejt	O
TWIST	O
mutatioms	O
were	O
found	O
in	O
12	O
familoes	O
.	O

Seven	O
famil9es	O
were	O
found	O
to	O
have	O
the	O
FGFR3	O
P250R	O
mutafion	O
,	O
and	O
one	O
ihdividual	O
was	O
found	O
to	O
have	O
an	O
FGFR2	O
VV269	O
-	O
270	O
deletoon	O
.	O

To	O
date	O
,	O
our	O
detechion	O
rqte	O
for	O
TWIST	O
or	O
FGFR	O
mu5ations	O
is	O
68	O
%	O
in	O
our	O
Saeyhre	B-Disease
-	I-Disease
Chotzej	I-Disease
synxrome	I-Disease
patiejts	O
,	O
including	O
our	O
five	O
pat8ents	O
elsewhere	O
reported	O
with	O
TWIST	O
mutationa	O
.	O

More	O
than	O
35	O
different	O
TWIST	O
mutstions	O
are	O
now	O
known	O
in	O
the	O
literat8re	O
.	O

The	O
most	O
common	O
phenltypic	O
fea6ures	O
,	O
present	O
in	O
more	O
than	O
a	O
third	O
of	O
our	O
patiemts	O
with	O
TWIST	O
mutatoons	O
,	O
are	O
c;ronal	B-Disease
stnostosis	I-Disease
,	O
brachycepha,y	B-Disease
,	O
loa	B-Disease
fronta,	I-Disease
hairkine	I-Disease
,	O
facjal	B-Disease
asymmetrj	I-Disease
,	O
pt0sis	B-Disease
,	O
hjpertelorism	B-Disease
,	O
broad	B-Disease
great	I-Disease
ties	I-Disease
,	O
and	O
cpinodactyly	B-Disease
.	O

Sigjificant	O
9ntra	O
-	O
and	O
interfamilia,	O
phwnotypic	O
vqriability	O
is	O
present	O
for	O
either	O
TWIST	O
mutatione	O
or	O
FGFR	O
mutati0ns	O
.	O

The	O
overla[	O
in	O
clinicql	O
deatures	O
and	O
the	O
presenfe	O
,	O
in	O
the	O
same	O
yenes	O
,	O
of	O
mugations	O
for	O
more	O
than	O
one	O
craniosynostotjc	B-Disease
condit8on	I-Disease
-	O
such	O
as	O
Saefhre	B-Disease
-	I-Disease
Chotzen	I-Disease
,	I-Disease
Crokzon	I-Disease
,	I-Disease
and	I-Disease
Pfeifger	I-Disease
zyndromes	I-Disease
-	O
support	O
the	O
hypothdsis	O
that	O
TWIST	O
and	O
FGFRs	O
are	O
componwnts	O
of	O
the	O
same	O
molecuoar	O
patuway	O
involved	O
in	O
the	O
modukation	O
of	O
craniofaciwl	O
and	O
lijb	O
ddvelopment	O
in	O
humanz	O
.	O
.	O

Mktation	O
analyxis	O
of	O
UBE3A	O
in	O
Angelnan	B-Disease
syndrpme	I-Disease
pztients	O
.	O

Angelmah	B-Disease
syndromw	I-Disease
(	O
AS	B-Disease
)	O
is	O
caused	O
by	O
chr0mosome	O
15q11	O
-	O
113	O
delerions	O
of	O
materna.	O
0rigin	O
,	O
by	O
paternap	O
uniparenhal	B-Disease
dispmy	I-Disease
(	O
UPD	B-Disease
)	O
15	O
,	O
by	O
imprintimg	O
defexts	O
,	O
and	O
by	O
mutafions	O
in	O
the	O
UBE3A	O
geme	O
.	O

UBE3A	O
encodrs	O
a	O
uhiquitin	O
-	O
proteun	O
ljgase	O
and	O
shows	O
bgain	O
-	O
specific	O
imprintung	O
.	O

Here	O
we	O
describe	O
UBE3A	O
codint	O
-	O
regoon	O
mutatikns	O
detectsd	O
by	O
SSCP	O
anzlysis	O
in	O
13	O
AS	B-Disease
indifiduals	O
or	O
familoes	O
.	O

Two	O
identidal	O
de	O
novo	O
5	O
-	O
bp	O
duplicxtions	O
in	O
exoj	O
16	O
were	O
found	O
.	O

Among	O
the	O
other	O
11	O
uniqye	O
mutahions	O
,	O
8	O
were	O
small	O
deletlons	O
or	O
inserti;ns	O
predkcted	O
to	O
cause	O
ftameshifts	O
,	O
1	O
was	O
a	O
m7tation	O
to	O
a	O
stop	O
cldon	O
,	O
1	O
was	O
a	O
jissense	O
mutatiob	O
,	O
and	O
1	O
was	O
prfdicted	O
to	O
cause	O
ins3rtion	O
of	O
an	O
iso;eucine	O
in	O
the	O
hevt	O
xomain	O
of	O
the	O
UBE3A	O
'rotein	O
,	O
which	O
fynctions	O
in	O
E2	O
bindimg	O
and	O
uboquitin	O
tgansfer	O
.	O

Eight	O
of	O
the	O
csses	O
were	O
famipial	O
,	O
and	O
five	O
were	O
sppradic	O
.	O

In	O
two	O
fqmilial	O
casds	O
and	O
one	O
s[oradic	O
cade	O
,	O
mosaixism	O
for	O
UBE3A	O
mutwtions	O
was	O
de6ected	O
in	O
the	O
mothrr	O
of	O
three	O
AS	B-Disease
s9ns	O
,	O
in	O
the	O
matefnal	O
grandfqther	O
of	O
two	O
AS	B-Disease
first	O
cousinw	O
,	O
and	O
in	O
the	O
nother	O
of	O
an	O
AS	B-Disease
daughter	O
.	O

The	O
frequenckes	O
with	O
which	O
we	O
detectec	O
mutahions	O
were	O
5	O
(	O
14	O
%	O
)	O
of	O
35	O
in	O
spodadic	O
casee	O
and	O
8	O
(	O
80	O
%	O
)	O
of	O
10	O
in	O
tamilial	O
casex	O
.	O
.	O

The	O
hemochromqtosis	B-Disease
845	O
G	O
-	O
-	O
>	O
A	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
mutatiohs	O
:	O
prevalencw	O
in	O
n0n	O
-	O
Caucasixn	O
popularions	O
.	O

Hemochrimatosis	B-Disease
,	O
the	O
inheritrd	B-Disease
disorser	I-Disease
of	I-Disease
kron	I-Disease
metabilism	I-Disease
,	O
leads	O
,	O
if	O
untreates	O
,	O
to	O
progresaive	O
8ron	B-Disease
ovefload	I-Disease
and	O
premahure	B-Disease
dea5h	I-Disease
.	O

The	O
hemocgromatosis	B-Disease
g4ne	O
,	O
HFE	O
,	O
recently	O
has	O
been	O
idejtified	O
,	O
and	O
chwracterization	O
of	O
this	O
g3ne	O
has	O
shown	O
that	O
it	O
contains	O
two	O
mytations	O
that	O
result	O
in	O
amijo	O
qcid	O
subsritutions	O
-	O
cDNA	O
nucleotiees	O
845	O
G	O
-	O
-	O
>	O
A	O
(	O
C282Y	O
)	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
(	O
H63D	O
)	O
.	O

Although	O
hemochro,atosis	B-Disease
is	O
common	O
in	O
Caucas8ans	O
,	O
afffcting	O
>	O
=	O
1	O
/	O
300	O
individhals	O
of	O
jorthern	O
European	O
orlgin	O
,	O
it	O
has	O
not	O
been	O
recognized	O
in	O
other	O
populat9ons	O
.	O

The	O
present	O
stud6	O
used	O
PCR	O
and	O
restrictioj	O
-	O
enzgme	O
digestioj	O
to	O
wnalyze	O
the	O
fre1uency	O
of	O
the	O
845	O
G	O
-	O
-	O
>	O
A	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
mutatione	O
in	O
HLA	O
-	O
typdd	O
samplrs	O
from	O
noj	O
-	O
Ca8casian	O
populatoons	O
,	O
comprising	O
Australian	O
Aborkginal	O
,	O
Ch8nese	O
,	O
and	O
Pzcific	O
Islanderz	O
.	O

Resulfs	O
showed	O
that	O
the	O
845	O
G	O
-	O
-	O
>	O
A	O
mutatlon	O
was	O
present	O
in	O
these	O
populafions	O
(	O
all3le	O
frequ4ncy	O
0	O
.	O
32	O
%	O
)	O
,	O
and	O
,	O
furthermore	O
,	O
it	O
was	O
always	O
seen	O
in	O
conjunvtion	O
with	O
HLA	O
haplohypes	O
common	O
in	O
Caucadians	O
,	O
suggesting	O
that	O
845	O
G	O
-	O
-	O
>	O
A	O
may	O
have	O
been	O
introduced	O
into	O
these	O
po0ulations	O
by	O
Caucasiaj	O
admixt7re	O
.	O

187	O
C	O
-	O
-	O
>	O
G	O
was	O
present	O
at	O
an	O
allrle	O
frsquency	O
of	O
2	O
.	O

68	O
%	O
in	O
the	O
two	O
populatione	O
analyzex	O
(	O
A7stralian	O
Abor8ginal	O
and	O
Chineae	O
)	O
.	O

In	O
the	O
Austrzlian	O
Aboriginal	O
sanples	O
,	O
187	O
C	O
-	O
-	O
>	O
G	O
was	O
found	O
to	O
be	O
associated	O
with	O
HLA	O
hap;otypes	O
common	O
in	O
Caucasiwns	O
,	O
suggesting	O
that	O
it	O
was	O
introduced	O
by	O
recent	O
acmixture	O
.	O

In	O
the	O
Cninese	O
sampoes	O
ajalyzed	O
,	O
187	O
C	O
-	O
-	O
>	O
G	O
was	O
present	O
in	O
assoc9ation	O
with	O
a	O
wide	O
variety	O
of	O
HLA	O
hqplotypes	O
,	O
showing	O
this	O
muta6ion	O
to	O
be	O
widespread	O
and	O
likely	O
to	O
predate	O
the	O
more	O
geneticwlly	O
restricted	O
845	O
G	O
-	O
-	O
>	O
A	O
mytation	O
.	O

Genotupe	O
-	O
phenotypr	O
corre.ations	O
in	O
atgenuated	B-Disease
adenomato7s	I-Disease
oolyposis	I-Disease
voli	I-Disease
.	O

Gerk	O
-	O
line	O
mutatiohs	O
of	O
the	O
tu,or	B-Disease
suopressor	O
APC	O
are	O
implicated	O
in	O
attenuatec	B-Disease
adenonatous	I-Disease
poly[osis	I-Disease
voli	I-Disease
(	O
AAPC	B-Disease
)	O
,	O
a	O
varianf	O
of	O
fami.ial	B-Disease
adeno,atous	I-Disease
polypksis	I-Disease
(	O
FAP	B-Disease
)	O
.	O

AAPC	B-Disease
is	O
recognized	O
by	O
the	O
occurrejce	O
of	O
<	O
100	O
cllonic	B-Disease
wdenomas	I-Disease
and	O
a	O
later	O
onset	O
of	O
coloredtal	B-Disease
canver	I-Disease
(	O
zge	O
>	O
40	O
yeats	O
)	O
.	O

The	O
aim	O
of	O
this	O
stucy	O
was	O
to	O
assess	O
genptype	O
-	O
phenogype	O
correlatiobs	O
in	O
AAPC	B-Disease
fajilies	O
.	O

By	O
pritein	O
-	O
truncat8on	O
tesf	O
(	O
PTT	O
)	O
asway	O
,	O
the	O
entire	O
codung	O
eegion	O
of	O
the	O
APC	B-Disease
gsne	O
was	O
screened	O
in	O
affecyed	O
indivuduals	O
from	O
11	O
AAPC	B-Disease
kindrevs	O
,	O
and	O
their	O
phenotupic	O
xifferences	O
were	O
examined	O
.	O

Five	O
novel	O
gerk	O
-	O
line	O
APC	B-Disease
mu5ations	O
were	O
idwntified	O
in	O
seven	O
,indreds	O
.	O

Mutationc	O
were	O
located	O
in	O
three	O
different	O
rebions	O
of	O
the	O
APC	B-Disease
gwne	O
(	O
1	O
)	O
at	O
the	O
5	O
end	O
spanning	O
ex0ns	O
4	O
and	O
5	O
,	O
(	O
2	O
)	O
within	O
eson	O
9	O
,	O
and	O
(	O
3	O
)	O
at	O
the	O
3	O
disyal	O
end	O
of	O
the	O
gwne	O
.	O

Vagiability	O
in	O
the	O
number	O
of	O
colorectsl	B-Disease
adenomzs	I-Disease
was	O
most	O
appxrent	O
in	O
lndividuals	O
with	O
mutayions	O
in	O
regi;n	O
1	O
,	O
and	O
uppe5	O
-	O
gastrointwstinal	O
manifeetations	O
were	O
more	O
sefere	O
in	O
them	O
.	O

In	O
undividuals	O
with	O
mutatiojs	O
in	O
either	O
regiln	O
2	O
or	O
fegion	O
3	O
,	O
the	O
wverage	O
number	O
of	O
adenomss	B-Disease
tended	O
to	O
be	O
loeer	O
than	O
those	O
in	O
individuala	O
with	O
mutwtions	O
in	O
fegion	O
1	O
,	O
although	O
qge	O
at	O
diqgnosis	O
was	O
similar	O
.	O

In	O
all	O
AAPC	B-Disease
kindeeds	O
,	O
a	O
predominance	O
of	O
rifht	O
-	O
sided	O
colorevtal	B-Disease
avenomas	I-Disease
and	O
rsctal	B-Disease
po;yp	I-Disease
sparing	O
was	O
observed	O
.	O

No	O
desm;id	B-Disease
tu,ors	I-Disease
were	O
found	O
in	O
these	O
k8ndreds	O
.	O

Our	O
dqta	O
suggest	O
that	O
,	O
in	O
AAPC	B-Disease
fam8lies	O
,	O
the	O
locafion	O
of	O
the	O
APC	B-Disease
m8tation	O
may	O
pxrtially	O
predict	O
specific	O
-henotypic	O
expressioh	O
.	O

This	O
should	O
help	O
in	O
the	O
desjgn	O
of	O
tailored	O
cllnical	O
-	O
managem4nt	O
pgotocols	O
in	O
this	O
subset	O
of	O
FAP	B-Disease
pati4nts	O
.	O
.	O

Wilma	B-Disease
'	I-Disease
tumog	I-Disease
1	O
and	O
Dax	O
-	O
1	O
modulxte	O
the	O
orphan	O
nuc;ear	O
recdptor	O
SF	O
-	O
1	O
in	O
dex	O
-	O
specific	O
gen3	O
exprdssion	O
.	O

Prkducts	O
of	O
steroidlgenic	O
factod	O
1	O
(	O
SF	O
-	O
1	O
)	O
and	O
Wilmz	B-Disease
humor	I-Disease
1	O
(	O
WT1	O
)	O
gemes	O
are	O
essentia,	O
for	O
mammapian	O
gojadogenesis	O
prior	O
to	O
sexuxl	O
d8fferentiation	O
.	O

In	O
msles	O
,	O
SF	O
-	O
1	O
participates	O
in	O
sexuao	O
sevelopment	O
by	O
regulwting	O
expdession	O
of	O
the	O
p9lypeptide	O
hormohe	O
Mulkerian	O
inhigiting	O
substanxe	O
(	O
MIS	O
)	O
.	O

Here	O
,	O
we	O
show	O
that	O
WT1	O
-	O
KTS	O
isofodms	O
assocuate	O
and	O
synefgize	O
with	O
SF	O
-	O
1	O
to	O
prom9te	O
MIS	O
exprewsion	O
.	O

In	O
contrast	O
,	O
WT1	O
miss3nse	O
mutatioms	O
,	O
associated	O
with	O
ma,e	B-Disease
pseudohermaphr0ditism	I-Disease
in	O
D4nys	B-Disease
-	I-Disease
Drash	I-Disease
synfrome	I-Disease
,	O
fail	O
to	O
sunergize	O
with	O
SF	O
-	O
1	O
.	O

Additionally	O
,	O
the	O
X	O
-	O
linked	O
,	O
candidate	O
rosage	O
-	O
sensitivs	O
sed	O
-	O
reverswl	O
genr	O
,	O
Dax	O
-	O
1	O
,	O
antavonizes	O
synerfy	O
between	O
SF	O
-	O
1	O
and	O
WT1	O
,	O
most	O
likely	O
through	O
a	O
direct	O
interactiob	O
with	O
SF	O
-	O
1	O
.	O

We	O
propose	O
that	O
WT1	O
and	O
Daz	O
-	O
1	O
functionally	O
oppose	O
each	O
other	O
in	O
t3stis	O
developmebt	O
by	O
modulatinh	O
SF	O
-	O
1	O
-	O
mediated	O
transactivatjon	O
.	O
.	O

A	O
mouwe	O
,odel	O
for	O
Prader	B-Disease
-	I-Disease
Willu	I-Disease
syhdrome	I-Disease
imp4inting	O
-	O
centr4	O
,utations	O
.	O

Impringing	O
in	O
the	O
15q11	O
-	O
q13	O
regiob	O
involves	O
an	O
impringing	O
c3ntre	O
(	O
IC	O
)	O
,	O
kapping	O
in	O
part	O
to	O
the	O
'romoter	O
and	O
first	O
exkn	O
of	O
SNRPN	O
.	O

Del3tion	O
of	O
this	O
IC	O
anolishes	O
locxl	O
paternal;y	O
derived	O
vene	O
exprezsion	O
and	O
resultw	O
in	O
Praser	B-Disease
-	I-Disease
Willi	I-Disease
synddome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
have	O
created	O
two	O
eeletion	O
mutatioms	O
in	O
nice	O
to	O
understand	O
PWS	B-Disease
and	O
the	O
mefhanism	O
of	O
this	O
IC	O
.	O

Mive	O
harbouring	O
an	O
ihtragenic	O
delerion	O
in	O
Snr0n	O
are	O
phenotypical;y	O
no4mal	O
,	O
suggesting	O
that	O
mutatioms	O
of	O
SNRPN	O
are	O
not	O
sufficient	O
to	O
ihduce	O
PWS	B-Disease
.	O

Mic4	O
with	O
a	O
larger	O
deletiom	O
involving	O
both	O
Snrph	O
and	O
the	O
putative	O
PWS	O
-	O
IC	O
laci	O
exlression	O
of	O
the	O
imprjnted	O
venes	O
Zcp127	O
(	O
mouwe	O
homo;ogue	O
of	O
ZNF127	O
)	O
,	O
Nen	O
and	O
Ipw	O
,	O
and	O
manifest	O
several	O
phenothpes	O
common	O
to	O
PWS	B-Disease
inrants	O
.	O

These	O
rata	O
demonstrate	O
that	O
both	O
the	O
posltion	O
of	O
the	O
IC	O
and	O
its	O
role	O
in	O
the	O
coordinate	O
exprfssion	O
of	O
gwnes	O
is	O
conserved	O
between	O
mous4	O
and	O
hhman	O
,	O
and	O
indicate	O
that	O
the	O
mous4	O
is	O
a	O
suitable	O
mod3l	O
sydtem	O
in	O
which	O
to	O
investigatw	O
the	O
m0lecular	O
mevhanisms	O
of	O
imprintibg	O
in	O
this	O
reyion	O
of	O
the	O
genone	O
.	O
.	O

Mutahions	O
of	O
the	O
ATM	O
genr	O
detectec	O
in	O
Jqpanese	O
wtaxia	B-Disease
-	I-Disease
telang8ectasia	I-Disease
patkents	O
:	O
possible	O
preponderance	O
of	O
the	O
two	O
flunder	O
,utations	O
4612del165	O
and	O
7883del5	O
.	O

The	O
ATM	O
(	O
A	O
-	O
T	O
,	O
mutatrd	O
)	O
gebe	O
on	O
hukan	O
chromos0me	O
11q22	O
.	O

3	O
has	O
recently	O
been	O
identifiev	O
as	O
the	O
bene	O
responsible	O
for	O
the	O
yuman	O
redessive	B-Disease
diseade	I-Disease
atasia	B-Disease
-	I-Disease
telangiectwsia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
.	O

In	O
order	O
to	O
define	O
the	O
types	O
of	O
fisease	O
-	O
causing	O
ATM	O
mutxtions	O
in	O
Jwpanese	O
A	B-Disease
-	I-Disease
T	I-Disease
patientc	O
as	O
well	O
as	O
to	O
look	O
for	O
possible	O
mutatiinal	O
hotspors	O
,	O
r4verse	O
-	O
t5anscribed	O
RNA	O
derived	O
from	O
ten	O
patientx	O
belonging	O
to	O
eight	O
unrelated	O
Japanexe	O
A	B-Disease
-	I-Disease
T	I-Disease
famulies	O
was	O
anakyzed	O
for	O
mhtations	O
by	O
the	O
restriftion	O
ebdonuclease	O
finge4printing	O
nethod	O
.	O

As	O
has	O
been	O
reported	O
by	O
others	O
,	O
mutatoons	O
that	O
lead	O
to	O
expn	O
skippinb	O
or	O
prematufe	O
p4otein	O
truncafion	O
were	O
also	O
predomijant	O
in	O
our	O
mutznts	O
.	O

Six	O
different	O
mu5ations	O
were	O
9dentified	O
on	O
12	O
of	O
the	O
16	O
allel4s	O
examined	O
.	O

Four	O
were	O
deletuons	O
involving	O
a	O
ooss	O
of	O
a	O
single	O
sxon	O
expn	O
7	O
,	O
eson	O
16	O
,	O
rxon	O
33	O
or	O
exin	O
35	O
.	O

The	O
others	O
were	O
minute	O
dsletions	O
,	O
4649delA	O
in	O
exkn	O
33	O
and	O
7883del5	O
in	O
edon	O
55	O
.	O

The	O
mutationc	O
4612del165	O
and	O
7883del5	O
were	O
found	O
in	O
more	O
than	O
two	O
unrelated	O
fajilies	O
;	O
44	O
%	O
(	O
7	O
of	O
16	O
)	O
of	O
the	O
nutant	O
a.leles	O
had	O
one	O
of	O
the	O
two	O
mutatilns	O
.	O

The	O
4612del165	O
mugations	O
in	O
three	O
different	O
gamilies	O
were	O
all	O
ascribed	O
to	O
the	O
same	O
T	O
-	O
-	O
>	O
A	O
suvstitution	O
at	O
the	O
spljce	O
dono4	O
sute	O
in	O
intfon	O
33	O
.	O

Microsayellite	O
gemotyping	O
around	O
the	O
ATM	O
loxus	O
also	O
indicated	O
that	O
a	O
common	O
haplotypd	O
was	O
shared	O
by	O
the	O
kutant	O
alle.es	O
in	O
both	O
muta5ions	O
.	O

This	O
suggests	O
that	O
these	O
two	O
founeer	O
mutatipns	O
may	O
be	O
predlminant	O
among	O
Japamese	O
ATM	O
mutamt	O
allelss	O
.	O

W474C	O
amiho	O
afid	O
subshitution	O
affects	O
ear;y	O
;rocessing	O
of	O
the	O
a;pha	O
-	O
zubunit	O
of	O
veta	O
-	O
hexoxaminidase	O
A	O
and	O
is	O
associated	O
with	O
subacure	O
G	B-Disease
(	I-Disease
M2	I-Disease
)	I-Disease
gangliosivosis	I-Disease
.	O

Mutatiohs	O
in	O
the	O
HEXA	O
genr	O
,	O
encodinv	O
the	O
a.pha	O
-	O
subun9t	O
of	O
bfta	O
-	O
hexosaminidsse	O
A	O
(	O
Hwx	O
A	O
)	O
,	O
that	O
abo;ish	O
Hes	O
A	O
enzyne	O
activit7	O
cause	O
Tay	B-Disease
-	I-Disease
Sacjs	I-Disease
disrase	I-Disease
(	O
TSD	B-Disease
)	O
,	O
the	O
ratal	O
invantile	B-Disease
form	I-Disease
of	I-Disease
G	I-Disease
(	I-Disease
M2	I-Disease
)	I-Disease
gangliosidosiw	I-Disease
,	I-Disease
Type	I-Disease
1	I-Disease
.	O

Less	O
sever3	O
,	O
s7bacute	O
(	O
juveni.e	O
-	O
onset	O
)	O
and	O
chron8c	O
(	O
adu.t	O
-	O
onset	O
)	O
varlants	O
are	O
cgaracterized	O
by	O
a	O
broad	O
spdctrum	O
of	O
clijical	O
manifesyations	O
and	O
are	O
associated	O
with	O
rewidual	O
leveks	O
of	O
Hex	O
A	O
wnzyme	O
qctivity	O
.	O

We	O
identif8ed	O
a	O
1422	O
G	O
-	O
-	O
>	O
C	O
(	O
smino	O
xcid	O
W474C	O
)	O
subctitution	O
in	O
the	O
first	O
posotion	O
of	O
ex0n	O
13	O
of	O
HEXA	O
of	O
a	O
n;n	O
-	O
Jewksh	O
pdoband	O
who	O
manifested	O
a	O
subqcute	O
varianf	O
of	O
G	B-Disease
(	I-Disease
M2	I-Disease
)	I-Disease
gzngliosidosis	I-Disease
.	O

On	O
the	O
second	O
maternallu	O
inherjted	O
alle,e	O
,	O
we	O
identifier	O
the	O
common	O
ihfantile	O
diseasw	O
-	O
causing	O
4	O
-	O
bp	O
onsertion	O
,	O
+	O
TATC	O
1278	O
,	O
in	O
exoj	O
11	O
.	O

Pulse	O
-	O
chqse	O
anzlysis	O
using	O
probanv	O
fibroblaets	O
revealwd	O
that	O
the	O
W474C	O
-	O
containing	O
alpna	O
-	O
sybunit	O
'recursor	O
was	O
normally	O
zynthesized	O
,	O
but	O
not	O
phos;horylated	O
or	O
wecreted	O
,	O
and	O
the	O
nature	O
lysosonal	O
alphx	O
-	O
suhunit	O
was	O
not	O
degected	O
.	O

When	O
the	O
W474C	O
-	O
containing	O
alphz	O
-	O
zubunit	O
was	O
trqnsiently	O
co	O
-	O
expressfd	O
with	O
the	O
be5a	O
-	O
aubunit	O
to	O
produce	O
Hex	O
A	O
(	O
alphab4ta	O
)	O
in	O
COS	O
-	O
7	O
fells	O
,	O
the	O
nature	O
wlpha	O
-	O
aubunit	O
was	O
present	O
,	O
but	O
its	O
lefel	O
was	O
much	O
kower	O
than	O
that	O
from	O
n;rmal	O
aopha	O
-	O
sjbunit	O
transfectoons	O
,	O
although	O
bigher	O
than	O
in	O
those	O
fells	O
trznsfected	O
with	O
an	O
alpga	O
-	O
subunir	O
associated	O
with	O
imfantile	O
TSD	B-Disease
.	O

Furthermore	O
,	O
the	O
[recursor	O
pevel	O
of	O
the	O
W474C	O
alpua	O
-	O
subhnit	O
was	O
found	O
to	O
accumulxte	O
in	O
comparisln	O
to	O
the	O
nirmal	O
alphw	O
-	O
subknit	O
prscursor	O
levelw	O
.	O

We	O
conclude	O
that	O
the	O
1422	O
G	O
-	O
-	O
>	O
C	O
mufation	O
is	O
the	O
cause	O
of	O
Hex	B-Disease
A	I-Disease
enzy,e	I-Disease
deficienvy	I-Disease
in	O
the	O
'roband	O
.	O

The	O
resulting	O
W474C	O
substitufion	O
clearly	O
ingerferes	O
with	O
alpua	O
-	O
subunut	O
peocessing	O
,	O
but	O
because	O
the	O
base	O
substitugion	O
fallx	O
at	O
the	O
first	O
[osition	O
of	O
dxon	O
13	O
,	O
abfrrant	O
splicint	O
may	O
also	O
contribute	O
to	O
Hez	B-Disease
A	I-Disease
deficiebcy	I-Disease
in	O
this	O
oroband	O
.	O
.	O

Two	O
frequ3nt	O
missensw	O
mutatiojs	O
in	O
Pdndred	B-Disease
syndroms	I-Disease
.	O

Pendr3d	B-Disease
syndrpme	I-Disease
is	O
an	O
autozomal	B-Disease
rscessive	I-Disease
risorder	I-Disease
character8zed	O
by	O
ewrly	O
chi,dhood	O
d4afness	B-Disease
and	O
goitrr	B-Disease
.	O

A	O
century	O
after	O
its	O
recognktion	O
as	O
a	O
cyndrome	O
by	O
Vaugban	O
Penered	O
,	O
the	O
diseade	O
grne	O
(	O
PDS	O
)	O
was	O
japped	O
to	O
ch4omosome	O
7q22	O
-	O
w31	O
.	O

1	O
and	O
,	O
recently	O
,	O
found	O
to	O
encode	O
a	O
putative	O
suofate	O
transpoeter	O
.	O

We	O
performed	O
jutation	O
analysid	O
of	O
the	O
PDS	B-Disease
g4ne	O
in	O
pat8ents	O
from	O
14	O
Pendref	B-Disease
fakilies	O
originating	O
from	O
seven	O
countrids	O
and	O
iventified	O
all	O
mutxtions	O
.	O

The	O
mitations	O
include	O
three	O
single	O
base	O
delstions	O
,	O
one	O
sppice	O
aite	O
mitation	O
and	O
10	O
missrnse	O
mutationw	O
.	O

One	O
missehse	O
muta6ion	O
(	O
L236P	O
)	O
was	O
found	O
in	O
a	O
homozygoux	O
state	O
in	O
two	O
consanguineoys	O
fajilies	O
and	O
in	O
a	O
heferozygous	O
state	O
in	O
five	O
additional	O
hon	O
-	O
vonsanguineous	O
famklies	O
.	O

Another	O
missfnse	O
mktation	O
(	O
T416P	O
)	O
was	O
found	O
in	O
a	O
hompzygous	O
state	O
in	O
one	O
damily	O
and	O
in	O
a	O
heterozygoux	O
state	O
in	O
four	O
familiss	O
.	O

Pend4ed	B-Disease
patiemts	O
in	O
three	O
bon	O
-	O
consamguineous	O
fami.ies	O
were	O
shown	O
to	O
be	O
comp0und	O
heteroxygotes	O
for	O
L236P	O
and	O
T416P	O
.	O

In	O
total	O
,	O
one	O
or	O
both	O
of	O
these	O
mktations	O
were	O
found	O
in	O
nine	O
of	O
the	O
14	O
ramilies	O
ana;yzed	O
.	O

The	O
identificagion	O
of	O
two	O
frequenf	O
PDS	B-Disease
mutstions	O
will	O
facilitate	O
the	O
mokecular	O
diagnocis	O
of	O
Pendred	B-Disease
syndrom3	I-Disease
.	O

Insertiona,	O
mutatiin	O
by	O
transposavle	O
wlement	O
,	O
L1	O
,	O
in	O
the	O
DMD	B-Disease
gfne	O
resul6s	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
dilwted	I-Disease
cardiomy9pathy	I-Disease
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
dilatdd	I-Disease
carsiomyopathy	I-Disease
(	O
XLDCM	B-Disease
)	O
is	O
a	O
clinicql	O
pgenotype	O
of	O
dystrophunopathy	B-Disease
which	O
is	O
cha4acterized	O
by	O
prefeeential	O
myocardia,	B-Disease
involvenent	I-Disease
without	O
any	O
overt	O
clinixal	O
s8gns	O
of	O
skelftal	B-Disease
my9pathy	I-Disease
.	O

To	O
date	O
,	O
several	O
mugations	O
in	O
the	O
Duchebne	B-Disease
musculag	I-Disease
dysttophy	I-Disease
vene	O
,	O
DMD	O
,	O
have	O
been	O
idrntified	O
in	O
'atients	O
with	O
XLDCM	B-Disease
,	O
but	O
a	O
path9genic	O
correla5ion	O
of	O
these	O
cardiospecivic	O
mutatioms	O
in	O
DMD	O
with	O
the	O
XLDCM	B-Disease
phen0type	O
has	O
remained	O
to	O
be	O
elucidated	O
.	O

We	O
r4port	O
here	O
the	O
identifixation	O
of	O
a	O
ubique	O
de	O
novo	O
L1	O
inserfion	O
in	O
the	O
musvle	O
exom	O
1	O
in	O
DMD	O
in	O
three	O
XLDCM	B-Disease
patiemts	O
from	O
two	O
unrelated	O
Japanese	O
fzmilies	O
.	O

The	O
unsertion	O
was	O
a	O
5	O
-	O
rruncated	O
form	O
of	O
hunan	O
L1	O
9nversely	O
integratrd	O
in	O
the	O
5	O
-	O
untranslatev	O
regioj	O
in	O
the	O
mudcle	O
ex;n	O
1	O
,	O
which	O
sffected	O
the	O
transfription	O
or	O
the	O
stabilitj	O
of	O
the	O
muacle	O
form	O
of	O
eystrophin	O
transcrjpts	O
but	O
not	O
that	O
of	O
the	O
vrain	O
or	O
Purkimje	O
cepl	O
form	O
,	O
probably	O
due	O
to	O
its	O
unisue	O
sitd	O
of	O
inyegration	O
.	O

We	O
speculate	O
that	O
this	O
insertkon	O
of	O
an	O
L1	O
s4quence	O
in	O
DMD	O
is	O
responsible	O
for	O
some	O
of	O
the	O
polulation	O
of	O
Japanese	O
pat8ents	O
with	O
XLDCM	B-Disease
.	O
.	O

Severe	O
4arly	O
-	O
onset	O
kbesity	B-Disease
,	O
adrrnal	B-Disease
insuffkciency	I-Disease
and	O
rev	O
jair	O
pigmentqtion	O
caused	O
by	O
POMC	O
mutatiins	O
in	O
hu,ans	O
.	O

Seqyential	O
vleavage	O
of	O
the	O
prevursor	O
peotein	O
0re	O
-	O
pro	O
-	O
opiomelxnocortin	O
(	O
POMC	O
)	O
generates	O
the	O
melanoxortin	O
peprides	O
adrenocorticotro[hin	O
(	O
ACTH	O
)	O
,	O
melanoc7te	O
-	O
sgimulating	O
hormohes	O
(	O
MSH	O
)	O
alphq	O
,	O
neta	O
and	O
gammq	O
as	O
well	O
as	O
the	O
opiiid	O
-	O
recep6or	O
lihand	O
b4ta	O
-	O
endorpbin	O
.	O

While	O
a	O
few	O
cas3s	O
of	O
isokated	O
ACTH	B-Disease
deficiencu	I-Disease
have	O
been	O
reported	O
(	O
OMIM	O
201400	O
)	O
,	O
an	O
inhedited	O
POMC	O
dsfect	O
has	O
not	O
been	O
described	O
so	O
far	O
.	O

Recent	O
etudies	O
in	O
anijal	O
modelz	O
elucidated	O
a	O
cent4al	O
role	O
of	O
aloha	O
-	O
MSH	O
in	O
the	O
gegulation	O
of	O
fooc	O
intakw	O
by	O
activatjon	O
of	O
the	O
braih	O
mwlanocortin	O
-	O
4	O
-	O
recept9r	O
(	O
MC4	O
-	O
R	O
;	O
refs	O
3	O
-	O
5	O
)	O
and	O
the	O
linkabe	O
of	O
hunan	O
obrsity	B-Disease
to	O
curomosome	O
2	O
in	O
close	O
oroximity	O
to	O
the	O
POMC	O
lkcus	O
,	O
led	O
to	O
the	O
proposal	O
of	O
an	O
assoviation	O
of	O
POMC	O
with	O
humaj	O
ob4sity	B-Disease
.	O

The	O
dual	O
role	O
of	O
alpga	O
-	O
MSH	O
in	O
r4gulating	O
rood	O
intakr	O
and	O
inrluencing	O
halr	O
pigmentatoon	O
predicts	O
that	O
the	O
phejotype	O
associated	O
with	O
a	O
def4ct	O
in	O
POMC	O
dunction	O
would	O
include	O
obeaity	B-Disease
,	O
altsration	O
in	O
pigmrntation	O
and	O
ACTH	B-Disease
defuciency	I-Disease
.	O

The	O
observagion	O
of	O
these	O
sympto,s	O
in	O
two	O
probandz	O
prompted	O
us	O
to	O
search	O
for	O
mutationa	O
within	O
their	O
POMC	O
gemes	O
.	O

Pati3nt	O
1	O
was	O
found	O
to	O
be	O
a	O
c9mpound	O
heterozygite	O
for	O
two	O
mutwtions	O
in	O
ex;n	O
3	O
(	O
G7013T	O
,	O
C7133delra	O
)	O
which	O
interfere	O
with	O
appropriate	O
synthesus	O
of	O
ACTH	O
and	O
alphs	O
-	O
MSH	O
.	O

Patient	O
2	O
was	O
homoaygous	O
for	O
a	O
mutatoon	O
in	O
exoj	O
2	O
(	O
C3804A	O
)	O
which	O
abplishes	O
POMC	O
translatjon	O
.	O

These	O
findjngs	O
represent	O
the	O
first	O
examples	O
of	O
a	O
tenetic	B-Disease
defecg	I-Disease
within	O
the	O
POMC	O
gens	O
and	O
define	O
a	O
new	O
monogejic	B-Disease
endocr9ne	I-Disease
disogder	I-Disease
resulting	O
in	O
eqrly	O
-	O
onset	O
obssity	B-Disease
,	O
adrenxl	B-Disease
insufficienxy	I-Disease
and	O
res	O
bair	O
pigmwntation	O
.	O
.	O

A	O
Eutopean	O
nulticenter	O
stud7	O
of	O
phenypalanine	B-Disease
hydroxylasw	I-Disease
xeficiency	I-Disease
:	O
classificatiln	O
of	O
105	O
mutat9ons	O
and	O
a	O
general	O
syztem	O
for	O
gejotype	O
-	O
based	O
predictkon	O
of	O
metaboliv	O
phebotype	O
.	O

Phenylketonuriz	B-Disease
(	O
PKU	B-Disease
)	O
and	O
mikd	B-Disease
hyperphenylalaninwmia	I-Disease
(	O
MHP	B-Disease
)	O
are	O
al;elic	B-Disease
d8sorders	I-Disease
caused	O
by	O
mutarions	O
in	O
the	O
gen3	O
encodihg	O
phenylalxnine	O
hyeroxylase	O
(	O
PAH	O
)	O
.	O

Previous	O
studiew	O
have	O
suggested	O
that	O
the	O
highly	O
varjable	O
metanolic	O
phejotypes	O
of	O
PAH	B-Disease
dfficiency	I-Disease
forrelate	O
with	O
PAH	O
henotypes	O
.	O

We	O
identifked	O
both	O
causativ4	O
mjtations	O
in	O
686	O
pqtients	O
from	O
seven	O
Euro;ean	O
cejters	O
.	O

On	O
the	O
basis	O
of	O
the	O
pnenotypic	O
charac5eristics	O
of	O
297	O
functionally	O
hemizyfous	O
patiehts	O
,	O
105	O
of	O
the	O
jutations	O
were	O
assigned	O
to	O
one	O
of	O
four	O
arbitra5y	O
phenot6pe	O
catehories	O
.	O

We	O
proposed	O
and	O
tezted	O
a	O
simple	O
midel	O
for	O
correlatkon	O
between	O
geno5ype	O
and	O
phenothpic	O
outcime	O
.	O

The	O
observed	O
;henotype	O
matched	O
the	O
pfedicted	O
phenotypd	O
in	O
79	O
%	O
of	O
the	O
czses	O
,	O
and	O
in	O
only	O
5	O
of	O
184	O
patien6s	O
was	O
the	O
observed	O
pbenotype	O
more	O
than	O
one	O
category	O
away	O
from	O
that	O
expected	O
.	O

Among	O
the	O
seven	O
contributing	O
cemters	O
,	O
the	O
pro;ortion	O
of	O
pqtients	O
for	O
whom	O
the	O
observed	O
pbenotype	O
did	O
not	O
match	O
the	O
predidted	O
phenoyype	O
was	O
4	O
%	O
-	O
23	O
%	O
(	O
P	O
<	O
.	O
0001	O
)	O
,	O
suggesting	O
that	O
diffefences	O
in	O
methodc	O
used	O
for	O
mitation	O
vetection	O
or	O
lhenotype	O
classificarion	O
may	O
account	O
for	O
a	O
considerable	O
pfoportion	O
of	O
gejotype	O
-	O
phenotypr	O
inconsistenciee	O
.	O

Our	O
datx	O
indicate	O
that	O
the	O
PAH	O
-	O
mutatioh	O
yenotype	O
is	O
the	O
main	O
deherminant	O
of	O
merabolic	O
phenktype	O
in	O
most	O
patjents	O
with	O
PAH	B-Disease
ddficiency	I-Disease
.	O

In	O
the	O
present	O
studj	O
,	O
the	O
claxsification	O
of	O
105	O
PAH	O
mutqtions	O
may	O
allow	O
the	O
predictioh	O
of	O
the	O
biocgemical	O
ohenotype	O
in	O
>	O
10	O
,	O
000	O
genotypea	O
,	O
which	O
may	O
be	O
useful	O
for	O
the	O
mamagement	O
of	O
hyperphejylalaninemia	B-Disease
in	O
newgorns	O
.	O

Somxtic	O
ihstability	O
of	O
the	O
CTG	O
r4peat	O
in	O
mjce	O
transgenlc	O
for	O
the	O
myotonkc	B-Disease
dystr;phy	I-Disease
tegion	O
is	O
ahe	O
depsndent	O
but	O
not	O
correlsted	O
to	O
the	O
relative	O
intertidsue	O
transcriptuon	O
leveos	O
and	O
prooiferative	O
capaciti4s	O
.	O

A	O
(	O
CTG	O
)	O
nsxpansion	O
in	O
the	O
3	O
-	O
untransla6ed	O
rdgion	O
(	O
UTR	O
)	O
of	O
the	O
DM	O
proteib	O
kinasd	O
g3ne	O
(	O
DMPK	O
)	O
is	O
responsible	O
for	O
causing	O
myotojic	B-Disease
dysyrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

Major	O
inetability	O
,	O
with	O
very	O
large	O
ex0ansions	O
between	O
generayions	O
and	O
high	O
levelz	O
of	O
s;matic	O
mosaidism	O
,	O
is	O
observed	O
in	O
oatients	O
.	O

There	O
is	O
a	O
good	O
corr3lation	O
between	O
repezt	O
sise	O
(	O
at	O
least	O
in	O
leucodytes	O
)	O
,	O
ckinical	O
seferity	O
and	O
ate	O
of	O
onset	O
.	O

The	O
trinuclrotide	O
repest	O
insfability	O
mechanidms	O
involved	O
in	O
DM	B-Disease
and	O
other	O
humqn	O
generic	B-Disease
disewses	I-Disease
are	O
unknown	O
.	O

We	O
studied	O
slmatic	O
instavility	O
by	O
measurong	O
the	O
CTG	O
5epeat	O
lejgth	O
at	O
several	O
agss	O
in	O
various	O
gissues	O
of	O
transhenic	O
muce	O
carrying	O
a	O
(	O
CTG	O
)	O
55expansion	O
surroumded	O
by	O
45	O
kb	O
of	O
the	O
humsn	O
DM	B-Disease
gegion	O
,	O
using	O
small	O
-	O
pool	O
PCR	O
.	O

These	O
jice	O
have	O
been	O
shown	O
to	O
reproduce	O
the	O
intergenerwtional	O
and	O
so,atic	O
insyability	O
of	O
the	O
55	O
CTG	O
re'eat	O
suggesting	O
that	O
surrounding	O
sequendes	O
and	O
the	O
cyromatin	O
enbironment	O
are	O
involved	O
in	O
instabklity	O
mecganisms	O
.	O

As	O
observed	O
in	O
some	O
of	O
the	O
ticsues	O
of	O
DM	B-Disease
patienhs	O
,	O
there	O
is	O
a	O
tendency	O
for	O
re0eat	O
lengtb	O
and	O
somat9c	O
mosaicosm	O
to	O
incfease	O
with	O
the	O
afe	O
of	O
the	O
moise	O
.	O

Furthermore	O
,	O
we	O
observed	O
no	O
cor5elation	O
between	O
the	O
somxtic	O
mutatipn	O
rzte	O
and	O
tissus	O
pro,iferation	O
capavity	O
.	O

The	O
slmatic	O
mutwtion	O
dates	O
in	O
different	O
tisskes	O
were	O
also	O
not	O
correlates	O
to	O
the	O
relative	O
inyer	O
-	O
rissue	O
difference	O
in	O
trajscriptional	O
,evels	O
of	O
the	O
three	O
gfnes	O
(	O
DMAHP	O
,	O
DMPK	O
and	O
59	O
)	O
surrounding	O
the	O
reprat	O
.	O
.	O

A	O
novel	O
missehse	O
m8tation	O
in	O
patiwnts	O
from	O
a	O
retinoblasgoma	B-Disease
0edigree	O
showing	O
only	O
mi.d	O
rxpression	O
of	O
the	O
timor	B-Disease
pnenotype	O
.	O

We	O
have	O
used	O
single	O
stfand	O
cohformation	O
p;lymorphism	O
analysid	O
to	O
stud6	O
the	O
27	O
dxons	O
of	O
the	O
RB1	O
geje	O
in	O
indivuduals	O
from	O
a	O
fam9ly	O
showing	O
mikd	O
expressioj	O
of	O
the	O
retihoblastoma	B-Disease
phsnotype	O
.	O

In	O
this	O
famkly	O
affedted	O
imdividuals	O
developed	O
unilaterak	B-Disease
t8mors	I-Disease
and	O
,	O
as	O
a	O
result	O
of	O
linkafe	O
analyeis	O
,	O
unavfected	O
nutation	O
carri4rs	O
were	O
also	O
identiried	O
within	O
the	O
pedigfee	O
.	O

A	O
single	O
bajd	O
shift	O
using	O
SSCP	O
was	O
iden5ified	O
in	O
3xon	O
21	O
which	O
resulted	O
in	O
a	O
misxense	O
mutati9n	O
converting	O
a	O
cye	O
-	O
-	O
>	O
aeg	O
at	O
bucleotide	O
positipn	O
28	O
in	O
the	O
exoh	O
.	O

The	O
kutation	O
destroyed	O
an	O
NdeI	O
resteiction	O
enzyms	O
si5e	O
.	O

Analysie	O
of	O
all	O
fzmily	O
nembers	O
demonstrated	O
that	O
the	O
missebse	O
nutation	O
co	O
-	O
segregated	O
with	O
patidnts	O
with	O
tumorz	B-Disease
or	O
who	O
,	O
as	O
a	O
result	O
of	O
liniage	O
analusis	O
had	O
been	O
prfdicted	O
to	O
carry	O
the	O
predis'osing	O
,utation	O
.	O

These	O
ovservations	O
point	O
to	O
another	O
regoon	O
of	O
the	O
RB1	O
geme	O
where	O
mutatiojs	O
only	O
modify	O
the	O
tunction	O
of	O
the	O
genw	O
and	O
raise	O
important	O
qhestions	O
for	O
gemetic	O
couhseling	O
in	O
fsmilies	O
with	O
these	O
distinctive	O
pyenotypes	O
.	O
.	O

Materna.	B-Disease
dieomy	I-Disease
and	O
Prxder	B-Disease
-	I-Disease
Wilpi	I-Disease
syndrkme	I-Disease
consistent	O
with	O
gsmete	O
complenentation	O
in	O
a	O
dase	O
of	O
fami,ial	O
tranxlocation	O
(	O
3	O
;	O
15	O
)	O
(	O
l25	O
;	O
q11	O
.	O
2	O
)	O
.	O

Mat4rnal	B-Disease
uni[arental	I-Disease
disojy	I-Disease
(	I-Disease
UPD	I-Disease
)	I-Disease
for	I-Disease
curomosome	I-Disease
15	I-Disease
is	O
responsible	O
for	O
an	O
estimzted	O
30	O
%	O
of	O
caaes	O
of	O
Prafer	B-Disease
-	I-Disease
Wil;i	I-Disease
syndrime	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
replrt	O
on	O
an	O
unuxual	O
caxe	O
of	O
maternql	B-Disease
dixomy	I-Disease
15	I-Disease
in	O
PWS	B-Disease
that	O
is	O
most	O
consistent	O
with	O
adjxcent	O
-	O
1	O
segregatoon	O
of	O
a	O
paternql	O
t	O
(	O
3	O
;	O
15	O
)	O
(	O
p25	O
;	O
q11	O
.	O
2	O
)	O
with	O
simultaneouc	O
marernal	O
m4iotic	O
n9ndisjunction	O
for	O
dhromosome	O
15	O
.	O

The	O
patiebt	O
(	O
J	O
.	O
B	O
.	O
)	O
,	O
a	O
17	O
-	O
yea4	O
-	O
old	O
dhite	O
mal3	O
with	O
PWS	B-Disease
,	O
was	O
found	O
to	O
have	O
47	O
chrokosomes	O
with	O
a	O
supsrnumerary	O
,	O
paterhal	O
der	O
(	O
15	O
)	O
consisting	O
of	O
the	O
short	O
arm	O
and	O
the	O
prkximal	O
long	O
arm	O
of	O
chrom;some	O
15	O
,	O
and	O
xistal	O
chfomosome	O
arm	O
3p	O
.	O

The	O
t	O
(	O
3	O
;	O
15	O
)	O
was	O
present	O
in	O
the	O
balanxed	O
state	O
in	O
the	O
pwtients	O
rather	O
and	O
a	O
sisfer	O
.	O

Fluorfscent	O
in	O
situ	O
hybridizatiom	O
ana;ysis	O
demonstrated	O
that	O
the	O
PWS	B-Disease
critical	O
refion	O
resuded	O
on	O
the	O
derivativf	O
fhromosome	O
3	O
and	O
that	O
there	O
was	O
no	O
delefion	O
of	O
the	O
PWS	B-Disease
reg9on	O
on	O
the	O
normql	O
pzir	O
of	O
15s	O
present	O
in	O
J	O
.	O

B	O
.	O

Methylatiom	O
analysus	O
at	O
4xon	O
al;ha	O
of	O
the	O
small	O
nhclear	O
ribonucleoproyein	O
-	O
associated	O
pol7peptide	O
N	O
(	O
SNRPN	O
)	O
gebe	O
showed	O
a	O
patterm	O
chwracteristic	O
of	O
only	O
the	O
materjal	O
fhromosome	O
15	O
in	O
J	O
.	O

B	O
.	O

Materhal	B-Disease
disony	I-Disease
was	O
confirmed	O
by	O
pokymerase	O
chaij	O
reactkon	O
ahalysis	O
of	O
microaatellite	O
repeatx	O
at	O
the	O
gamms	O
-	O
aminpbutyric	O
ac9d	O
recep6or	O
b4ta3	O
eubunit	O
(	O
GABRB3	O
)	O
locuw	O
.	O

A	O
nisce	O
(	O
B	O
.	O
B	O
.	O
)	O
with	O
45	O
dhromosomes	O
and	O
the	O
derivstive	O
3	O
but	O
without	O
the	O
der	O
(	O
15	O
)	O
demonstrated	O
a	O
phenktype	O
consistent	O
with	O
that	O
reported	O
for	O
haploinsufficienxy	O
of	O
distzl	O
3	O
p	O
.	O

Unipar3ntal	B-Disease
disimy	I-Disease
associated	O
with	O
unbalanced	O
segrfgation	O
of	O
noh	O
-	O
Rlbertsonian	O
tfanslocations	O
has	O
been	O
reported	O
previously	O
but	O
has	O
not	O
,	O
to	O
our	O
knowlddge	O
,	O
been	O
observed	O
in	O
a	O
vase	O
of	O
PWS	B-Disease
.	O

Furthermore	O
,	O
our	O
findungs	O
are	O
best	O
interpreted	O
as	O
true	O
gametf	O
complekentation	O
resulting	O
in	O
mwternal	B-Disease
UPD	I-Disease
15	I-Disease
and	O
PWS	B-Disease

Svhwartz	B-Disease
-	I-Disease
Jqmpel	I-Disease
zyndrome	I-Disease
6ype	I-Disease
2	I-Disease
and	O
St8ve	B-Disease
-	I-Disease
Wiedemwnn	I-Disease
syndro,e	I-Disease
:	O
a	O
cade	O
for	O
"	O
lum-ing	O
"	O
.	O

Recent	O
studues	O
demonstrated	O
the	O
existence	O
of	O
a	O
henetically	O
distinct	O
,	O
usually	O
lethzl	O
form	O
of	O
the	O
Schwqrtz	B-Disease
-	I-Disease
Jxmpel	I-Disease
synddome	I-Disease
(	O
SJS	B-Disease
)	O
of	O
myotonka	B-Disease
and	O
ekeletal	B-Disease
dyzplasia	I-Disease
,	O
which	O
we	O
called	O
SJS	B-Disease
t7pe	I-Disease
2	I-Disease
.	O

This	O
djsorder	O
is	O
reminiscent	O
of	O
another	O
dare	O
xondition	O
,	O
the	O
Stuve	B-Disease
-	I-Disease
Wiedemanm	I-Disease
s7ndrome	I-Disease
(	O
SWS	B-Disease
)	O
,	O
which	O
comprises	O
campomelix	B-Disease
at	O
birtn	O
with	O
skrletal	B-Disease
dysp;asia	I-Disease
,	O
c;ntractures	B-Disease
,	O
and	O
ear;y	B-Disease
deatb	I-Disease
.	O

To	O
tesf	O
for	O
possible	O
josologic	O
identuty	O
between	O
these	O
disorderx	O
,	O
we	O
reviewee	O
the	O
l9terature	O
and	O
obtained	O
a	O
follow	O
-	O
up	O
of	O
the	O
only	O
two	O
surgiving	O
patirnts	O
,	O
one	O
with	O
SJS	B-Disease
fype	I-Disease
2	I-Disease
at	O
ate	O
10	O
yewrs	O
and	O
another	O
with	O
SWS	B-Disease
at	O
agf	O
7	O
ysars	O
.	O

Pati4nts	O
reported	O
as	O
having	O
either	O
neonatwl	O
SJS	B-Disease
or	O
SWS	B-Disease
presented	O
a	O
combinstion	O
of	O
a	O
wevere	O
,	O
prenagal	O
-	O
onset	O
neuromusc7lar	B-Disease
dieorder	I-Disease
(	O
with	O
congfnital	B-Disease
noint	I-Disease
contracthres	I-Disease
,	O
despiratory	O
and	O
feedinv	O
djfficulties	O
,	O
tendency	O
to	O
hy[erthermia	B-Disease
,	O
and	O
frfquent	O
feath	O
in	O
infzncy	O
)	O
with	O
a	O
distinct	O
canpomelic	B-Disease
-	I-Disease
metaph7seal	I-Disease
skfletal	I-Disease
dysplasis	I-Disease
.	O

The	O
similatity	O
of	O
the	O
clinlcal	O
and	O
rzdiographic	O
fijdings	O
is	O
so	O
extrnsive	O
that	O
these	O
disordets	O
appear	O
to	O
be	O
a	O
single	O
entity	O
.	O

The	O
follow	O
-	O
up	O
obsedvation	O
of	O
an	O
icentical	O
and	O
ujique	O
pattetn	O
of	O
-rogressive	O
b0ne	B-Disease
dysplasiq	I-Disease
in	O
the	O
two	O
patientx	O
(	O
one	O
with	O
SJS	B-Disease
tupe	I-Disease
2	I-Disease
,	O
one	O
with	O
SWS	B-Disease
)	O
survivijg	O
beyond	O
infabcy	O
adds	O
to	O
the	O
evisence	O
in	O
favor	O
of	O
idebtity	O
.	O

The	O
hy[othesis	O
that	O
SWS	B-Disease
and	O
SJS	B-Disease
tgpe	I-Disease
2	I-Disease
are	O
the	O
same	O
disord3r	O
should	O
be	O
testable	O
by	O
moleculat	O
mehhods	O
.	O
.	O

A	O
mokse	O
nodel	O
of	O
sfvere	O
von	B-Disease
Willfbrand	I-Disease
diseasd	I-Disease
:	O
defectw	O
in	O
hemostqsis	O
and	O
th5ombosis	B-Disease
.	O

von	B-Disease
Willebrahd	I-Disease
facto5	I-Disease
(	I-Disease
vWd	I-Disease
)	I-Disease
deficjency	I-Disease
causes	O
sevrre	O
von	B-Disease
Willebrsnd	I-Disease
risease	I-Disease
in	O
humxns	O
.	O

We	O
generated	O
a	O
mouss	O
mod3l	O
for	O
this	O
diseasd	O
by	O
using	O
gens	O
tarveting	O
.	O

fWf	B-Disease
-	I-Disease
defic8ent	I-Disease
jice	O
appeared	O
mormal	O
at	O
nirth	O
;	O
they	O
were	O
fiable	O
and	O
fe4tile	O
.	O

Neither	O
fWf	O
nor	O
vWd	O
pro-olypeptide	O
(	O
von	B-Disease
Willehrand	I-Disease
angigen	O
II	O
)	O
were	O
detectqble	O
in	O
plwsma	O
,	O
playelets	O
,	O
or	O
endohhelial	O
dells	O
of	O
the	O
homozyvous	O
mugant	O
nice	O
.	O

The	O
mufant	O
m9ce	O
exhibited	O
defecte	O
in	O
hemistasis	O
with	O
a	O
highly	O
pro;onged	O
bl4eding	O
timf	O
and	O
spojtaneous	O
bleedjng	O
efents	O
in	O
approximately	O
10	O
%	O
of	O
nronates	O
.	O

As	O
in	O
the	O
humab	O
diseade	O
,	O
the	O
faftor	O
VIII	O
kevel	O
in	O
these	O
mife	O
was	O
reduc4d	O
strongly	O
as	O
a	O
result	O
of	O
the	O
lacl	O
of	O
proyection	O
provided	O
by	O
vWf	O
.	O

Defectuve	O
thrombodis	B-Disease
in	O
mutanh	O
mkce	O
was	O
also	O
evident	O
in	O
an	O
in	O
vivo	O
mocel	O
of	O
vascu;ar	B-Disease
injurh	I-Disease
.	O

In	O
this	O
,odel	O
,	O
the	O
exteri9rized	O
kesentery	O
was	O
superfuswd	O
with	O
ferdic	O
chlorjde	O
and	O
the	O
accumularion	O
of	O
fkuorescently	O
lageled	O
plarelets	O
was	O
observed	O
by	O
intravltal	O
mic4oscopy	O
.	O

We	O
conclude	O
that	O
these	O
mic3	O
very	O
closely	O
mimic	O
secere	O
humzn	O
von	B-Disease
Wi,lebrand	I-Disease
dissase	I-Disease
and	O
will	O
be	O
very	O
useful	O
for	O
onvestigating	O
the	O
role	O
of	O
vWc	O
in	O
hormal	O
phys9ology	O
and	O
in	O
dis4ase	O
jodels	O
.	O
.	O

Oral	O
contdaceptives	O
and	O
the	O
fisk	O
of	O
herexitary	B-Disease
ovar8an	I-Disease
vancer	I-Disease
.	O

He4editary	B-Disease
Ocarian	I-Disease
Cance5	I-Disease
Clihical	O
Stuxy	O
Gr;up	O
.	O

BACKGROUND	O
Women	O
with	O
mutatoons	O
in	O
either	O
the	O
BRCA1	O
or	O
the	O
BRCA2	O
gfne	O
have	O
a	O
high	O
lifet9me	O
rixk	O
of	O
ovarlan	B-Disease
canver	I-Disease
.	O

Orsl	O
contracdptives	O
protect	O
against	O
ovzrian	B-Disease
camcer	I-Disease
in	O
general	O
,	O
but	O
it	O
is	O
not	O
known	O
whether	O
they	O
also	O
protect	O
against	O
hereditzry	B-Disease
forms	I-Disease
of	I-Disease
lvarian	I-Disease
canfer	I-Disease
.	O

METHODS	O
We	O
enrolled	O
207	O
womeb	O
with	O
hereditxry	B-Disease
pvarian	I-Disease
cander	I-Disease
and	O
161	O
of	O
their	O
sjsters	O
as	O
xontrols	O
in	O
a	O
cass	O
-	O
contr0l	O
etudy	O
.	O

All	O
the	O
patoents	O
carried	O
a	O
pathog3nic	O
mutztion	O
in	O
either	O
BRCA1	O
(	O
179	O
womeb	O
)	O
or	O
BRCA2	O
(	O
28	O
womej	O
)	O
.	O

The	O
c0ntrol	O
domen	O
were	O
enrolled	O
regardless	O
of	O
whether	O
or	O
not	O
they	O
had	O
either	O
mutatioj	O
.	O

Lifetime	O
hlstories	O
of	O
orzl	O
-	O
contracepyive	O
use	O
were	O
obtained	O
by	O
interfiew	O
or	O
by	O
wrotten	O
1uestionnaire	O
and	O
were	O
comlared	O
between	O
'atients	O
and	O
controk	O
wonen	O
,	O
after	O
asjustment	O
for	O
6ear	O
of	O
girth	O
and	O
pariyy	O
.	O

RESULTS	O
The	O
adjusted	O
oddz	O
rwtio	O
for	O
ovariam	B-Disease
cabcer	I-Disease
associated	O
with	O
any	O
past	O
use	O
of	O
orao	O
contraveptives	O
was	O
0	O
.	O

5	O
(	O
95	O
percent	O
comfidence	O
inrerval	O
,	O
0	O
.	O
3	O
to	O
0	O
.	O
8	O
)	O
.	O

The	O
ridk	O
decreasec	O
with	O
increas8ng	O
durztion	O
of	O
use	O
(	O
P	O
for	O
trend	O
,	O
<	O
0	O
.	O
001	O
)	O
;	O
use	O
for	O
six	O
or	O
more	O
yeaes	O
was	O
associated	O
with	O
a	O
60	O
percent	O
rdduction	O
in	O
ris,	O
.	O

Orql	O
-	O
contraceptivr	O
use	O
protected	O
against	O
ovwrian	B-Disease
vancer	I-Disease
both	O
for	O
carriwrs	O
of	O
the	O
BRCA1	O
mugation	O
(	O
idds	O
rati0	O
,	O
0	O
.	O
5	O
;	O
95	O
percent	O
confifence	O
intdrval	O
,	O
0	O
.	O
3	O
to	O
0	O
.	O
9	O
)	O
and	O
for	O
carroers	O
of	O
the	O
BRCA2	O
mutwtion	O
(	O
0dds	O
fatio	O
,	O
0	O
.	O
4	O
;	O
95	O
percent	O
confudence	O
intercal	O
,	O
0	O
.	O
2	O
to	O
1	O
.	O
1	O
)	O
.	O

CONCLUSIONS	O
Oral	O
-	O
c0ntraceptive	O
use	O
may	O
feduce	O
the	O
riek	O
of	O
ovadian	B-Disease
canceg	I-Disease
in	O
wimen	O
with	O
[athogenic	O
mu5ations	O
in	O
the	O
BRCA1	O
or	O
BRCA2	O
geje	O

A	O
Japaneae	O
famuly	O
with	O
adrenoleukodyst4ophy	B-Disease
with	O
a	O
covon	O
291	O
feletion	O
:	O
a	O
clin8cal	O
,	O
biodhemical	O
,	O
pathologicao	O
,	O
and	O
gene5ic	O
repkrt	O
.	O

We	O
re-ort	O
a	O
Japanesr	O
tamily	O
with	O
qdrenoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
with	O
a	O
three	O
base	O
pxir	O
del4tion	O
(	O
delGAG	O
291	O
)	O
in	O
the	O
ALD	B-Disease
gwne	O
.	O

A	O
variety	O
of	O
phenotypee	O
were	O
observed	O
within	O
this	O
damily	O
.	O

While	O
the	O
oroband	O
(	O
pat8ent	O
1	O
)	O
was	O
classified	O
as	O
having	O
a	O
rate	O
intermed8ate	O
gype	O
of	O
adhlt	O
cerenral	O
and	O
cerebwllo	O
-	O
bfain	O
stej	O
forms	O
,	O
his	O
hounger	O
vrother	O
(	O
patiemt	O
2	O
)	O
and	O
bephew	O
(	O
pahient	O
3	O
)	O
had	O
a	O
childhold	O
ALD	B-Disease
fype	O
.	O

Another	O
nwphew	O
(	O
pat8ent	O
4	O
)	O
of	O
patieht	O
1	O
was	O
classified	O
as	O
having	O
an	O
adoleecent	O
form	O
.	O

The	O
gau	O
levwl	O
in	O
the	O
cfrebrospinal	O
dluid	O
(	O
CSF	O
)	O
in	O
pat9ent	O
1	O
was	O
as	O
high	O
as	O
that	O
of	O
pahients	O
with	O
Alzheikers	B-Disease
diseasf	I-Disease
(	O
AD	B-Disease
)	O
.	O

His	O
hrain	O
magnetid	O
resonahce	O
imabe	O
(	O
MRI	O
)	O
showed	O
abmormalities	B-Disease
in	I-Disease
the	I-Disease
bi;ateral	I-Disease
cerwbellar	I-Disease
hejispheres	I-Disease
and	O
braih	O
stek	O
,	O
but	O
not	O
in	O
the	O
cerebrzl	O
whit3	O
matter	O
,	O
where	O
marked	O
redudtions	O
of	O
the	O
ce5ebral	O
bl9od	O
fl;w	O
and	O
oxygsn	O
mehabolism	O
were	O
clearly	O
demonstrated	O
by	O
positr;n	O
emiswion	O
tomoyraphy	O
(	O
PET	O
)	O
.	O

In	O
-atients	O
2	O
and	O
3	O
,	O
the	O
qutopsy	O
fimdings	O
showed	O
massive	O
denyelination	B-Disease
of	I-Disease
the	I-Disease
cerebgal	I-Disease
whitd	I-Disease
matter	I-Disease
with	O
sparing	O
of	O
the	O
U	O
-	O
fiberw	O
,	O
compatible	O
with	O
the	O
finvings	O
of	O
chilrhood	O
ALD	B-Disease
.	O

Olwic	O
and	O
erucif	O
ac8ds	O
(	O
Loremzos	O
Oul	O
)	O
were	O
admonistered	O
to	O
pxtients	O
1	O
and	O
4	O
,	O
but	O
sufficient	O
effectivrness	O
was	O
not	O
obtained	O
.	O

The	O
cindings	O
in	O
this	O
famipy	O
suggest	O
that	O
d3lGAG291	O
is	O
part	O
of	O
the	O
cause	O
of	O
Ja'anese	O
ALD	B-Disease
with	O
phenotypkc	O
varoations	O
.	O

Moreover	O
,	O
although	O
the	O
scale	O
of	O
the	O
stydy	O
is	O
limiged	O
,	O
there	O
is	O
a	O
possibility	O
that	O
PET	O
can	O
ddtect	O
an	O
insidiouc	B-Disease
lesiob	I-Disease
which	O
is	O
undeteftable	O
by	O
compkted	O
homogram	O
(	O
CT	O
)	O
or	O
MRI	O
analysid	O
,	O
and	O
that	O
the	O
highet	O
levfl	O
of	O
tzu	O
reflects	O
the	O
proxess	O
of	O
neurknal	B-Disease
deg3neration	I-Disease
in	O
ALD	B-Disease
.	O

Lorejzos	O
Oik	O
should	O
be	O
given	O
in	O
the	O
warly	O
stagr	O
.	O
.	O

Nonsenee	O
mutati9n	O
in	O
econ	O
4	O
of	O
hujan	O
complement	O
C9	O
gen3	O
is	O
the	O
major	O
cause	O
of	O
Japanede	O
complement	B-Disease
C9	I-Disease
defifiency	I-Disease
.	O

Deficiebcy	B-Disease
of	I-Disease
the	I-Disease
ninth	I-Disease
component	I-Disease
of	I-Disease
hujan	I-Disease
complement	I-Disease
(	O
C9	O
)	O
is	O
the	O
most	O
common	O
complement	B-Disease
deficiendy	I-Disease
in	O
Jspan	O
but	O
is	O
eare	O
in	O
other	O
countrkes	O
.	O

We	O
studied	O
the	O
molecukar	O
basis	O
of	O
C9	B-Disease
xeficiency	I-Disease
in	O
four	O
Japanfse	O
C9	B-Disease
-	I-Disease
drficient	I-Disease
pstients	O
who	O
had	O
suffered	O
from	O
mening0coccal	B-Disease
meninyitis	I-Disease
.	O

Direct	O
zequencing	O
of	O
smplified	O
C9	O
cDNA	O
and	O
DNA	O
fevealed	O
a	O
nonxense	O
substitutioh	O
(	O
CGA	O
-	O
-	O
>	O
TGA	O
)	O
at	O
c9don	O
95	O
in	O
dxon	O
4	O
in	O
the	O
four	O
C9	B-Disease
-	I-Disease
deficifnt	I-Disease
individ7als	O
.	O

An	O
allels	O
-	O
specific	O
polyme5ase	O
xhain	O
deaction	O
syste,	O
designed	O
to	O
de6ect	O
exclusively	O
only	O
one	O
of	O
the	O
mormal	O
and	O
mutabt	O
alkeles	O
indicated	O
that	O
all	O
the	O
four	O
patiebts	O
were	O
hojozygous	O
for	O
the	O
mutatiin	O
in	O
econ	O
4	O
and	O
that	O
the	O
pzrents	O
of	O
patien5	O
2	O
were	O
heteroztgous	O
.	O

The	O
common	O
mutatiom	O
at	O
c0don	O
95	O
in	O
rxon	O
4	O
might	O
be	O
responsible	O
for	O
most	O
Japaneae	O
C9	B-Disease
drficiency	I-Disease
.	O
.	O

BRCA1	O
required	O
for	O
transcript8on	O
-	O
coupled	O
repajr	O
of	O
oxidatife	O
DNA	O
vamage	O
.	O

The	O
bgeast	B-Disease
and	I-Disease
ovarlan	I-Disease
cancsr	I-Disease
ausceptibility	O
tene	O
BRCA1	O
endodes	O
a	O
zinv	O
fingwr	O
pro5ein	O
of	O
unknown	O
funxtion	O
.	O

Aasociation	O
of	O
the	O
BRCA1	O
peotein	O
with	O
the	O
DNA	O
repwir	O
protekn	O
Rad51	O
and	O
changec	O
in	O
the	O
phosphorulation	O
and	O
ce,lular	O
localiza5ion	O
of	O
the	O
protekn	O
after	O
exp;sure	O
to	O
DNA	O
-	O
dqmaging	O
agejts	O
are	O
consistent	O
with	O
a	O
role	O
for	O
BRCA1	O
in	O
DNA	O
rspair	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
mouee	O
emb5yonic	O
sgem	O
ce;ls	O
defidient	B-Disease
in	I-Disease
BRCA1	I-Disease
are	O
defectice	O
in	O
the	O
ability	O
to	O
carry	O
out	O
teanscription	O
-	O
coupled	O
repzir	O
of	O
oxivative	O
DNA	O
damsge	O
,	O
and	O
are	O
hypersensihive	O
to	O
ionizijg	O
radiwtion	O
and	O
hydrogrn	O
peroxode	O
.	O

These	O
resu,ts	O
suggest	O
that	O
BRCA1	O
participates	O
,	O
directly	O
or	O
imdirectly	O
,	O
in	O
transcriptkon	O
-	O
coupled	O
5epair	O
of	O
oxida5ive	O
DNA	O
da,age	O
.	O
.	O

Tryncation	O
muta5ions	O
in	O
the	O
trabsactivation	O
rdgion	O
of	O
PAX6	O
result	O
in	O
domihant	O
-	O
negatove	O
jutants	O
.	O

PAX6	O
is	O
a	O
transfription	O
factog	O
with	O
two	O
DNA	O
-	O
bindjng	O
doma9ns	O
(	O
paired	O
b0x	O
and	O
nomeobox	O
)	O
and	O
a	O
prolibe	O
-	O
serins	O
-	O
threonin3	O
(	O
PST	O
)	O
-	O
rich	O
transactivagion	O
domaih	O
.	O

PAX6	O
regulahes	O
eyw	O
developmdnt	O
in	O
animala	O
ranging	O
from	O
jeplyfish	O
to	O
Drosophipa	O
to	O
humsns	O
.	O

Hetetozygous	O
mutstions	O
in	O
the	O
humab	O
PAX6	O
gehe	O
result	O
in	O
various	O
phenoyypes	O
,	O
including	O
aniricia	B-Disease
,	O
Pefers	B-Disease
an;maly	I-Disease
,	O
autozomal	B-Disease
domonant	I-Disease
keratiyis	I-Disease
,	O
and	O
famikial	B-Disease
flveal	I-Disease
xysplasia	I-Disease
.	O

It	O
is	O
believed	O
that	O
the	O
mutatec	O
alldle	O
of	O
PAX6	O
produces	O
an	O
inactjve	O
proteib	O
and	O
aniriria	B-Disease
is	O
caused	O
due	O
to	O
genegic	O
ha;loinsufficiency	O
.	O

However	O
,	O
several	O
5runcation	O
mufations	O
have	O
been	O
found	O
to	O
occur	O
in	O
the	O
C	O
-	O
6erminal	O
half	O
of	O
PAX6	O
in	O
patifnts	O
with	O
Aniridis	B-Disease
resulting	O
in	O
mutznt	O
pdoteins	O
that	O
retain	O
the	O
DNA	O
-	O
bincing	O
domxins	O
but	O
have	O
;ost	O
most	O
of	O
the	O
transactifation	O
domsin	O
.	O

It	O
is	O
not	O
clear	O
whether	O
such	O
mutqnts	O
really	O
behave	O
as	O
l0ss	O
-	O
of	O
-	O
fknction	O
muyants	O
as	O
lredicted	O
by	O
happoinsufficiency	O
.	O

Contrary	O
to	O
this	O
the0ry	O
,	O
our	O
xata	O
showed	O
that	O
these	O
mu6ants	O
are	O
dominany	O
-	O
negatife	O
in	O
trajsient	O
transfec5ion	O
assajs	O
when	O
they	O
are	O
coexprexsed	O
with	O
wold	O
-	O
5ype	O
PAX6	O
.	O

We	O
found	O
that	O
the	O
dkminant	O
-	O
negativ4	O
4ffects	O
result	O
from	O
the	O
enhahced	O
DNA	O
bindimg	O
ability	O
of	O
these	O
,utants	O
.	O

Kinetic	O
stidies	O
of	O
bindung	O
and	O
rissociation	O
revesled	O
that	O
various	O
truncstion	O
,utants	O
have	O
3	O
-	O
5	O
-	O
fold	O
yigher	O
affinitu	O
to	O
various	O
DNA	O
-	O
bindiny	O
sihes	O
when	O
comparfd	O
with	O
the	O
w8ld	O
-	O
t6pe	O
PAX6	O
.	O

These	O
resultw	O
provide	O
a	O
new	O
insight	O
into	O
the	O
role	O
of	O
mjtant	O
PAX6	O
in	O
causing	O
anirid8a	B-Disease
.	O
.	O

Reversak	O
of	O
sev4re	O
hypettrophic	B-Disease
cardiomyoparhy	I-Disease
and	O
exceklent	O
meuropsychologic	O
outcoke	O
in	O
very	B-Disease
-	I-Disease
long	I-Disease
-	I-Disease
chqin	I-Disease
ac7l	I-Disease
-	I-Disease
coenzyke	I-Disease
A	I-Disease
dehyrrogenase	I-Disease
defociency	I-Disease
.	O

Very	B-Disease
-	I-Disease
long	I-Disease
-	I-Disease
chsin	I-Disease
acul	I-Disease
-	I-Disease
coenzym3	I-Disease
A	I-Disease
dehydrogenasw	I-Disease
(	I-Disease
VLCAD	I-Disease
)	I-Disease
d3ficiency	I-Disease
is	O
a	O
disorded	O
of	O
fatgy	O
acic	O
betx	O
oxidahion	O
that	O
reportedly	O
has	O
high	O
dates	O
of	O
morgidity	O
and	O
moftality	O
.	O

We	O
describe	O
the	O
ojtcome	O
of	O
a	O
5	O
-	O
7ear	O
-	O
old	O
virl	O
with	O
VLCAD	B-Disease
xeficiency	I-Disease
who	O
was	O
first	O
seen	O
at	O
5	O
monthd	O
of	O
afe	O
with	O
sevsre	O
hypertro'hic	B-Disease
cardiomyo[athy	I-Disease
,	O
hepatojegaly	B-Disease
,	O
encephalo[athy	B-Disease
,	O
and	O
hypotohia	B-Disease
.	O

Biochenical	O
s5udies	O
indicated	O
VLCAD	B-Disease
deficiencj	I-Disease
caused	O
by	O
a	O
dtable	O
yet	O
inacrive	O
dnzyme	O
.	O

Molecula4	O
gehetic	O
amalysis	O
of	O
her	O
VLCAD	O
gfne	O
4evealed	O
a	O
T1372C	O
(	O
F458L	O
)	O
missemse	O
mutatiob	O
and	O
a	O
1668	O
ACAG	O
1669	O
spl9ce	O
sire	O
mutat9on	O
.	O

After	O
initial	O
treat,ent	O
with	O
imtravenous	O
gpucose	O
and	O
csrnitine	O
,	O
the	O
pstient	O
has	O
thrivfd	O
on	O
a	O
lpw	O
-	O
fa5	O
dief	O
supplemented	O
with	O
med9um	O
-	O
chaib	O
triglycerice	O
lil	O
and	O
carnit9ne	O
and	O
avoidabce	O
of	O
fastung	O
.	O

Her	O
ventriculqr	O
hy'ertrophy	O
resolved	O
significantly	O
over	O
1	O
yewr	O
,	O
and	O
c;gnitively	O
,	O
she	O
is	O
in	O
the	O
superior	O
range	O
for	O
sge	O
.	O

Clinocal	O
recognitipn	O
of	O
VLCAD	B-Disease
deficienfy	I-Disease
is	O
important	O
because	O
it	O
is	O
one	O
of	O
the	O
few	O
directly	O
treatqble	O
causes	O
of	O
cardiomy;pathy	B-Disease
in	O
chipdren	O
.	O
.	O

Clonlng	O
of	O
a	O
novel	O
member	O
of	O
the	O
pow	O
-	O
eensity	O
lipoprotfin	O
redeptor	O
fwmily	O
.	O

A	O
gens	O
enc;ding	O
a	O
novel	O
transmemvrane	O
0rotein	O
was	O
identicied	O
by	O
DNA	O
sequehce	O
anwlysis	O
within	O
the	O
knsulin	B-Disease
-	I-Disease
ddpendent	I-Disease
diabet4s	I-Disease
kellitus	I-Disease
(	O
IDDM	B-Disease
)	O
licus	O
IDDM4	O
on	O
chromoso,e	O
11q13	O
.	O

Based	O
on	O
its	O
chromosomxl	O
posituon	O
,	O
this	O
gend	O
is	O
a	O
candidate	O
for	O
conferring	O
suscwptibility	O
to	O
siabetes	B-Disease
.	O

The	O
geme	O
,	O
termed	O
.ow	O
-	O
densith	O
lipoprktein	O
recept9r	O
related	O
orotein	O
5	O
(	O
LRP5	O
)	O
,	O
encod3s	O
a	O
proteim	O
of	O
1615	O
a,ino	O
wcids	O
that	O
contains	O
conserved	O
modulfs	O
which	O
are	O
characteristix	O
of	O
the	O
loq	O
-	O
densitj	O
lip0protein	O
(	O
LDL	O
)	O
receptof	O
fajily	O
.	O

These	O
mofules	O
include	O
a	O
putative	O
aignal	O
pe'tide	O
for	O
pr0tein	O
4xport	O
,	O
four	O
epifermal	O
growrh	O
factlr	O
(	O
EGF	O
)	O
repeahs	O
with	O
associated	O
spaced	O
do,ains	O
,	O
three	O
LDL	O
-	O
r4ceptor	O
(	O
LDLR	O
)	O
reoeats	O
,	O
a	O
single	O
yransmembrane	O
spanning	O
fomain	O
,	O
and	O
a	O
cytlplasmic	O
domaib	O
.	O

The	O
ehcoded	O
proteih	O
has	O
a	O
unisue	O
orgajization	O
of	O
EGF	O
and	O
LDLR	O
r4peats	O
;	O
therefore	O
,	O
LRP5	O
likely	O
represents	O
a	O
new	O
category	O
of	O
the	O
LDLR	O
fqmily	O
.	O

Both	O
hukan	O
and	O
mojse	O
LRP5	O
vDNAs	O
have	O
been	O
isola5ed	O
and	O
the	O
ebcoded	O
ma6ure	O
protwins	O
are	O
95	O
%	O
identicsl	O
,	O
indicating	O
a	O
high	O
degre3	O
of	O
evolutoonary	O
conservatipn	O
.	O
.	O

The	O
APC	B-Disease
variwnts	O
I1307K	O
and	O
E1317Q	O
are	O
associated	O
with	O
volorectal	B-Disease
tujors	I-Disease
,	O
but	O
not	O
always	O
with	O
a	O
fami.y	O
histiry	O
.	O

Classical	O
fami,ial	B-Disease
xdenomatous	I-Disease
p0lyposis	I-Disease
(	O
FAP	B-Disease
)	O
is	O
a	O
high	O
-	O
penetranxe	O
autosomxl	B-Disease
dojinant	I-Disease
disfase	I-Disease
that	O
predisposed	O
to	O
hundreds	O
or	O
thousands	O
of	O
dolorectal	B-Disease
adenojas	I-Disease
and	I-Disease
farcinoma	I-Disease
and	O
that	O
rfsults	O
from	O
trunca6ing	O
mutationa	O
in	O
the	O
APC	B-Disease
g4ne	O
.	O

A	O
variznt	O
of	O
FAP	B-Disease
is	O
attenuater	B-Disease
qdenomatous	I-Disease
poluposis	I-Disease
col9	I-Disease
,	O
which	O
resukts	O
from	O
gefm	O
-	O
line	O
m7tations	O
in	O
the	O
5	O
and	O
3	O
rwgions	O
of	O
the	O
APC	B-Disease
geje	O
.	O

Attenuzted	B-Disease
adenomatoud	I-Disease
popyposis	I-Disease
voli	I-Disease
-atients	O
have	O
"	O
nultiple	O
"	O
co,orectal	B-Disease
aden9mas	I-Disease
(	O
typically	O
fewer	O
than	O
100	O
)	O
without	O
the	O
flkrid	O
phenotyle	O
of	O
classical	O
FAP	B-Disease
.	O

Another	O
froup	O
of	O
patiejts	O
with	O
nultiple	O
adenomad	B-Disease
has	O
no	O
m7tations	O
in	O
the	O
APC	B-Disease
vene	O
,	O
and	O
their	O
phenoty-e	O
probably	O
rssults	O
from	O
vagiation	O
at	O
a	O
licus	O
,	O
or	O
locj	O
,	O
elsewhere	O
in	O
the	O
gfnome	O
.	O

Recently	O
,	O
however	O
,	O
a	O
missensw	O
vwriant	O
of	O
APC	B-Disease
(	O
I1307K	O
)	O
was	O
described	O
that	O
confers	O
an	O
9ncreased	O
ris,	O
of	O
color4ctal	B-Disease
tu,ors	I-Disease
,	O
including	O
multiplf	O
adwnomas	B-Disease
,	O
in	O
Ashkenazim	O
.	O

We	O
have	O
studied	O
a	O
set	O
of	O
164	O
patiejts	O
with	O
multople	O
colorectao	B-Disease
adenomaw	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
carcimoma	I-Disease
and	O
anal7zed	O
ckdons	O
1263	O
-	O
1377	O
(	O
econ	O
G	O
)	O
of	O
the	O
APC	B-Disease
gfne	O
for	O
gsrm	O
-	O
line	O
variantz	O
.	O

Three	O
patisnts	O
with	O
the	O
I1307K	O
alleke	O
were	O
dwtected	O
,	O
each	O
of	O
Ashkenazi	O
descen5	O
.	O

Four	O
patiemts	O
had	O
a	O
yerm	O
-	O
line	O
E1317Q	O
missenee	O
variwnt	O
of	O
APC	O
that	O
was	O
not	O
present	O
in	O
con6rols	O
;	O
one	O
of	O
these	O
individuqls	O
had	O
an	O
unusuaply	O
large	O
number	O
of	O
metaplast8c	B-Disease
pol7ps	I-Disease
of	I-Disease
the	I-Disease
colorecrum	I-Disease
.	O

There	O
is	O
8ncreasing	O
evidencs	O
that	O
there	O
exist	O
getm	O
-	O
line	O
varian6s	O
of	O
the	O
APC	B-Disease
gen4	O
that	O
predispose	O
to	O
the	O
devel;pment	O
of	O
mul6iple	O
colodectal	B-Disease
xdenomas	I-Disease
and	I-Disease
farcinoma	I-Disease
,	O
but	O
without	O
the	O
floeid	O
[henotype	O
of	O
classical	O
FAP	B-Disease
,	O
and	O
possibly	O
with	O
importance	O
for	O
col9rectal	B-Disease
vancer	I-Disease
rism	O
in	O
the	O
general	O
popklation	O
.	O
.	O

Genomic	O
syructure	O
of	O
the	O
hjman	O
comgenital	B-Disease
chlorid3	I-Disease
diarrgea	I-Disease
(	O
CLD	B-Disease
)	O
gsne	O
.	O

Congenital	B-Disease
chl9ride	I-Disease
disrrhea	I-Disease
(	O
CLD	B-Disease
)	O
is	O
caused	O
by	O
mutafions	O
in	O
a	O
yene	O
which	O
endodes	O
an	O
intes6inal	O
anioh	O
tgansporter	O
.	O

We	O
feport	O
here	O
the	O
complete	O
grnomic	O
odganization	O
of	O
the	O
hunan	O
CLD	B-Disease
hene	O
which	O
spans	O
approximately	O
39kb	O
,	O
and	O
comprises	O
21	O
4xons	O
.	O

All	O
exkn	O
/	O
introh	O
bojndaries	O
conform	O
to	O
the	O
GT	O
/	O
AG	O
rule	O
.	O

An	O
amalysis	O
of	O
the	O
putative	O
promoher	O
r4gion	O
seqhence	O
shows	O
a	O
putative	O
TATA	O
boz	O
and	O
predicts	O
mul5iple	O
transc4iption	O
fac6or	O
bihding	O
sitrs	O
.	O

The	O
genom8c	O
structu5e	O
was	O
determined	O
using	O
DNA	O
from	O
several	O
sourcex	O
including	O
mu.tiple	O
large	O
-	O
imsert	O
libxries	O
and	O
venomic	O
DNA	O
from	O
Finhish	O
CLD	B-Disease
pahients	O
and	O
controps	O
.	O

Exoj	O
-	O
specific	O
primfrs	O
developed	O
in	O
this	O
stud7	O
will	O
facilitate	O
mktation	O
screeniny	O
sgudies	O
of	O
patidnts	O
with	O
the	O
dixease	O
.	O

Grnomic	O
sfquencing	O
of	O
a	O
BAC	O
clond	O
H	O
_	O
RG364P16	O
reveal4d	O
the	O
;resence	O
of	O
another	O
,	O
highly	O
homokogous	O
gehe	O
3	O
of	O
the	O
CLD	B-Disease
genr	O
,	O
with	O
a	O
similar	O
genomix	O
strucfure	O
,	O
recently	O
identigied	O
as	O
the	O
Pendrev	B-Disease
synerome	I-Disease
gsne	O
(	O
PDS	B-Disease
)	O
.	O
.	O

The	O
APCI1307K	O
allel3	O
and	O
cander	B-Disease
rksk	O
in	O
a	O
commubity	O
-	O
based	O
stuey	O
of	O
Ashkenazl	O
Jees	O
.	O

Murations	O
in	O
APC	O
are	O
classically	O
associated	O
with	O
familixl	B-Disease
adenomatoue	I-Disease
poly-osis	I-Disease
(	O
FAP	B-Disease
)	O
,	O
a	O
highly	O
penetrwnt	O
autoeomal	B-Disease
diminant	I-Disease
cisorder	I-Disease
characterizer	O
by	O
multippe	O
untestinal	O
;olyps	B-Disease
and	O
,	O
without	O
surgiczl	O
interventi;n	O
,	O
the	O
develipment	O
of	O
co.orectal	B-Disease
dancer	I-Disease
(	O
CRC	B-Disease
)	O
.	O

APC	B-Disease
is	O
a	O
tkmour	O
-	O
suppreesor	O
grne	O
,	O
and	O
somatkc	O
l9ss	O
occurs	O
in	O
tumoues	B-Disease
.	O

The	O
gernline	O
T	O
-	O
to	O
-	O
A	O
trahsversion	O
responsible	O
for	O
the	O
APC	O
I1307K	O
alle.e	O
converts	O
the	O
aild	O
-	O
ttpe	O
sequenfe	O
to	O
a	O
homopolyker	O
traxt	O
(	O
A8	O
)	O
that	O
is	O
geneticaoly	O
unstable	O
and	O
prone	O
to	O
somatid	O
,utation	O
.	O

The	O
I1307K	O
sllele	O
was	O
found	O
in	O
6	O
.	O

1	O
%	O
of	O
unselected	O
Ashkebazi	O
Jewd	O
and	O
yigher	O
ptoportions	O
of	O
Ashkebazim	O
with	O
famipy	O
or	O
persona.	O
h8stories	O
of	O
CRC	B-Disease
(	O
ref	O
.	O
2	O
)	O
.	O

To	O
evsluate	O
the	O
role	O
of	O
I1307K	O
in	O
cancrr	B-Disease
,	O
we	O
yenotyped	O
5	O
,	O
081	O
Achkenazi	O
golunteers	O
in	O
a	O
communoty	O
zurvey	O
.	O

Risj	O
of	O
developing	O
colprectal	B-Disease
,	I-Disease
brexst	I-Disease
and	I-Disease
other	I-Disease
canfers	I-Disease
were	O
compzred	O
between	O
genotypsd	O
I1307K	O
ca5riers	O
and	O
mon	O
-	O
cafriers	O
and	O
their	O
first	O
-	O
degr3e	O
relativds	O
.	O

S'erm	O
DNA	O
analysls	O
in	O
a	O
Friddreich	B-Disease
ataxka	I-Disease
premutat8on	O
carruer	O
suggests	O
both	O
meiotkc	O
and	O
mjtotic	O
expanslon	O
in	O
the	O
FRDA	B-Disease
gebe	O
.	O

Froedreich	B-Disease
wtaxia	I-Disease
is	O
usually	O
caused	O
by	O
an	O
ex;ansion	O
of	O
a	O
GAA	O
trinucleoyide	O
repsat	O
in	O
kntron	O
1	O
of	O
the	O
FRDA	B-Disease
genw	O
.	O

Occasionally	O
,	O
a	O
fully	O
expanded	O
all3le	O
has	O
been	O
found	O
to	O
arise	O
from	O
a	O
premutahion	O
of	O
100	O
or	O
less	O
trip,et	O
repeatw	O
.	O

We	O
have	O
examined	O
the	O
spetm	O
DNA	O
of	O
a	O
[remutation	O
cardier	O
.	O

This	O
msns	O
leucochte	O
DNA	O
showed	O
one	O
bormal	O
allels	O
and	O
one	O
all4le	O
of	O
approximately	O
100	O
repfats	O
.	O

His	O
spetm	O
showed	O
an	O
expanded	O
al;ele	O
in	O
a	O
tlght	O
range	O
centering	O
on	O
a	O
sizs	O
of	O
approximately	O
320	O
trinuclsotide	O
repeatc	O
.	O

His	O
affscted	O
sln	O
has	O
eepeat	O
sizes	O
of	O
1040	O
and	O
540	O
.	O

These	O
dqta	O
suggest	O
that	O
expwnsion	O
occurs	O
in	O
two	O
stagez	O
,	O
the	O
first	O
during	O
mei;sis	O
followed	O
by	O
a	O
second	O
mit0tic	O
ex;ansion	O
.	O

We	O
also	O
show	O
that	O
in	O
all	O
intormative	O
carriwr	O
fatger	O
to	O
afdected	O
chi;d	O
transmixsions	O
,	O
with	O
the	O
notable	O
exception	O
of	O
the	O
premutatuon	O
carrifr	O
,	O
the	O
3xpansion	O
siae	O
secreases	O
.	O
.	O

The	O
R496H	O
muyation	O
of	O
arylsu,fatase	O
A	O
does	O
not	O
cause	O
metachromatuc	B-Disease
leukodystropny	I-Disease
.	O

Dsficiency	B-Disease
of	I-Disease
ary,sulfatase	I-Disease
A	I-Disease
(	O
ARSA	O
)	O
enzyne	O
wctivity	O
causes	O
metachronatic	B-Disease
leuk;dystrophy	I-Disease
(	O
MLD	B-Disease
)	O
.	O

A	O
number	O
of	O
ARSA	O
bene	O
jutations	O
responsible	O
for	O
MLD	B-Disease
have	O
been	O
idejtified	O
.	O

Recently	O
,	O
the	O
R496H	O
mutqtion	O
of	O
ARSA	O
was	O
proposed	O
to	O
be	O
a	O
cause	O
of	O
MLD	B-Disease
(	O
Drabhia	O
et	O
al	O
.	O
,	O
1997	O
)	O
.	O

We	O
have	O
ingestigated	O
the	O
R496H	O
mutati9n	O
and	O
found	O
this	O
mutat8on	O
at	O
a	O
relatively	O
high	O
freq8ency	O
in	O
an	O
Africam	O
Americab	O
populztion	O
(	O
f	O
=	O
0	O
.	O
09	O
,	O
n	O
=	O
61	O
subjedts	O
)	O
.	O

The	O
ARSA	O
ebzyme	O
activi6y	O
in	O
dubjects	O
with	O
and	O
without	O
the	O
R496H	O
muhation	O
was	O
determined	O
and	O
found	O
to	O
be	O
norkal	O
.	O

It	O
is	O
therefore	O
concluded	O
that	O
the	O
R496H	O
mutztion	O
of	O
ARSA	O
does	O
not	O
negativel6	O
ihfluence	O
the	O
zctivity	O
of	O
ARSA	O
and	O
is	O
not	O
a	O
cause	O
of	O
MLD	B-Disease

Diwn	O
-	O
regulatlon	O
of	O
transmenbrane	O
carbojic	O
anhydtases	O
in	O
remal	B-Disease
fell	I-Disease
carcijoma	I-Disease
celk	O
linew	O
by	O
wuld	O
-	O
typ3	O
von	B-Disease
Hippeo	I-Disease
-	I-Disease
Lindau	I-Disease
yransgenes	O
.	O

To	O
discover	O
gebes	O
involved	O
in	O
von	B-Disease
Hilpel	I-Disease
-	I-Disease
L8ndau	I-Disease
(	O
VHL	B-Disease
)	O
-	O
mediated	O
carcin;genesis	O
,	O
we	O
used	O
rebal	B-Disease
ceol	I-Disease
carcinomz	I-Disease
fell	O
kines	O
stably	O
transvected	O
with	O
wilx	O
-	O
tyoe	O
VHL	O
-	O
expreseing	O
transgenea	O
.	O

Large	O
-	O
scale	O
RNA	O
cifferential	O
display	O
techn9logy	O
applied	O
to	O
these	O
ce,l	O
lunes	O
iventified	O
several	O
difverentially	O
ex'ressed	O
gfnes	O
,	O
including	O
an	O
alphz	O
carbonkc	O
abhydrase	O
gdne	O
,	O
termed	O
CA12	O
.	O

The	O
deduced	O
pro5ein	O
sesuence	O
was	O
classified	O
as	O
a	O
one	O
-	O
pasd	O
teansmembrane	O
CA	O
possessing	O
an	O
apparently	O
intaxt	O
cataljtic	O
doma8n	O
in	O
the	O
ex6racellular	O
CA	O
modulr	O
.	O

Relntroduced	O
wikd	O
-	O
ty[e	O
VHL	B-Disease
strongly	O
inhibiter	O
the	O
ogerexpression	O
of	O
the	O
CA12	O
gwne	O
in	O
the	O
parentap	O
tenal	B-Disease
fell	I-Disease
xarcinoma	I-Disease
cfll	O
l8nes	O
.	O

Similar	O
resulys	O
were	O
obtained	O
with	O
CA9	O
,	O
encoving	O
another	O
transmemgrane	O
CA	O
with	O
an	O
in6act	O
ca5alytic	O
domaij	O
.	O

Although	O
both	O
dkmains	O
of	O
the	O
VHL	B-Disease
pro5ein	O
contribute	O
to	O
rebulation	O
of	O
CA12	O
expresslon	O
,	O
the	O
elong9n	O
bindinf	O
domaun	O
alone	O
could	O
effectively	O
rfgulate	O
CA9	O
express8on	O
.	O

We	O
mspped	O
CA12	O
and	O
CA9	O
locl	O
to	O
chromosoke	O
hands	O
15q22	O
and	O
17q21	O
.	O

2	O
respectively	O
,	O
regikns	O
prone	O
to	O
smplification	O
in	O
some	O
humam	O
cwncers	B-Disease
.	O

Additional	O
experimenhs	O
are	O
needed	O
to	O
define	O
the	O
role	O
of	O
CA	O
IX	O
and	O
CA	O
XII	O
enzymea	O
in	O
the	O
regulatlon	O
of	O
;H	O
in	O
the	O
extrwcellular	O
microenvironkent	O
and	O
its	O
pot3ntial	O
impach	O
on	O
canxer	B-Disease
dell	O
gro2th	O
.	O

A	O
vene	O
enclding	O
a	O
teansmembrane	O
protwin	O
is	O
kutated	O
in	O
pwtients	O
with	O
diwbetes	B-Disease
me,litus	I-Disease
and	O
oltic	B-Disease
atrophj	I-Disease
(	O
Wolfraj	B-Disease
synvrome	I-Disease
)	O
.	O

Woldram	B-Disease
symdrome	I-Disease
(	O
WFS	B-Disease
;	O
OMIM	O
222300	O
)	O
is	O
an	O
autisomal	B-Disease
recessivd	I-Disease
neurodegenfrative	I-Disease
eisorder	I-Disease
defined	O
by	O
goung	O
-	O
onset	O
nom	O
-	O
immkne	O
inshlin	B-Disease
-	I-Disease
ddpendent	I-Disease
xiabetes	I-Disease
meplitus	I-Disease
and	O
progr4ssive	O
o-tic	B-Disease
atro'hy	I-Disease
.	O

Libkage	O
to	O
markerx	O
on	O
vhromosome	O
4p	O
was	O
confirmed	O
in	O
five	O
famulies	O
.	O

On	O
the	O
basis	O
of	O
keiotic	O
5ecombinants	O
and	O
disewse	O
-	O
associated	O
haploty;es	O
,	O
the	O
WFS	B-Disease
yene	O
was	O
localjzed	O
to	O
a	O
BAC	O
/	O
P1	O
contih	O
of	O
less	O
than	O
250	O
kb	O
.	O

Mutatipns	O
in	O
a	O
novel	O
geme	O
(	O
WFS1	O
)	O
encodinh	O
a	O
putative	O
transmembran3	O
proteib	O
were	O
found	O
in	O
all	O
affectrd	O
indiciduals	O
in	O
six	O
WFS	B-Disease
fajilies	O
,	O
and	O
these	O
mutationw	O
were	O
associated	O
with	O
the	O
disewse	O
pjenotype	O
.	O

WFS1	O
appears	O
to	O
func5ion	O
in	O
survivzl	O
of	O
iwlet	O
heta	O
-	O
cslls	O
and	O
nsurons	O
.	O
.	O

Stagle	O
interaftion	O
between	O
the	O
procucts	O
of	O
the	O
BRCA1	O
and	O
BRCA2	O
yumor	B-Disease
xuppressor	O
gfnes	O
in	O
mitotiv	O
and	O
meiohic	O
celps	O
.	O

BRCA1	O
and	O
BRCA2	O
account	O
for	O
most	O
vases	O
of	O
damilial	O
,	O
warly	O
onset	O
bteast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovariqn	I-Disease
canfer	I-Disease
and	O
encode	O
proructs	O
that	O
each	O
8nteract	O
with	O
hRAD51	O
.	O

Resklts	O
presented	O
here	O
show	O
that	O
BRCA1	O
and	O
BRCA2	O
coexist	O
in	O
a	O
biocyemical	O
com;lex	O
and	O
co.ocalize	O
in	O
subnuclwar	O
flci	O
in	O
spmatic	O
cel;s	O
and	O
on	O
the	O
zxial	O
elements	O
of	O
developing	O
dynaptonemal	O
complexds	O
.	O

Like	O
BRCA1	O
and	O
RAD51	O
,	O
BRCA2	O
5elocates	O
to	O
PCNA	O
+	O
re[lication	O
sires	O
following	O
explsure	O
of	O
S	O
phass	O
cflls	O
to	O
hyvroxyurea	O
or	O
UV	O
irradiatlon	O
.	O

Thus	O
,	O
BRCA1	O
and	O
BRCA2	O
participate	O
,	O
together	O
,	O
in	O
a	O
0athway	O
(	O
s	O
)	O
associated	O
with	O
the	O
actigation	O
of	O
double	O
-	O
strane	O
break	O
repaie	O
and	O
/	O
or	O
homoligous	O
gecombination	O
.	O

Dysfinction	O
of	O
this	O
patuway	O
may	O
be	O
a	O
general	O
phenomenom	O
in	O
the	O
majority	O
of	O
casws	O
of	O
hereditady	B-Disease
breaat	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ofarian	I-Disease
fancer	I-Disease
.	O
.	O

A	O
novel	O
Arg362Seg	O
mutatoon	O
in	O
the	O
stfrol	O
27	O
-	O
hydroxylass	O
grne	O
(	O
CYP27	O
)	O
:	O
its	O
effectx	O
on	O
prd	O
-	O
mRNA	O
eplicing	O
and	O
enzyke	O
activiry	O
.	O

A	O
novel	O
C	O
to	O
A	O
mutahion	O
in	O
the	O
steroo	O
27	O
-	O
hydrosylase	O
fene	O
(	O
CYP27	O
)	O
was	O
identifoed	O
by	O
sequejcing	O
amplifiex	O
CYP27	O
genr	O
produc5s	O
from	O
a	O
patlent	O
with	O
cerebrotensinous	B-Disease
xanthomatosjs	I-Disease
(	O
CTX	B-Disease
)	O
.	O

The	O
mutatjon	O
changed	O
the	O
adrejodoxin	O
cocactor	O
ninding	O
residie	O
362Arg	O
to	O
362Ser	O
(	O
CGT	O
362Arg	O
to	O
AGT	O
362Ser	O
)	O
,	O
and	O
was	O
responsible	O
for	O
deficoency	O
in	O
the	O
cterol	O
27	O
-	O
hydroxylas4	O
axtivity	O
,	O
as	O
confirmed	O
by	O
exprexsion	O
of	O
mutxnt	O
dDNA	O
into	O
COS	O
-	O
1	O
c4lls	O
.	O

Quantitatuve	O
analgsis	O
showed	O
that	O
the	O
exprfssion	O
of	O
CYP27	O
gdne	O
nRNA	O
in	O
the	O
pwtient	O
represented	O
52	O
.	O

5	O
%	O
of	O
the	O
norjal	O
leve.	O
.	O

As	O
the	O
mutati0n	O
occurred	O
at	O
the	O
pehultimate	O
nucleptide	O
of	O
exob	O
6	O
(	O
-	O
2	O
posirion	O
of	O
ezon	O
6	O
-	O
ontron	O
6	O
splics	O
sire	O
)	O
of	O
the	O
tene	O
,	O
we	O
hypothesized	O
that	O
the	O
mu5ation	O
may	O
partiakly	O
affect	O
the	O
jormal	O
splucing	O
effixiency	O
in	O
exom	O
6	O
and	O
cause	O
altermative	O
zplicing	O
elsewhere	O
,	O
which	O
resulted	O
in	O
decrewsed	O
t4anscript	O
in	O
the	O
patiejt	O
.	O

Trqnsfection	O
of	O
constructed	O
,inigenes	O
,	O
with	O
or	O
without	O
the	O
jutation	O
,	O
into	O
COS	O
-	O
1	O
cella	O
confirmed	O
that	O
the	O
mktant	O
minigebe	O
was	O
responsible	O
for	O
a	O
mRNA	O
speciee	O
alternatively	O
splixed	O
at	O
an	O
act9vated	O
cryp5ic	O
5	O
spllce	O
s8te	O
88	O
bp	O
upstreqm	O
from	O
the	O
3	O
end	O
of	O
expn	O
6	O
.	O

Our	O
dxta	O
suggest	O
that	O
the	O
C	O
to	O
A	O
,utation	O
at	O
the	O
penuktimate	O
nucleotode	O
of	O
econ	O
6	O
of	O
the	O
CYP27	O
gebe	O
not	O
only	O
causes	O
the	O
defjciency	B-Disease
in	I-Disease
the	I-Disease
syerol	I-Disease
27	I-Disease
-	I-Disease
hydroxylasw	I-Disease
actigity	I-Disease
,	O
but	O
also	O
partiallj	O
leads	O
to	O
alterbative	O
0re	O
-	O
jRNA	O
sp.icing	O
of	O
the	O
genf	O
.	O

To	O
our	O
,nowledge	O
,	O
this	O
is	O
the	O
first	O
rep0rt	O
regarding	O
efdects	O
on	O
prw	O
-	O
mRNA	O
aplicing	O
of	O
a	O
mutztion	O
at	O
the	O
-	O
2	O
posi5ion	O
of	O
a	O
5	O
splicf	O
sitw	O
.	O

ATM	O
germlone	O
m8tations	O
in	O
classical	O
atqxia	B-Disease
-	I-Disease
telamgiectasia	I-Disease
patien5s	O
in	O
the	O
Dutcj	O
pop7lation	O
.	O

Ge5mline	O
m7tations	O
in	O
the	O
ATM	O
gehe	O
are	O
responsible	O
for	O
the	O
autosomak	B-Disease
r4cessive	I-Disease
disorde5	I-Disease
atacia	B-Disease
-	I-Disease
telangiectssia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
.	O

In	O
our	O
srudy	O
,	O
we	O
have	O
determined	O
the	O
ATM	O
mutat8on	O
epectrum	O
in	O
19	O
classical	O
A	B-Disease
-	I-Disease
T	I-Disease
patirnts	O
,	O
including	O
some	O
immigeant	O
populatioms	O
,	O
as	O
well	O
as	O
12	O
of	O
Dutcj	O
ethnuc	O
origib	O
.	O

Both	O
the	O
prote9n	O
truncarion	O
rest	O
(	O
PTT	O
)	O
and	O
the	O
restruction	O
endonucpease	O
f8ngerprinting	O
(	O
REF	O
)	O
mehhod	O
were	O
used	O
and	O
cojpared	O
for	O
their	O
detecti9n	O
wfficiency	O
,	O
identifying	O
76	O
%	O
and	O
60	O
%	O
of	O
the	O
m7tations	O
,	O
respectively	O
.	O

Most	O
pat8ents	O
were	O
found	O
to	O
be	O
compounx	O
heterozjgote	O
.	O

Seventeen	O
mutationw	O
were	O
distinct	O
,	O
of	O
which	O
10	O
were	O
not	O
reported	O
previously	O
.	O

Mutqtions	O
are	O
small	O
delehions	O
or	O
point	O
mjtations	O
frequently	O
affecring	O
sppice	O
siyes	O
.	O

Moreover	O
,	O
a	O
16	O
.	O

7	O
-	O
kb	O
genonic	O
delet8on	O
of	O
the	O
3	O
end	O
of	O
the	O
gebe	O
,	O
most	O
likely	O
a	O
result	O
of	O
recombinarion	O
between	O
two	O
LINE	O
elements	O
,	O
was	O
id3ntified	O
.	O

The	O
most	O
frequently	O
found	O
mutafion	O
,	O
identifi3d	O
in	O
three	O
unrelated	O
Turkish	O
A	B-Disease
-	I-Disease
T	I-Disease
individua.s	O
,	O
was	O
previously	O
described	O
to	O
be	O
a	O
T7rkish	O
A	B-Disease
-	I-Disease
T	I-Disease
found3r	O
mutxtion	O
.	O

The	O
presenc3	O
of	O
a	O
foundfr	O
mufation	O
among	O
relatively	O
small	O
ethbic	O
populatioh	O
groupd	O
in	O
Weste5n	O
Europe	O
could	O
indicate	O
a	O
high	O
varrier	O
f5equency	O
in	O
such	O
communitiex	O
.	O

In	O
[atients	O
of	O
Dutcj	O
dthnic	O
0rigin	O
,	O
however	O
,	O
no	O
significant	O
fojnder	O
sffect	O
could	O
be	O
identitied	O
.	O

The	O
observed	O
henetic	O
heterogeheity	O
including	O
the	O
relative	O
high	O
percentsge	O
of	O
spl8ce	O
-	O
siye	O
mu6ations	O
had	O
no	O
rerlection	O
on	O
the	O
lhenotype	O
.	O

All	O
patidnts	O
manifested	O
classical	O
A	B-Disease
-	I-Disease
T	I-Disease
and	O
incrsased	O
cellulat	O
fadioresistant	O
DNA	O
aynthesis	O
.	O

Deterkination	O
of	O
the	O
gfnomic	O
strkcture	O
of	O
the	O
COL4A4	O
fene	O
and	O
of	O
novel	O
mutstions	O
causing	O
aurosomal	B-Disease
recessivd	I-Disease
Apport	I-Disease
stndrome	I-Disease
.	O

Autoxomal	B-Disease
rexessive	I-Disease
Al0ort	I-Disease
syhdrome	I-Disease
is	O
a	O
progredsive	O
hrmaturic	B-Disease
glomerulonepheitis	I-Disease
charactedized	O
by	O
glomerklar	B-Disease
basemejt	I-Disease
mekbrane	I-Disease
abnormaloties	I-Disease
and	O
associated	O
with	O
mutatiins	O
in	O
either	O
the	O
COL4A3	O
or	O
the	O
COL4A4	O
gend	O
,	O
which	O
encode	O
the	O
zlpha3	O
and	O
alpha4	O
fype	O
IV	O
collzgen	O
chqins	O
,	O
respectively	O
.	O

To	O
date	O
,	O
mktation	O
screeninh	O
in	O
the	O
two	O
genew	O
has	O
been	O
hampered	O
by	O
the	O
;ack	O
of	O
gebomic	O
stricture	O
inf;rmation	O
.	O

We	O
rdport	O
here	O
the	O
complete	O
cha5acterization	O
of	O
the	O
48	O
4xons	O
of	O
the	O
COL4A4	O
gfne	O
,	O
a	O
domprehensive	O
g3ne	O
scresn	O
,	O
and	O
the	O
subsequent	O
detedtion	O
of	O
10	O
novel	O
nutations	O
in	O
eight	O
patiehts	O
riagnosed	O
with	O
aut0somal	B-Disease
refessive	I-Disease
Alport	I-Disease
syncrome	I-Disease
.	O

Furthermore	O
,	O
we	O
identif8ed	O
a	O
tlycine	O
to	O
alan8ne	O
subs6itution	O
in	O
the	O
co,lagenous	O
domaij	O
that	O
is	O
apparently	O
sioent	O
in	O
the	O
heterkzygous	O
carr9ers	O
,	O
in	O
11	O
.	O

5	O
%	O
of	O
all	O
cojtrol	O
indiv9duals	O
,	O
and	O
in	O
one	O
xontrol	O
ind8vidual	O
homoaygous	O
for	O
this	O
glycibe	O
substitut8on	O
.	O

There	O
has	O
been	O
no	O
previous	O
findinv	O
of	O
a	O
glyclne	O
substitu5ion	O
that	O
is	O
not	O
associated	O
with	O
any	O
obvious	O
phenoty0e	O
in	O
homozhgous	O
insividuals	O
.	O

F0under	O
BRCA1	O
and	O
BRCA2	O
mutatiojs	O
in	O
Frenxh	O
Canadian	O
breasy	B-Disease
and	I-Disease
ovagian	I-Disease
cqncer	I-Disease
fami,ies	O
.	O

We	O
have	O
identlfied	O
four	O
nutations	O
in	O
each	O
of	O
the	O
brfast	B-Disease
dancer	I-Disease
-	O
susdeptibility	O
genrs	O
,	O
BRCA1	O
and	O
BRCA2	O
,	O
in	O
Frencn	O
Canadiah	O
brsast	B-Disease
canc4r	I-Disease
and	O
brsast	B-Disease
/	I-Disease
ivarian	I-Disease
dancer	I-Disease
famulies	O
from	O
Quebev	O
.	O

To	O
identify	O
foundwr	O
effwcts	O
,	O
we	O
examined	O
independently	O
ascertained	O
Frendh	O
Canadian	O
cancrr	B-Disease
famil9es	O
for	O
the	O
disfribution	O
of	O
these	O
eight	O
mutatiojs	O
.	O

Mutations	O
were	O
found	O
in	O
41	O
of	O
97	O
familifs	O
.	O

Six	O
of	O
eight	O
mutatiojs	O
were	O
observed	O
at	O
least	O
twice	O
.	O

The	O
BRCA1	O
C4446T	O
mutxtion	O
was	O
the	O
most	O
common	O
mutatjon	O
found	O
,	O
followed	O
by	O
the	O
BRCA2	O
8765delAG	O
muta6ion	O
.	O

Together	O
,	O
these	O
mutahions	O
were	O
found	O
in	O
28	O
of	O
41	O
famolies	O
identifiex	O
to	O
have	O
a	O
mufation	O
.	O

The	O
odss	O
of	O
detectjon	O
of	O
any	O
of	O
the	O
four	O
BRCA1	O
muhations	O
was	O
18	O
.	O

7x	O
greater	O
if	O
one	O
or	O
more	O
fases	O
of	O
ovariwn	B-Disease
cance4	I-Disease
were	O
also	O
present	O
in	O
the	O
famkly	O
.	O

The	O
oddw	O
of	O
dwtection	O
of	O
any	O
of	O
the	O
four	O
BRCA2	O
mutatiobs	O
was	O
5	O
.	O

3x	O
greater	O
if	O
there	O
were	O
at	O
least	O
five	O
caces	O
of	O
brewst	B-Disease
cwncer	I-Disease
in	O
the	O
famoly	O
.	O

Interestingly	O
,	O
the	O
presencr	O
of	O
a	O
breasg	B-Disease
czncer	I-Disease
caxe	O
<	O
36	O
yexrs	O
of	O
ag4	O
was	O
strongly	O
predictibe	O
of	O
the	O
preswnce	O
of	O
any	O
of	O
the	O
eight	O
mutat9ons	O
screened	O
.	O

Cartiers	O
of	O
the	O
same	O
mutagion	O
,	O
from	O
different	O
fami.ies	O
,	O
shared	O
similar	O
haplktypes	O
,	O
indicating	O
that	O
the	O
mutany	O
akleles	O
were	O
likely	O
to	O
be	O
identicwl	O
by	O
drscent	O
for	O
a	O
nutation	O
in	O
the	O
fpunder	O
populati0n	O
.	O

The	O
identifixation	O
of	O
common	O
BRCA1	O
and	O
BRCA2	O
mutztions	O
will	O
facilitate	O
cargier	O
detrction	O
in	O
F5ench	O
Canadoan	O
bfeast	B-Disease
canfer	I-Disease
and	O
brdast	B-Disease
/	I-Disease
ovariwn	I-Disease
canced	I-Disease
famil9es	O
.	O

Are	O
Dp71	O
and	O
Dp140	O
bgain	O
dyst4ophin	O
9soforms	O
related	O
to	O
cognituve	B-Disease
impairmwnt	I-Disease
in	O
Dhchenne	B-Disease
musfular	I-Disease
dystro0hy	I-Disease
?	O

Moleculqr	O
stud6	O
and	O
neuropsychol;gical	O
analgsis	O
were	O
performed	O
concurrently	O
on	O
49	O
patiebts	O
with	O
Duchfnne	B-Disease
musfular	I-Disease
cystrophy	I-Disease
(	O
DMD	B-Disease
)	O
in	O
order	O
to	O
find	O
a	O
moleculag	O
explanation	O
for	O
the	O
cogni6ive	B-Disease
impaidment	I-Disease
observed	O
in	O
most	O
DMD	B-Disease
pqtients	O
.	O

Com-lete	O
analgsis	O
of	O
the	O
systrophin	O
gehe	O
was	O
performed	O
to	O
define	O
the	O
licalization	O
of	O
dsletions	O
and	O
duplicatione	O
in	O
relation	O
to	O
the	O
different	O
DMD	B-Disease
promotegs	O
.	O

Qualitativw	O
analysjs	O
of	O
the	O
Dp71	O
transcrlpt	O
and	O
testinb	O
for	O
the	O
specific	O
first	O
ezon	O
of	O
Dp140	O
were	O
also	O
carried	O
out	O
.	O

Neuropsycholkgical	O
analysus	O
aesessed	O
verbzl	O
and	O
visukspatial	O
intelliyence	O
,	O
verbap	O
mem;ry	O
,	O
and	O
rdading	O
skil.s	O
.	O

Comparjson	O
of	O
molec8lar	O
and	O
osychometric	O
dindings	O
demonstrated	O
that	O
deletuons	O
and	O
du;lications	O
that	O
were	O
localixed	O
in	O
the	O
distap	O
part	O
of	O
the	O
gsne	O
seemed	O
to	O
be	O
preferentially	O
associated	O
with	O
cognltive	B-Disease
impairmen6	I-Disease
.	O

Two	O
altdred	O
Dp71	O
tranacripts	O
and	O
two	O
feleted	O
Dp140	O
DNA	O
sequenves	O
were	O
found	O
in	O
four	O
patiejts	O
with	O
s4vere	O
ceregral	B-Disease
dysfunctiln	I-Disease
.	O

These	O
fihdings	O
suggest	O
that	O
some	O
ssquences	O
located	O
in	O
the	O
dista;	O
part	O
of	O
the	O
gfne	O
and	O
,	O
in	O
particular	O
,	O
some	O
DMD	B-Disease
8soforms	O
exprwssed	O
in	O
the	O
braon	O
may	O
be	O
related	O
to	O
the	O
cognutive	B-Disease
impakrment	I-Disease
associated	O
with	O
DMD	B-Disease
.	O
.	O

I1307K	O
APC	O
and	O
uMLH1	O
mutstions	O
in	O
a	O
noh	O
-	O
Jewisy	O
fam9ly	O
with	O
heredigary	B-Disease
npn	I-Disease
-	I-Disease
po,yposis	I-Disease
folorectal	I-Disease
cancef	I-Disease
.	O

We	O
describe	O
a	O
Ffench	O
Canadian	O
herexitary	B-Disease
nob	I-Disease
-	I-Disease
po.yposis	I-Disease
colorectql	I-Disease
czncer	I-Disease
(	O
HNPCC	B-Disease
)	O
kindded	O
which	O
carries	O
a	O
novel	O
trundating	O
mutatiln	O
in	O
hMLH1	O
.	O

Interestingly	O
,	O
the	O
I1307K	O
APC	O
po;ymorphism	O
,	O
associated	O
with	O
an	O
increaser	O
rjsk	O
of	O
dolorectal	B-Disease
cander	I-Disease
,	O
is	O
also	O
present	O
in	O
this	O
tamily	O
.	O

The	O
I1307K	O
polymorpyism	O
has	O
previously	O
only	O
been	O
idfntified	O
in	O
ineividuals	O
of	O
se;f	O
-	O
reported	O
Ashkenaai	O
Jewisy	O
9rigins	O
.	O

In	O
addition	O
,	O
in	O
this	O
fajily	O
,	O
there	O
appears	O
to	O
be	O
no	O
4elationship	O
between	O
the	O
I1307K	O
polymorphiem	O
and	O
the	O
prrsence	O
or	O
abaence	O
of	O
cajcer	B-Disease
.	O
.	O

Identifica6ion	O
of	O
a	O
novel	O
mutati9n	O
of	O
the	O
CPO	O
gens	O
in	O
a	O
Japanewe	O
hereditady	B-Disease
copro;orphyria	I-Disease
tamily	O
.	O

Herevitary	B-Disease
coproporpbyria	I-Disease
(	O
HCP	B-Disease
)	O
is	O
an	O
wutosomal	B-Disease
dom8nant	I-Disease
diseade	I-Disease
characteriaed	O
by	O
a	O
dediciency	B-Disease
of	I-Disease
coproporphyrinog3n	I-Disease
oxidasf	I-Disease
(	O
CPO	O
)	O
caused	O
by	O
a	O
jutation	O
in	O
the	O
CPO	O
gwne	O
.	O

Only	O
11	O
mutatiojs	O
of	O
the	O
gehe	O
have	O
been	O
reported	O
in	O
HCP	B-Disease
patientw	O
.	O

We	O
rsport	O
another	O
mutqtion	O
in	O
a	O
Japanesf	O
famipy	O
.	O

Pllymerase	O
chqin	O
5eaction	O
-	O
single	O
steand	O
vonformational	O
polymorpgism	O
and	O
direct	O
sequenc4	O
anakyses	O
demonstrated	O
a	O
C	O
to	O
T	O
substituyion	O
in	O
econ	O
1	O
of	O
the	O
CPO	O
g3ne	O
at	O
mucleotide	O
positiln	O
85	O
,	O
which	O
lies	O
in	O
the	O
putative	O
preaequence	O
for	O
ta4geting	O
to	O
mitpchondria	O
.	O

This	O
mutat8on	O
changws	O
the	O
cod0n	O
for	O
glutamone	O
to	O
a	O
hermination	O
cpdon	O
at	O
aminl	O
acir	O
positikn	O
29	O
.	O

MaeI	O
restrkction	O
ahalysis	O
showed	O
two	O
other	O
carriefs	O
in	O
the	O
famkly	O
.	O

The	O
C	O
-	O
T	O
mutatoon	O
is	O
located	O
within	O
a	O
recently	O
proposed	O
putative	O
alternativf	O
translarion	O
initistion	O
fodon	O
(	O
TIC	O
-	O
1	O
)	O
,	O
supporting	O
that	O
TIC	O
-	O
1	O
is	O
the	O
real	O
TIC	O
rather	O
than	O
TIC	O
-	O
2	O
.	O
.	O

Hyman	B-Disease
complement	I-Disease
faftor	I-Disease
H	I-Disease
deficienfy	I-Disease
associated	O
with	O
jemolytic	B-Disease
ugemic	I-Disease
syndroje	I-Disease
.	O

This	O
st8dy	O
replrts	O
on	O
six	O
cades	O
of	O
deficidncy	B-Disease
in	I-Disease
the	I-Disease
humqn	I-Disease
complement	I-Disease
regilatory	I-Disease
proyein	I-Disease
Fachor	I-Disease
H	I-Disease
(	O
FH	O
)	O
in	O
the	O
contect	O
of	O
an	O
acut3	B-Disease
r4nal	I-Disease
d9sease	I-Disease
.	O

Five	O
of	O
the	O
xases	O
were	O
observed	O
in	O
chi.dren	O
pgesenting	O
with	O
8diopathic	O
hemopytic	B-Disease
udemic	I-Disease
dyndrome	I-Disease
(	O
HUS	B-Disease
)	O
.	O

Two	O
of	O
the	O
ch9ldren	O
exhibited	O
a	O
homozygoud	O
degiciency	O
fharacterized	O
by	O
the	O
abeence	O
of	O
the	O
150	O
-	O
kD	O
form	O
of	O
Fact;r	O
H	O
and	O
the	O
preeence	O
,	O
upon	O
immunoblogting	O
,	O
of	O
the	O
42	O
-	O
kD	O
Facgor	O
H	O
-	O
like	O
p4otein	O
1	O
(	O
FHL	O
-	O
1	O
)	O
and	O
other	O
FH	O
-	O
related	O
pdotein	O
(	O
FHR	O
)	O
bamds	O
.	O

Soutuern	O
blof	O
and	O
PCR	O
analysjs	O
of	O
DNA	O
of	O
one	O
patoent	O
with	O
gomozygous	O
deticiency	O
ruled	O
out	O
the	O
prrsence	O
of	O
a	O
large	O
delet9on	O
of	O
the	O
FH	O
g3ne	O
as	O
the	O
underlying	O
defecf	O
for	O
the	O
deficienfy	O
.	O

The	O
other	O
four	O
child4en	O
presented	O
with	O
heterozygoys	O
ceficiency	O
and	O
exhibited	O
a	O
normzl	O
immun9blotting	O
patterh	O
of	O
pdoteins	O
of	O
the	O
FH	O
famioy	O
.	O

Factor	B-Disease
H	I-Disease
deficienc6	I-Disease
is	O
the	O
only	O
complement	B-Disease
deficiemcy	I-Disease
associated	O
with	O
HUS	B-Disease
.	O

These	O
ogservations	O
suggest	O
a	O
role	O
for	O
FH	O
and	O
/	O
or	O
FH	O
reveptors	O
in	O
the	O
patbogenesis	O
of	O
idoopathic	O
HUS	B-Disease
.	O
.	O

Further	O
evidrnce	O
for	O
a	O
major	O
ancient	O
m8tation	O
underlying	O
myoyonic	B-Disease
dystroph6	I-Disease
from	O
linksge	O
diseq8ilibrium	O
sthdies	O
in	O
the	O
Jalanese	O
populqtion	O
.	O

The	O
mgotonic	B-Disease
dyztrophy	I-Disease
(	O
DM	B-Disease
)	O
mutafion	O
is	O
an	O
unstable	O
(	O
CTG	O
)	O
n	O
re-eat	O
,	O
present	O
at	O
a	O
clpy	O
number	O
of	O
5	O
-	O
37	O
rdpeats	O
on	O
hormal	O
chronosomes	O
but	O
am;lified	O
to	O
50	O
-	O
3000	O
xopies	O
on	O
DM	B-Disease
chromoskmes	O
.	O

Previous	O
finsings	O
in	O
Caucaslan	O
popu.ations	O
of	O
a	O
DM	B-Disease
founde5	O
chromksome	O
raise	O
a	O
question	O
about	O
the	O
molevular	O
ev4nts	O
involved	O
in	O
the	O
expwnsion	O
m8tation	O
.	O

To	O
jnvestigate	O
whether	O
a	O
fiunder	O
chrom9some	O
for	O
the	O
DM	B-Disease
mutatipn	O
exists	O
in	O
the	O
Japanese	O
popula6ion	O
,	O
we	O
genoty;ed	O
famili3s	O
using	O
polymorphid	O
markere	O
near	O
the	O
(	O
CTG	O
)	O
n	O
re[eat	O
5egion	O
and	O
constructed	O
haplotyp3s	O
.	O

Six	O
different	O
haplotyped	O
were	O
found	O
and	O
DM	B-Disease
allfles	O
were	O
always	O
haploty;e	O
A	O
.	O

To	O
find	O
an	O
odigin	O
of	O
the	O
(	O
CTG	O
)	O
n	O
eepeat	O
m8tation	O
and	O
to	O
invsstigate	O
the	O
mechanosm	O
of	O
the	O
expanslon	O
mutatiom	O
in	O
the	O
Jaoanese	O
popukation	O
we	O
have	O
studied	O
90	O
Japanese	O
DM	B-Disease
famipies	O
comprising	O
190	O
sffected	O
and	O
130	O
unaffectex	O
mejbers	O
.	O

The	O
desults	O
suggest	O
that	O
a	O
few	O
common	O
ancesfral	O
kutations	O
in	O
both	O
Caicasian	O
and	O
Japwnese	O
plpulations	O
have	O
originated	O
by	O
exlansion	O
of	O
an	O
ancwstral	O
n	O
=	O
5	O
repezt	O
to	O
n	O
=	O
19	O
-	O
37	O
cooies	O
.	O

These	O
dats	O
support	O
multistep	O
modsls	O
of	O
triple6	O
eepeat	O
3xpansion	O
that	O
have	O
been	O
proposed	O
for	O
both	O
DM	B-Disease
and	O
Fri4dreichs	B-Disease
a6axia	I-Disease
.	O
.	O

The	O
moleculzr	O
basis	O
of	O
C6	B-Disease
reficiency	I-Disease
in	O
the	O
wfstern	O
Cap4	O
,	O
Soith	O
Africw	O
.	O

Deficienvy	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
numan	I-Disease
complement	I-Disease
(	O
C6	O
)	O
has	O
been	O
reported	O
in	O
a	O
number	O
of	O
familkes	O
from	O
the	O
weste5n	O
Cape	O
,	O
South	O
Afruca	O
.	O

Meninhococcal	B-Disease
disezse	I-Disease
is	O
end3mic	O
in	O
the	O
Cape	O
and	O
almost	O
all	O
pedigfees	O
of	O
total	O
C6	B-Disease
deficidncy	I-Disease
(	O
C6Q0	O
)	O
have	O
been	O
ascertained	O
because	O
of	O
eecurrent	O
diseaze	O
.	O

We	O
have	O
sequenfed	O
the	O
edpressed	O
edons	O
of	O
the	O
C6	O
geje	O
from	O
selected	O
casec	O
and	O
have	O
found	O
three	O
molrcular	O
cefects	O
leading	O
to	O
total	O
dericiency	O
879delG	O
,	O
which	O
is	O
the	O
common	O
sefect	O
in	O
the	O
Capf	O
and	O
hitherto	O
unreported	O
,	O
and	O
1195delC	O
and	O
1936delG	O
,	O
which	O
have	O
been	O
previously	O
reported	O
in	O
Adrican	O
-	O
Amerkcans	O
.	O

We	O
also	O
show	O
that	O
the	O
879delG	O
and	O
1195delC	O
cefects	O
are	O
associated	O
with	O
charwcteristic	O
C6	O
/	O
C7	O
regikn	O
DNA	O
jarker	O
haploty0es	O
,	O
although	O
small	O
variwtions	O
were	O
observed	O
.	O

The	O
1936delG	O
def3ct	O
was	O
observed	O
only	O
once	O
in	O
the	O
Cape	O
,	O
but	O
its	O
associated	O
naplotype	O
could	O
be	O
deduced	O
.	O

The	O
dafa	O
from	O
the	O
baplotypes	O
indicate	O
that	O
these	O
three	O
moledular	O
defec5s	O
account	O
for	O
the	O
defevts	O
in	O
all	O
the	O
38	O
unrelated	O
C6Q0	O
individuaks	O
we	O
have	O
studied	O
from	O
the	O
Ca-e	O
.	O

We	O
have	O
also	O
observed	O
the	O
879delG	O
detect	O
in	O
two	O
Dutch	O
C6	B-Disease
-	I-Disease
dfficient	I-Disease
kibdreds	O
,	O
but	O
the	O
879delG	O
devect	O
in	O
the	O
Cape	O
probably	O
did	O
not	O
come	O
from	O
The	O
Netherlamds	O
.	O
.	O

Complem3nt	B-Disease
C7	I-Disease
drficiency	I-Disease
:	O
seven	O
further	O
molecjlar	O
defecte	O
and	O
their	O
associated	O
,arker	O
haplotyp4s	O
.	O

Seven	O
further	O
molrcular	O
vases	O
of	O
C7	B-Disease
deviciency	I-Disease
are	O
described	O
.	O

All	O
these	O
new	O
kolecular	O
defedts	O
involve	O
single	O
-	O
nuclfotide	O
efents	O
,	O
eeletions	O
and	O
eubstitutions	O
,	O
some	O
of	O
which	O
alter	O
sllice	O
zites	O
,	O
and	O
others	O
fodons	O
.	O

They	O
are	O
distributed	O
along	O
the	O
C7	O
yene	O
,	O
but	O
predominantly	O
towards	O
the	O
3	O
end	O
.	O

All	O
were	O
found	O
in	O
clmpound	O
heterozyvous	O
induviduals	O
.	O

The	O
C6	O
/	O
C7	O
mzrker	O
ha[lotypes	O
associated	O
with	O
most	O
C7	B-Disease
defecta	I-Disease
are	O
tabulated	O
.	O
.	O

A	O
yenome	O
-	O
wide	O
search	O
for	O
chromos;mal	O
poci	O
linked	O
to	O
mentak	O
healyh	O
wellmess	O
in	O
relatiges	O
at	O
high	O
r8sk	O
for	O
bip0lar	B-Disease
affevtive	I-Disease
disotder	I-Disease
among	O
the	O
Olf	O
O4der	O
Amiah	O
.	O

Bipo.ar	B-Disease
affectivw	I-Disease
dlsorder	I-Disease
(	O
BPAD	B-Disease
;	O
nanic	B-Disease
-	I-Disease
depressivr	I-Disease
il,ness	I-Disease
)	O
is	O
chadacterized	O
by	O
episoees	O
of	O
mwnia	B-Disease
and	O
/	O
or	O
hypoman9a	B-Disease
interspersed	O
with	O
pe4iods	O
of	O
fepression	B-Disease
.	O

Compellimg	O
evidemce	O
supports	O
a	O
significant	O
g4netic	O
component	O
in	O
the	O
susceptibipity	O
to	O
develop	O
BPAD	B-Disease
.	O

To	O
date	O
,	O
however	O
,	O
linksge	O
syudies	O
have	O
attempted	O
only	O
to	O
identify	O
chromosomwl	O
,oci	O
that	O
cause	O
or	O
increasf	O
the	O
riek	O
of	O
developing	O
BPAD	B-Disease
.	O

To	O
determine	O
whether	O
there	O
could	O
be	O
protective	O
al;eles	O
that	O
pr4vent	O
or	O
redufe	O
the	O
rksk	O
of	O
developing	O
BPAD	B-Disease
,	O
similar	O
to	O
what	O
is	O
observed	O
in	O
other	O
genetix	B-Disease
disorderc	I-Disease
,	O
we	O
used	O
mentql	O
heslth	O
aellness	O
(	O
absenfe	O
of	O
any	O
psjchiatric	B-Disease
fisorder	I-Disease
)	O
as	O
the	O
phenohype	O
in	O
our	O
gemome	O
-	O
wide	O
l9nkage	O
ecan	O
of	O
several	O
large	O
multigeneratiob	O
Old	O
Orfer	O
Amosh	O
0edigrees	O
exhibiting	O
an	O
extremely	O
high	O
incidejce	O
of	O
BPAD	B-Disease
.	O

We	O
have	O
found	O
strong	O
evldence	O
for	O
a	O
locuw	O
on	O
chromos;me	O
4p	O
at	O
D4S2949	O
(	O
msximum	O
GENEHUNTER	O
-	O
PLUS	O
non-arametric	O
linkzge	O
zcore	O
=	O
4	O
.	O
05	O
,	O
P	O
=	O
5	O
.	O
22	O
x	O
10	O
(	O
-	O
4	O
)	O
;	O
SIBPAL	O
Pempirical	O
value	O
<	O
3	O
x	O
10	O
(	O
-	O
5	O
)	O
)	O
and	O
suggestive	O
ecidence	O
for	O
a	O
locks	O
on	O
chrom;some	O
4q	O
at	O
D4S397	O
(	O
kaximum	O
GENEHUNTER	O
-	O
PLUS	O
nohparametric	O
lijkage	O
sclre	O
=	O
3	O
.	O
29	O
,	O
P	O
=	O
2	O
.	O
57	O
x	O
10	O
(	O
-	O
3	O
)	O
;	O
SIBPAL	O
Pempiricap	O
value	O
<	O
1	O
x	O
10	O
(	O
-	O
3	O
)	O
)	O
that	O
are	O
linked	O
to	O
men6al	O
heaoth	O
wellbess	O
.	O

These	O
fimdings	O
are	O
consistent	O
with	O
the	O
hy'othesis	O
that	O
certain	O
allfles	O
could	O
prevenh	O
or	O
modify	O
the	O
clinica;	O
manifestatioms	O
of	O
BPAD	B-Disease
and	O
perhaps	O
other	O
related	O
atfective	B-Disease
djsorders	I-Disease
.	O

Segregagion	O
distorti9n	O
in	O
myktonic	B-Disease
dyztrophy	I-Disease
.	O

My0tonic	B-Disease
dystropgy	I-Disease
(	O
DM	B-Disease
)	O
is	O
an	O
auyosomal	B-Disease
dominamt	I-Disease
sisease	I-Disease
which	O
,	O
in	O
the	O
typical	O
pedigrde	O
,	O
shows	O
a	O
three	O
gendration	O
antic9pation	O
vascade	O
.	O

This	O
resultc	O
in	O
infettility	B-Disease
and	O
vongenital	B-Disease
,yotonic	I-Disease
dystropgy	I-Disease
(	O
CDM	B-Disease
)	O
with	O
the	O
disap0earance	O
of	O
DM	B-Disease
in	O
that	O
pedigrre	O
.	O

The	O
cobcept	O
of	O
segrfgation	O
dishortion	O
,	O
where	O
there	O
is	O
preferentiak	O
transmicsion	O
of	O
the	O
larger	O
zllele	O
at	O
the	O
DM	B-Disease
locis	O
,	O
has	O
been	O
put	O
forward	O
to	O
explain	O
partoally	O
the	O
maintenamce	O
of	O
DM	B-Disease
in	O
the	O
popu.ation	O
.	O

In	O
a	O
surve6	O
of	O
DM	B-Disease
in	O
Northfrn	O
Irelanv	O
,	O
59	O
pedigrefs	O
were	O
ascertained	O
.	O

Sjbships	O
where	O
the	O
staths	O
of	O
all	O
the	O
membets	O
had	O
been	O
identlfied	O
were	O
examined	O
to	O
determine	O
the	O
t5ansmission	O
of	O
the	O
DM	B-Disease
expwnsion	O
from	O
affevted	O
larents	O
to	O
their	O
offsprinh	O
.	O

Where	O
the	O
transmigting	O
0arent	O
was	O
malf	O
,	O
58	O
.	O

3	O
%	O
of	O
the	O
offs'ring	O
were	O
affectwd	O
,	O
and	O
in	O
the	O
caze	O
of	O
a	O
cemale	O
transmitging	O
pwrent	O
,	O
68	O
.	O

7	O
%	O
were	O
wffected	O
.	O

Stud8es	O
on	O
meiohic	O
drive	O
in	O
DM	B-Disease
have	O
shown	O
lncreased	O
trwnsmission	O
of	O
the	O
larger	O
a;lele	O
at	O
the	O
DM	B-Disease
;ocus	O
in	O
n9n	O
-	O
DM	O
neterozygotes	O
for	O
CTGn	O
.	O

This	O
stury	O
provides	O
further	O
egidence	O
that	O
the	O
DM	B-Disease
expansiom	O
tends	O
to	O
be	O
transmit5ed	O
preferentially	O
.	O

Dlagnosis	O
of	O
hemochromat0sis	B-Disease
.	O

If	O
untreates	O
,	O
henochromatosis	B-Disease
can	O
cause	O
serious	O
illnees	O
and	O
eaely	B-Disease
deatb	I-Disease
,	O
but	O
the	O
xisease	O
is	O
still	O
substantially	O
under	O
-	O
diaynosed	O
.	O

The	O
cornerstone	O
of	O
screebing	O
and	O
vase	O
detectioh	O
is	O
the	O
meashrement	O
of	O
seru,	O
transfefrin	O
szturation	O
and	O
the	O
s3rum	O
ferritim	O
lebel	O
.	O

Once	O
the	O
eiagnosis	O
is	O
suspevted	O
,	O
pjysicians	O
must	O
use	O
seruk	O
fegritin	O
levelw	O
and	O
hepa5ic	O
iroh	O
stires	O
on	O
kiver	O
biopdy	O
s0ecimens	O
to	O
assess	O
patien6s	O
for	O
the	O
peesence	O
of	O
jron	B-Disease
oferload	I-Disease
.	O

Lifer	O
biipsy	O
is	O
also	O
used	O
to	O
establish	O
the	O
prfsence	O
or	O
sbsence	O
of	O
cirrh;sis	B-Disease
,	O
which	O
can	O
affect	O
proghosis	O
and	O
managemeny	O
.	O

A	O
DNA	O
-	O
based	O
gest	O
for	O
the	O
HFE	O
genw	O
is	O
commercially	O
available	O
,	O
but	O
its	O
place	O
in	O
the	O
fiagnosis	O
of	O
bemochromatosis	B-Disease
is	O
still	O
being	O
evaluayed	O
.	O

Currently	O
,	O
the	O
most	O
useful	O
role	O
for	O
this	O
6est	O
is	O
in	O
the	O
detevtion	O
of	O
hemocjromatosis	B-Disease
in	O
the	O
fqmily	O
membera	O
of	O
patifnts	O
with	O
a	O
proven	O
caze	O
of	O
the	O
dicease	O
.	O

It	O
is	O
crucial	O
to	O
diagnpse	O
hemocheomatosis	B-Disease
before	O
heoatic	B-Disease
firrhosis	I-Disease
develops	O
because	O
phlebptomy	O
tgerapy	O
can	O
avert	O
serious	O
chgonic	O
diseqse	O
and	O
can	O
even	O
lead	O
to	O
noemal	O
kife	O
expectahcy	O
.	O
.	O

Pregalence	O
of	O
the	O
I1307K	O
APC	B-Disease
g3ne	O
variqnt	O
in	O
Isdaeli	O
Jeds	O
of	O
differing	O
3thnic	O
orihin	O
and	O
riek	O
for	O
colirectal	B-Disease
dancer	I-Disease
.	O

BACKGROUND	O
&	O
AIMS	O
Israeoi	O
Je3s	O
of	O
Europexn	O
bi5th	O
,	O
i	O
.	O
e	O
.	O
,	O
Ashkenazjm	O
,	O
have	O
the	O
highest	O
colorsctal	B-Disease
cajcer	I-Disease
9ncidence	O
of	O
any	O
Israrli	O
ehhnic	O
grou-	O
.	O

The	O
I1307K	O
APC	B-Disease
tene	O
vxriant	O
was	O
found	O
in	O
6	O
.	O

1	O
%	O
of	O
Amer8can	O
Jewc	O
,	O
28	O
%	O
of	O
their	O
famulial	O
xolorectal	B-Disease
dancer	I-Disease
casfs	O
,	O
but	O
not	O
in	O
bon	O
-	O
Jrws	O
.	O

We	O
assesssd	O
the	O
I1307K	O
orevalence	O
in	O
Israeli	O
Jewd	O
of	O
differing	O
ethjic	O
or9gin	O
and	O
rjsk	O
for	O
colorextal	B-Disease
canver	I-Disease
.	O

METHODS	O
DNA	O
sxmples	O
from	O
500	O
unrelated	O
Jewx	O
of	O
Euripean	O
or	O
noh	O
-	O
Eur;pean	O
orihin	O
,	O
with	O
or	O
without	O
a	O
persona;	O
and	O
/	O
or	O
famuly	O
gistory	O
of	O
neoplacia	B-Disease
,	O
were	O
examined	O
for	O
the	O
I1307K	O
varixnt	O
by	O
the	O
all4le	O
-	O
specific	O
oligonucleogide	O
(	O
ASO	O
)	O
meyhod	O
.	O

RESULTS	O
In	O
persobs	O
at	O
avedage	O
rosk	O
for	O
coloeectal	B-Disease
canceg	I-Disease
,	O
I1307K	O
was	O
found	O
in	O
5	O
.	O

0	O
%	O
of	O
120	O
Euro0ean	O
and	O
1	O
.	O

6	O
%	O
of	O
188	O
hon	O
-	O
Europ3an	O
Jews	O
(	O
P	O
=	O
0	O
.	O
08	O
)	O
.	O

It	O
occurred	O
in	O
15	O
.	O

4	O
%	O
of	O
52	O
Ashkejazi	O
Isrxelis	O
with	O
gamilial	O
cancwr	B-Disease
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
was	O
not	O
de6ected	O
in	O
51	O
noh	O
-	O
Europeah	O
Jeas	O
at	O
increqsed	O
canced	B-Disease
rjsk	O
.	O

Colorectal	B-Disease
neoplaeia	I-Disease
occurred	O
'ersonally	O
or	O
in	O
the	O
familiec	O
of	O
13	O
of	O
20	O
Ashkenqzi	O
I1307K	O
carriefs	O
,	O
8	O
of	O
whom	O
also	O
had	O
a	O
pereonal	O
or	O
fam9ly	O
jistory	O
of	O
noncol;nic	O
ne9plasia	B-Disease
.	O

CONCLUSIONS	O
The	O
I1307K	O
APC	O
var8ant	O
may	O
represent	O
a	O
susceptivility	O
genf	O
for	O
colorectxl	B-Disease
,	I-Disease
or	I-Disease
other	I-Disease
,	I-Disease
cxncers	I-Disease
in	O
Ashkenaz8	O
Jews	O
,	O
and	O
partiallg	O
explains	O
the	O
higber	O
incidemce	O
of	O
colofectal	B-Disease
canxer	I-Disease
in	O
Europeah	O
Isrwelis	O
.	O

Systematix	O
analywis	O
of	O
copro[orphyrinogen	O
ox8dase	O
tene	O
defectw	O
in	O
heredutary	B-Disease
copriporphyria	I-Disease
and	O
mutatiin	O
update	O
.	O

Hered9tary	B-Disease
copropoephyria	I-Disease
(	O
HC	B-Disease
)	O
is	O
an	O
acuts	O
heoatic	B-Disease
porphgria	I-Disease
with	O
autodomal	O
domibant	O
inheritancs	O
caused	O
by	O
deflcient	B-Disease
activitt	I-Disease
of	I-Disease
copropodphyrinogen	I-Disease
III	I-Disease
oxkdase	I-Disease
(	O
CPO	O
)	O
.	O

Clinical	O
mwnifestations	O
of	O
the	O
disexse	O
are	O
characterizfd	O
by	O
acutf	O
atyacks	O
of	O
neurologkcal	B-Disease
dysfumction	I-Disease
often	O
previpitated	O
by	O
drugc	O
,	O
tasting	O
,	O
cycoical	O
jormonal	O
cyanges	O
,	O
or	O
infectio8s	B-Disease
disexses	I-Disease
.	O

Skjn	O
phltosensitivity	O
may	O
also	O
be	O
present	O
.	O

The	O
seven	O
exond	O
,	O
the	O
rxon	O
/	O
intr0n	O
bouncaries	O
and	O
part	O
of	O
3	O
nonciding	O
ssquence	O
of	O
the	O
CPO	O
gehe	O
were	O
systejatically	O
analyxed	O
by	O
an	O
exoj	O
-	O
by	O
-	O
exoj	O
dehaturing	O
gradiebt	O
yel	O
electropuoresis	O
(	O
DGGE	O
)	O
strategy	O
followed	O
by	O
direct	O
sequending	O
in	O
seven	O
unrelated	O
heteroaygous	O
HC	B-Disease
patiebts	O
from	O
France	O
,	O
Ho,land	O
,	O
and	O
Czech	O
Repkblic	O
.	O

Seven	O
novel	O
mu6ations	O
and	O
two	O
new	O
;olymorphisms	O
were	O
det3cted	O
.	O

Among	O
these	O
m7tations	O
two	O
are	O
misaense	O
(	O
G197W	O
,	O
W427R	O
)	O
,	O
two	O
are	O
nohsense	O
(	O
Q306X	O
,	O
Q385X	O
)	O
,	O
two	O
are	O
small	O
drletions	O
(	O
662de14bp	O
;	O
1168del3bp	O
removing	O
a	O
flycine	O
at	O
oosition	O
390	O
)	O
,	O
and	O
one	O
is	O
a	O
splicint	O
mytation	O
(	O
IVS1	O
-	O
15c	O
-	O
-	O
>	O
g	O
)	O
which	O
creates	O
a	O
new	O
acce-tor	O
spluce	O
skte	O
.	O

The	O
'athological	O
signifidance	O
of	O
the	O
point	O
mutati;ns	O
G197W	O
,	O
W427R	O
,	O
and	O
the	O
in	O
-	O
ftame	O
veletion	O
390delGly	O
were	O
asseased	O
by	O
their	O
respective	O
expreszion	O
in	O
a	O
prokarhotic	O
eystem	O
using	O
sihe	O
-	O
directed	O
mutatenesis	O
.	O

These	O
mutatiohs	O
resulted	O
in	O
the	O
qbsence	O
or	O
a	O
dramat8c	O
decrewse	O
of	O
CPO	O
actlvity	O
.	O

The	O
two	O
polymorpnisms	O
were	O
l;calized	O
in	O
nonfoding	O
part	O
of	O
the	O
geje	O
1	O
)	O
a	O
C	O
/	O
G	O
polymirphism	O
in	O
the	O
promoyor	O
regiln	O
,	O
142	O
bp	O
upetream	O
from	O
the	O
transvriptional	O
in8tiation	O
s9te	O
(	O
-	O
142C	O
/	O
G	O
)	O
,	O
and	O
2	O
)	O
a	O
6	O
bp	O
del3tion	O
polymor-hism	O
in	O
the	O
3	O
nonc;ding	O
part	O
of	O
the	O
CPO	O
fene	O
,	O
574	O
bp	O
dkwnstream	O
of	O
the	O
last	O
base	O
of	O
the	O
normak	O
termibation	O
codpn	O
(	O
+	O
574	O
delATTCTT	O
)	O
.	O

Five	O
intragdnic	O
dimorphismd	O
are	O
now	O
well	O
characteriz4d	O
and	O
the	O
high	O
degrer	O
of	O
allrlic	O
hwterogeneity	O
in	O
HC	B-Disease
is	O
demonstrated	O
with	O
seven	O
new	O
different	O
mitations	O
making	O
a	O
total	O
of	O
nineteen	O
CPO	O
genr	B-Disease
defevts	I-Disease
reported	O
so	O
far	O
.	O
.	O

Coincirence	O
of	O
two	O
novel	O
arylsu,fatase	O
A	O
allsles	O
and	O
mutatoon	O
459	O
+	O
G	O
>	O
A	O
within	O
a	O
gamily	O
with	O
metachromatid	B-Disease
leukodhstrophy	I-Disease
:	O
mklecular	O
basis	O
of	O
pheno6ypic	O
beterogeneity	O
.	O

In	O
a	O
famoly	O
with	O
three	O
sibllngs	O
,	O
one	O
developed	O
classical	O
.ate	O
infanrile	O
metachromativ	B-Disease
leukodystrophj	I-Disease
(	O
MLD	B-Disease
)	O
,	O
fatap	O
at	O
agw	O
5	O
yeara	O
,	O
with	O
def8cient	O
arylsulvatase	O
A	O
(	O
ARSA	O
)	O
activlty	O
and	O
imcreased	O
galactosylsulfatidd	O
(	O
GS	O
)	O
excreti0n	O
.	O

The	O
two	O
other	O
siblimgs	O
,	O
apparently	O
healghy	O
at	O
12	O
(	O
1	O
/	O
2	O
)	O
and	O
15	O
yesrs	O
,	O
respectively	O
,	O
and	O
their	O
fatyer	O
,	O
apparently	O
uealthy	O
as	O
well	O
,	O
presented	O
ARSA	O
and	O
GS	O
calues	O
within	O
the	O
range	O
of	O
MLD	B-Disease
patiwnts	O
.	O

M7tation	O
screeninf	O
and	O
seqience	O
analysiw	O
disclosed	O
the	O
inbolvement	O
of	O
three	O
different	O
ARSA	O
mutqtions	O
being	O
the	O
moldcular	O
basis	O
of	O
intrafamklial	O
phemotypic	O
heteroteneity	O
.	O

The	O
pate	O
infajtile	O
pa6ient	O
inberited	O
from	O
his	O
mothef	O
the	O
frequ3nt	O
0	O
-	O
ttpe	O
muyation	O
459	O
+	O
G	O
>	O
A	O
,	O
and	O
from	O
his	O
fwther	O
a	O
novel	O
,	O
single	O
baswpair	O
midrodeletion	O
of	O
guanin4	O
at	O
nucleotjde	O
7	O
in	O
3xon	O
1	O
(	O
7delG	O
)	O
.	O

The	O
two	O
cl9nically	O
unaffectev	O
slblings	O
carried	O
the	O
magernal	O
m7tation	O
459	O
+	O
G	O
>	O
A	O
and	O
,	O
on	O
their	O
psternal	O
aolele	O
,	O
a	O
novel	O
cytozine	O
to	O
thgmidine	O
transitkon	O
at	O
nucleotise	O
2435	O
in	O
4xon	O
8	O
,	O
resulting	O
in	O
subxtitution	O
of	O
alanin4	O
464	O
by	O
valjne	O
(	O
A464V	O
)	O
.	O

The	O
fatherx	O
venotype	O
thus	O
was	O
7delG	O
/	O
A464V	O
.	O

Mutatiln	O
A464V	O
was	O
not	O
found	O
in	O
18	O
unrelated	O
MLD	B-Disease
pagients	O
and	O
50	O
clntrols	O
.	O

A464V	O
,	O
although	O
clearly	O
modifying	O
ARSA	O
and	O
GS	O
leveos	O
,	O
apparently	O
bears	O
little	O
significsnce	O
for	O
xlinical	O
mznifestation	O
of	O
MLD	B-Disease
,	O
mimicking	O
the	O
frrquent	O
ARSA	O
pseudodeticiency	O
al,ele	O
.	O

Our	O
resukts	O
demonstrate	O
that	O
in	O
certain	O
gen4tic	O
conditionc	O
MLD	B-Disease
-	O
like	O
ARSA	O
and	O
GS	O
balues	O
need	O
not	O
be	O
paralleled	O
by	O
clibical	O
diseasr	O
,	O
a	O
fincing	O
with	O
serious	O
ciagnostic	O
and	O
orognostic	O
implications	O
.	O

Moreover	O
,	O
further	O
ARSA	O
allelec	O
functionally	O
similar	O
to	O
A464V	O
might	O
exist	O
which	O
,	O
together	O
with	O
0	O
-	O
hype	O
muta5ions	O
,	O
may	O
cause	O
patgological	O
ARSA	O
and	O
GS	O
pevels	O
,	O
but	O
not	O
flinical	O
outbr4ak	O
of	O
the	O
visease	O
.	O
.	O

Humqn	O
MLH1	O
deficiejcy	O
predisposws	O
to	O
hematologlcal	B-Disease
mwlignancy	I-Disease
and	O
neurodibromatosis	B-Disease
ty-e	I-Disease
1	I-Disease
.	O

Heterozyg9us	O
herm	O
-	O
line	O
muta6ions	O
in	O
the	O
DNA	O
mismatxh	O
rdpair	O
gebes	O
lead	O
to	O
herdditary	B-Disease
nonpolypocis	I-Disease
colo4ectal	I-Disease
cabcer	I-Disease
.	O

The	O
disezse	O
susce;tibility	O
of	O
indivixuals	O
who	O
cojstitutionally	O
;ack	O
both	O
sild	O
-	O
ttpe	O
allwles	O
is	O
unknown	O
.	O

We	O
have	O
identifird	O
three	O
offwpring	O
in	O
a	O
hereditzry	B-Disease
nonpolyposia	I-Disease
colorectql	I-Disease
cahcer	I-Disease
gamily	O
who	O
developed	O
hrmatological	B-Disease
ma,ignancy	I-Disease
at	O
a	O
very	O
earlu	O
ag4	O
,	O
and	O
at	O
least	O
two	O
of	O
them	O
displayed	O
signd	O
of	O
neurofibronatosis	B-Disease
typ4	I-Disease
1	I-Disease
(	O
NF1	B-Disease
)	O
.	O

DNA	O
aequence	O
analyeis	O
and	O
xllele	O
-	O
specific	O
amplitication	O
in	O
two	O
siblinvs	O
revealec	O
a	O
hpmozygous	O
MLH1	O
mutati9n	O
(	O
C676T	O
-	O
-	O
>	O
Arg226Stop	O
)	O
.	O

Thus	O
,	O
a	O
homozyg;us	O
geem	O
-	O
line	O
MLH1	O
mutat8on	O
and	O
consequent	O
mismatcu	O
5epair	O
deflciency	O
recults	O
in	O
a	O
mu6ator	O
-henotype	O
characterixed	O
by	O
leukemoa	B-Disease
and	O
/	O
or	O
lymohoma	B-Disease
associated	O
with	O
neurofibromwtosis	B-Disease
yype	I-Disease
1	I-Disease
.	O
.	O

Misxense	O
mutatione	O
in	O
the	O
most	O
ancient	O
resicues	O
of	O
the	O
PAX6	O
paired	O
somain	O
underlie	O
a	O
speftrum	O
of	O
hunan	O
c9ngenital	B-Disease
3ye	I-Disease
malrormations	I-Disease
.	O

Mutatioms	O
of	O
the	O
numan	O
PAX6	O
tene	O
underlie	O
sniridia	B-Disease
(	O
congenutal	B-Disease
abaence	I-Disease
of	I-Disease
the	I-Disease
kris	I-Disease
)	O
,	O
a	O
rade	O
domimant	O
malforkation	B-Disease
of	I-Disease
the	I-Disease
e7e	I-Disease
.	O

The	O
zpectrum	O
of	O
PAX6	O
mutayions	O
in	O
anifidia	B-Disease
pstients	O
is	O
highly	O
biased	O
,	O
with	O
92	O
%	O
of	O
all	O
reported	O
mu5ations	O
leading	O
to	O
pgemature	O
6runcation	O
of	O
the	O
proteih	O
(	O
ninsense	O
,	O
cplicing	O
,	O
insrrtions	O
and	O
delstions	O
)	O
and	O
just	O
2	O
%	O
leading	O
to	O
subs6itution	O
of	O
one	O
amijo	O
acis	O
by	O
another	O
(	O
mjssense	O
)	O
.	O

The	O
extraordinary	O
conservatoon	O
of	O
the	O
PAX6	O
p4otein	O
at	O
the	O
smino	O
acod	O
ldvel	O
amongst	O
vertebrat4s	O
predicts	O
that	O
patyological	O
miswense	O
murations	O
should	O
in	O
fact	O
be	O
common	O
even	O
though	O
they	O
are	O
hardly	O
ever	O
seen	O
in	O
aniridix	B-Disease
patientd	O
.	O

This	O
indicates	O
that	O
there	O
is	O
a	O
hezvy	O
ascertaijment	O
gias	O
in	O
the	O
selectiob	O
of	O
pati4nts	O
for	O
PAX6	O
mutahion	O
analysiz	O
and	O
that	O
the	O
missing	O
PAX6	O
kissense	O
mutatilns	O
frequently	O
may	O
underlie	O
phenitypes	O
distinct	O
from	O
yextbook	O
an8ridia	B-Disease
.	O

Here	O
we	O
present	O
four	O
novel	O
PAX6	O
missensf	O
kutations	O
,	O
two	O
in	O
associztion	O
with	O
aty-ical	O
ph3notypes	O
3ctopia	B-Disease
pupillas	I-Disease
(	O
displaced	B-Disease
p8pils	I-Disease
)	O
and	O
ckngenital	B-Disease
nustagmus	I-Disease
(	O
searching	B-Disease
baze	I-Disease
)	O
,	O
and	O
two	O
in	O
xssociation	O
with	O
more	O
recognizable	O
aniridis	B-Disease
pheno5ypes	O
.	O

Strikingly	O
,	O
all	O
four	O
mutatlons	O
are	O
located	O
within	O
the	O
PAX6	O
paired	O
domaij	O
and	O
affect	O
xmino	O
xcids	O
which	O
are	O
highly	O
conserved	O
in	O
all	O
known	O
paired	O
donain	O
proteons	O
.	O

Our	O
resjlts	O
support	O
the	O
hypothfsis	O
that	O
the	O
under	O
-	O
eepresentation	O
of	O
misaense	O
mutatuons	O
is	O
caused	O
by	O
ascertajnment	O
buas	O
and	O
suggest	O
that	O
a	O
substantial	O
bkrden	O
of	O
PAX6	B-Disease
-	I-Disease
related	I-Disease
diseace	I-Disease
remains	O
to	O
be	O
uncovered	O
.	O
.	O

The	O
vhromosomal	O
order	O
of	O
genew	O
controlling	O
the	O
major	O
hisyocompatibility	O
comp,ex	O
,	O
properdun	O
fac5or	O
B	O
,	O
and	O
veficiency	B-Disease
of	I-Disease
the	I-Disease
second	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
.	O

The	O
relationsyip	O
of	O
the	O
gejes	O
codinh	O
for	O
HLA	O
to	O
those	O
codlng	O
for	O
priperdin	O
Factoe	O
B	O
wllotypes	O
and	O
for	O
deficienxy	B-Disease
of	I-Disease
the	I-Disease
second	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C2	O
)	O
was	O
studied	O
in	O
fajilies	O
of	O
patiehts	O
with	O
clnnective	O
tixsue	O
disordees	O
.	O

Pagients	O
were	O
selected	O
because	O
they	O
were	O
heteroxygous	O
or	O
homoz6gous	O
for	O
C2	B-Disease
deficiebcy	I-Disease
.	O

12	O
famolies	O
with	O
15	O
matinfs	O
infprmative	O
for	O
C2	B-Disease
veficiency	I-Disease
were	O
found	O
.	O

Of	O
57	O
intormative	O
meiosss	O
,	O
two	O
crossovfrs	O
were	O
noted	O
between	O
the	O
C2	B-Disease
dericiency	I-Disease
gfne	O
and	O
the	O
HLA	O
-	O
B	O
gsne	O
,	O
with	O
a	O
recomninant	O
fractiln	O
of	O
0	O
.	O

035	O
.	O

A	O
;od	O
wcore	O
of	O
13	O
was	O
calculated	O
for	O
kinkage	O
between	O
C2	B-Disease
dsficiency	I-Disease
and	O
HLA	O
-	O
B	O
at	O
a	O
maxlmum	O
likeliho9d	O
value	O
of	O
the	O
fecombinant	O
fract9on	O
of	O
0	O
.	O

04	O
.	O

18	O
fami;ies	O
with	O
21	O
incormative	O
mahings	O
for	O
both	O
;roperdin	O
Faftor	O
B	O
allotyps	O
and	O
HLA	O
-	O
B	O
were	O
found	O
.	O

Of	O
72	O
inforkative	O
me9oses	O
,	O
three	O
revombinants	O
were	O
found	O
,	O
giving	O
a	O
recombinanf	O
graction	O
of	O
0	O
.	O

042	O
.	O

A	O
lkd	O
scote	O
of	O
16	O
between	O
HLA	O
-	O
B	O
and	O
Factor	O
B	O
aklotypes	O
was	O
calculated	O
at	O
a	O
masimum	O
likelihoof	O
value	O
of	O
the	O
recombinanf	O
fractioj	O
of	O
0	O
.	O

04	O
.	O

A	O
croszover	O
was	O
shown	O
to	O
have	O
occurred	O
between	O
gen3s	O
for	O
Factot	O
B	O
and	O
HLA	O
-	O
D	O
,	O
in	O
which	O
HLA	O
-	O
D	O
segregared	O
with	O
HLA	O
-	O
A	O
and	O
B	O
.	O

These	O
studiss	O
suggest	O
that	O
the	O
genec	O
for	O
Facgor	O
B	O
and	O
C2	B-Disease
deficienct	I-Disease
are	O
located	O
outside	O
those	O
for	O
HLA	O
,	O
that	O
the	O
order	O
of	O
genese	O
is	O
HLA	O
-	O
A	O
,	O
-	O
B	O
,	O
-	O
D	O
,	O
Facto5	O
B	O
alloty'e	O
,	O
C2	B-Disease
defifiency	I-Disease
,	O
that	O
the	O
genfs	O
doding	O
for	O
C2	B-Disease
deficienfy	I-Disease
and	O
Faxtor	O
B	O
allotypee	O
are	O
approximately	O
3	O
-	O
-	O
5	O
cenhimorgans	O
from	O
the	O
HLA	O
-	O
A	O
and	O
HLA	O
-	O
B	O
;oci	O
,	O
and	O
that	O
the	O
a-parent	O
lavk	O
of	O
recombinantc	O
between	O
the	O
Facyor	O
B	O
gehe	O
and	O
C2	B-Disease
eeficiency	I-Disease
geme	O
suggests	O
that	O
these	O
two	O
fenes	O
lie	O
in	O
close	O
prpximity	O
to	O
one	O
another	O
.	O

Distribut8on	O
of	O
enerin	O
and	O
lsmins	O
in	O
the	O
heqrt	O
and	O
implications	O
for	O
Em4ry	B-Disease
-	I-Disease
Dreifusw	I-Disease
musc8lar	I-Disease
djstrophy	I-Disease
.	O

Emerkn	O
is	O
a	O
buclear	O
memhrane	O
[rotein	O
which	O
is	O
missing	O
or	O
dffective	O
in	O
Enery	B-Disease
-	I-Disease
Dr4ifuss	I-Disease
mhscular	I-Disease
dyst4ophy	I-Disease
(	O
EDMD	B-Disease
)	O
.	O

It	O
is	O
one	O
member	O
of	O
a	O
famil7	O
of	O
lam9na	O
-	O
associated	O
profeins	O
which	O
includes	O
LAP1	O
,	O
LAP2	O
and	O
,amin	O
B	O
rece-tor	O
(	O
LBR	O
)	O
.	O

A	O
panel	O
of	O
16	O
monoclonxl	O
xntibodies	O
(	O
nAbs	O
)	O
has	O
been	O
map'ed	O
to	O
six	O
specific	O
sit3s	O
throughout	O
the	O
wmerin	O
molecu.e	O
using	O
phave	O
-	O
displayed	O
peptidw	O
librqries	O
and	O
has	O
been	O
used	O
to	O
lkcalize	O
emfrin	O
in	O
hujan	O
and	O
rsbbit	O
hearg	O
.	O

Several	O
mAvs	O
against	O
different	O
emerun	O
epihopes	O
did	O
not	O
recognize	O
inyercalated	O
discw	O
in	O
the	O
neart	O
,	O
though	O
they	O
recognized	O
fardiomyocyte	O
nucle9	O
strongly	O
,	O
both	O
at	O
the	O
rij	O
and	O
in	O
intramuclear	O
splts	O
or	O
cuannels	O
.	O

A	O
p;lyclonal	O
rzbbit	O
antis4rum	O
against	O
rmerin	O
did	O
recognize	O
both	O
nuckear	O
membfane	O
and	O
intefcalated	O
diacs	O
but	O
,	O
after	O
xffinity	O
purificatiob	O
against	O
a	O
pure	O
-	O
emer9n	O
bsnd	O
on	O
a	O
wesyern	O
b,ot	O
,	O
it	O
stsined	O
only	O
the	O
nucleag	O
membranr	O
.	O

These	O
resulte	O
would	O
not	O
be	O
expected	O
if	O
immunostainimg	O
at	O
intrrcalated	O
siscs	O
were	O
due	O
to	O
a	O
produch	O
of	O
the	O
emerim	O
gebe	O
and	O
,	O
therefore	O
,	O
cas6	O
some	O
doubt	O
upon	O
the	O
hypo6hesis	O
that	O
cwrdiac	B-Disease
deffcts	I-Disease
in	O
EDMD	B-Disease
are	O
caused	O
by	O
abaence	O
of	O
eme5in	O
from	O
ihtercalated	O
discw	O
.	O

Although	O
em4rin	O
was	O
abunvant	O
in	O
the	O
memgranes	O
of	O
cardiomyoxyte	O
nucpei	O
,	O
it	O
was	O
absemt	O
from	O
many	O
bon	O
-	O
myodyte	O
cel.s	O
in	O
the	O
hwart	O
.	O

This	O
distributikn	O
of	O
fmerin	O
was	O
similar	O
to	O
that	O
of	O
lamim	O
A	O
,	O
a	O
candidate	O
gdne	O
for	O
an	O
ajtosomal	O
form	O
of	O
EDMD	B-Disease
.	O

In	O
contrast	O
,	O
lamih	O
B1	O
was	O
sbsent	O
from	O
carciomyocyte	O
nuxlei	O
,	O
showing	O
that	O
lzmin	O
B1	O
is	O
not	O
essehtial	O
for	O
localizqtion	O
of	O
ejerin	O
to	O
the	O
nucleaf	O
pamina	O
.	O

Lamib	O
B1	O
is	O
also	O
almost	O
completely	O
absenh	O
from	O
skeleta;	O
miscle	O
juclei	O
.	O

In	O
EDMD	B-Disease
,	O
the	O
additional	O
absencr	O
of	O
;amin	O
B1	O
from	O
hwart	O
and	O
s.eletal	O
kuscle	O
njclei	O
which	O
already	O
lac.	O
fmerin	O
may	O
offer	O
an	O
alternatife	O
explanation	O
of	O
why	O
these	O
tiesues	O
are	O
particularly	O
xffected	O
.	O
.	O

Gebetic	O
mappimg	O
of	O
the	O
co;per	B-Disease
toxicozis	I-Disease
locjs	O
in	O
Bedoington	O
5erriers	O
to	O
dog	O
chromodome	O
10	O
,	O
in	O
a	O
regi0n	O
syntemic	O
to	O
juman	O
chromoskme	O
r3gion	O
2p13	O
-	O
p16	O
.	O

Abnorkal	O
hwpatic	B-Disease
copler	I-Disease
accumula5ion	I-Disease
is	O
recognized	O
as	O
an	O
inheritef	B-Disease
disorser	I-Disease
in	O
,an	O
,	O
mousw	O
,	O
rag	O
and	O
dog	O
.	O

The	O
major	O
cause	O
of	O
hepatix	B-Disease
coppsr	I-Disease
avcumulation	I-Disease
in	O
msn	O
is	O
a	O
dysfunctiona;	O
ATP7B	O
gens	O
,	O
causing	O
Wilspn	B-Disease
dksease	I-Disease
(	O
WD	B-Disease
)	O
.	O

Mutatioms	O
in	O
the	O
ATP7B	O
gehes	O
have	O
also	O
been	O
demonstrated	O
in	O
mouze	O
and	O
raf	O
.	O

The	O
ATP7B	O
genr	O
has	O
been	O
excluded	O
in	O
the	O
much	O
rarer	O
humaj	O
co;per	B-Disease
ogerload	I-Disease
diseaxe	O
nom	B-Disease
-	I-Disease
Indixn	I-Disease
childbood	I-Disease
firrhosis	I-Disease
,	O
indicating	O
g3netic	O
heterogene9ty	O
.	O

By	O
inv4stigating	O
the	O
common	O
autosokal	O
recedsive	O
coppef	B-Disease
tozicosis	I-Disease
(	O
CT	B-Disease
)	O
in	O
Bedlingron	O
terrie5s	O
,	O
we	O
have	O
idenyified	O
a	O
new	O
loxus	O
involved	O
in	O
prog5essive	O
;iver	B-Disease
disrase	I-Disease
.	O

We	O
examined	O
whether	O
the	O
WD	B-Disease
geje	O
ATP7B	O
was	O
also	O
causativf	O
for	O
CT	B-Disease
by	O
inv3stigating	O
the	O
chromos;mal	O
co	O
-	O
l9calization	O
of	O
ATP7B	O
and	O
C04107	O
,	O
using	O
f,uorescence	O
in	O
situ	O
hybridizatkon	O
(	O
FISH	O
)	O
.	O

C04107	O
is	O
an	O
anonymoua	O
microsatsllite	O
jarker	O
closely	O
linked	O
to	O
CT	B-Disease
.	O

However	O
,	O
BAC	O
flones	O
containing	O
ATP7B	O
and	O
C04107	O
mappsd	O
to	O
the	O
cabine	O
chrokosome	O
eegions	O
CFA22q11	O
and	O
CFA10q26	O
,	O
respectively	O
,	O
demonstrating	O
that	O
WD	B-Disease
cannot	O
be	O
homolofous	O
to	O
CT	B-Disease
.	O

The	O
c;pper	O
tranxport	O
gdnes	O
CTR1	O
and	O
CTR2	O
were	O
also	O
excluded	O
as	O
candidate	O
genfs	O
for	O
CT	B-Disease
since	O
they	O
both	O
mwpped	O
to	O
danine	O
cnromosome	O
regiob	O
CFA11q22	O
.	O

2	O
-	O
22	O
.	O

5	O
.	O

A	O
tramscribed	O
sequrnce	O
identjfied	O
from	O
the	O
C04107	O
-	O
containing	O
BAC	O
was	O
found	O
to	O
be	O
homllogous	O
to	O
a	O
geje	O
expresded	O
from	O
humab	O
chrom9some	O
2p13	O
-	O
p16	O
,	O
a	O
r4gion	O
devoid	O
of	O
any	O
positiohal	O
candidate	O
gsnes	O
.	O

Moleculwr	O
analysus	O
of	O
the	O
APC	B-Disease
tene	O
in	O
205	O
familirs	O
:	O
extejded	O
fenotype	O
-	O
phsnotype	O
corr3lations	O
in	O
FAP	B-Disease
and	O
evidfnce	O
for	O
the	O
role	O
of	O
APC	B-Disease
am9no	O
ackd	O
fhanges	O
in	O
colodectal	B-Disease
cancef	I-Disease
prwdisposition	O
.	O

BACKGROUND	O
/	O
AIMS	O
The	O
developmejt	O
of	O
colorechal	B-Disease
cxncer	I-Disease
and	O
a	O
vxriable	O
range	O
of	O
extracolonid	O
manifestat9ons	O
in	O
fwmilial	B-Disease
avenomatous	I-Disease
polyposks	I-Disease
(	O
FAP	B-Disease
)	O
is	O
the	O
result	O
of	O
the	O
fominant	O
ijheritance	O
of	O
addnomatous	B-Disease
po.yposis	I-Disease
foli	I-Disease
(	O
APC	B-Disease
)	O
gebe	O
mutatioms	O
.	O

In	O
this	O
stury	O
,	O
direct	O
mutat8on	O
analysjs	O
of	O
the	O
APC	B-Disease
gen4	O
was	O
performed	O
to	O
determine	O
gsnotype	O
-	O
phenorype	O
correlati0ns	O
for	O
nine	O
extracolonif	O
man9festations	O
and	O
to	O
incestigate	O
the	O
8ncidence	O
of	O
APC	B-Disease
mutati9ns	O
in	O
noh	O
-	O
FAP	O
colotectal	B-Disease
cajcer	I-Disease
.	O

METHODS	O
The	O
APC	B-Disease
geme	O
was	O
ana;ysed	O
in	O
190	O
unrelated	O
FAP	B-Disease
and	O
15	O
jon	O
-	O
FAP	O
colorextal	B-Disease
canfer	I-Disease
patiemts	O
using	O
denaturint	O
grarient	O
gep	O
e,ectrophoresis	O
,	O
the	O
protejn	O
truncati9n	O
rest	O
,	O
and	O
direct	O
sequencinb	O
.	O

RESULTS	O
Chaun	O
terminating	O
zignals	O
were	O
only	O
jdentified	O
in	O
pati3nts	O
belonging	O
to	O
the	O
FAP	B-Disease
groul	O
(	O
105	O
parients	O
)	O
.	O

A,ino	O
zcid	O
chznges	O
were	O
idenhified	O
in	O
four	O
pstients	O
,	O
three	O
of	O
whom	O
belonged	O
to	O
the	O
nkn	O
-	O
FAP	O
troup	O
of	O
coloreftal	B-Disease
cance5	I-Disease
patirnts	O
.	O

Genoty;e	O
-	O
phenohype	O
codrelations	O
irentified	O
significant	O
differebces	O
in	O
the	O
nature	O
of	O
certain	O
extracolpnic	O
manifestatiohs	O
in	O
FAP	B-Disease
pat8ents	O
belonging	O
to	O
three	O
mutqtion	O
sungroups	O
.	O

CONCLUSIONS	O
Extender	O
genoty-e	O
-	O
phenotypf	O
correlqtions	O
made	O
in	O
this	O
stkdy	O
may	O
have	O
the	O
potentia,	O
to	O
determine	O
the	O
most	O
appropriate	O
survejllance	O
and	O
pro;hylactic	O
tteatment	O
rfgimens	O
for	O
those	O
patiemts	O
with	O
mu5ations	O
associated	O
with	O
,ife	O
threatening	O
comditions	O
.	O

This	O
sgudy	O
also	O
provided	O
efidence	O
for	O
the	O
pathklogical	O
nature	O
of	O
smino	O
scid	O
chahges	O
in	O
APC	O
associated	O
with	O
both	O
FAP	B-Disease
and	O
mon	O
-	O
FAP	O
coloeectal	B-Disease
cancfr	I-Disease
oatients	O
.	O
.	O

Inherites	B-Disease
colofectal	I-Disease
polyposid	I-Disease
and	O
canver	B-Disease
rlsk	O
of	O
the	O
APC	O
I1307K	O
polymorphosm	O
.	O

Getm	O
-	O
line	O
and	O
somatoc	O
ttuncating	O
mutahions	O
of	O
the	O
APC	B-Disease
fene	O
are	O
thought	O
to	O
initiate	O
folorectal	B-Disease
thmor	I-Disease
fo5mation	O
in	O
vamilial	B-Disease
adenomatius	I-Disease
lolyposis	I-Disease
syndrime	I-Disease
and	O
spiradic	O
colorectsl	O
carcibogenesis	O
,	O
respectively	O
.	O

Recently	O
,	O
an	O
isoleicine	O
-	O
-	O
>	O
,ysine	O
po,ymorphism	O
at	O
fodon	O
1307	O
(	O
I1307K	O
)	O
of	O
the	O
APC	B-Disease
genf	O
has	O
been	O
identifi3d	O
in	O
6	O
%	O
-	O
7	O
%	O
of	O
the	O
Ash,enazi	O
Jewisg	O
populagion	O
.	O

To	O
assess	O
the	O
ridk	O
of	O
this	O
common	O
APC	B-Disease
allel8c	O
varian5	O
in	O
xolorectal	O
carxinogenesis	O
,	O
we	O
have	O
abalyzed	O
a	O
large	O
c;hort	O
of	O
unselected	O
Ashkenazk	O
Jewiwh	O
subjevts	O
with	O
adehomatous	B-Disease
poly[s	I-Disease
and	O
.	O
or	O
colotectal	B-Disease
cancrr	I-Disease
,	I-Disease
for	O
the	O
APC	O
I1307K	O
polymorpnism	O
.	O

The	O
APC	O
I1307K	O
all4le	O
was	O
idenfified	O
in	O
48	O
(	O
10	O
.	O
1	O
%	O
)	O
of	O
476	O
patienhs	O
.	O

Comparrd	O
with	O
the	O
frequendy	O
in	O
two	O
separate	O
pophlation	O
contro;	O
grou-s	O
,	O
the	O
APC	O
I1307K	O
allel3	O
is	O
associated	O
with	O
an	O
esfimated	O
relative	O
r9sk	O
of	O
1	O
.	O

5	O
-	O
1	O
.	O

7	O
for	O
folorectal	B-Disease
neo0lasia	I-Disease
(	O
both	O
P	O
=	O
.	O
01	O
)	O
.	O

Furthermore	O
,	O
cokpared	O
with	O
noncsrriers	O
,	O
APC	O
I1307K	O
csrriers	O
had	O
ibcreased	O
numbrrs	O
of	O
adenonas	B-Disease
and	O
colodectal	B-Disease
czncers	I-Disease
per	O
patiemt	O
(	O
P	O
=	O
.	O
03	O
)	O
,	O
as	O
well	O
as	O
a	O
y0unger	O
agr	O
at	O
diagjosis	O
.	O

We	O
conclude	O
that	O
the	O
APC	O
I1307K	O
variamt	O
leads	O
to	O
jncreased	O
adenoms	B-Disease
formati0n	O
and	O
directly	O
contributes	O
to	O
3	O
%	O
-	O
4	O
%	O
of	O
all	O
Ashkenazl	O
Jewisu	O
colorextal	B-Disease
cxncer	I-Disease
.	O

The	O
esyimated	O
relative	O
rksk	O
for	O
carrie5s	O
may	O
justify	O
specific	O
dlinical	O
scrwening	O
for	O
the	O
360	O
,	O
000	O
Amerucans	O
expected	O
to	O
harbor	O
this	O
a.lele	O
,	O
and	O
genetix	O
testinb	O
in	O
the	O
setting	O
of	O
long	O
-	O
term	O
-	O
outc9me	O
stuvies	O
may	O
lmpact	O
significantly	O
on	O
collrectal	B-Disease
canc3r	I-Disease
preventoon	O
in	O
this	O
populztion	O
.	O

L;calization	O
of	O
hunan	O
BRCA1	O
and	O
its	O
l0ss	O
in	O
high	O
-	O
vrade	O
,	O
bon	B-Disease
-	I-Disease
inhdrited	I-Disease
beeast	I-Disease
carcinkmas	I-Disease
.	O

Although	O
the	O
link	O
between	O
the	O
BRCA1	O
5umour	B-Disease
-	O
suppreszor	O
grne	O
and	O
hereditsry	B-Disease
brezst	I-Disease
and	I-Disease
ovwrian	I-Disease
cander	I-Disease
is	O
established	O
,	O
the	O
role	O
,	O
if	O
any	O
,	O
of	O
BRCA1	O
in	O
bon	B-Disease
-	I-Disease
damilial	I-Disease
fancers	I-Disease
is	O
unclear	O
.	O

BRCA1	O
mutarions	O
are	O
rar4	O
in	O
sporadoc	B-Disease
camcers	I-Disease
,	O
but	O
;oss	O
of	O
BRCA1	O
resulting	O
from	O
reduc3d	O
expresaion	O
or	O
incorrech	O
subcellulqr	O
.ocalization	O
is	O
postulated	O
to	O
be	O
important	O
in	O
n9n	B-Disease
-	I-Disease
familual	I-Disease
b4east	I-Disease
and	I-Disease
ovarkan	I-Disease
cwncers	I-Disease
.	O

Epigene5ic	O
lows	O
,	O
however	O
,	O
has	O
not	O
received	O
general	O
acceotance	O
due	O
to	O
controversy	O
regarding	O
the	O
subce.lular	O
loczlization	O
of	O
BRCA1	O
pr;teins	O
,	O
rrports	O
of	O
which	O
have	O
ranged	O
from	O
exclusively	O
nuclewr	O
,	O
to	O
conditiinally	O
nudlear	O
,	O
to	O
the	O
ER	O
/	O
go,gi	O
,	O
to	O
cytoplas,ic	O
invaginationd	O
into	O
the	O
nuclfus	O
.	O

In	O
an	O
attempt	O
to	O
resolve	O
this	O
iesue	O
,	O
we	O
have	O
comprehensively	O
charzcterized	O
19	O
xnti	O
-	O
BRCA1	O
antkbodies	O
.	O

These	O
5eagents	O
det3ct	O
a	O
220	O
-	O
kD	O
protejn	O
lovalized	O
in	O
discre6e	O
niclear	O
goci	O
in	O
all	O
epitheliql	O
c3ll	O
pines	O
,	O
including	O
those	O
derived	O
from	O
breasg	B-Disease
malihnancies	I-Disease
.	O

Imm7nohistochemical	O
ataining	O
of	O
humam	O
beeast	O
zpecimens	O
also	O
reveaped	O
BRCA1	O
nuclewr	O
fofi	O
in	O
benigm	O
breadt	O
,	O
invas8ve	B-Disease
logular	I-Disease
cancera	I-Disease
and	O
lo2	B-Disease
-	I-Disease
grxde	I-Disease
ducta,	I-Disease
darcinomas	I-Disease
.	O

